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Abstract 
  Mastitis, the inflammation of the mammary gland, dramatically decreases dairy 
industry revenues and milk quality, making improved control and prevention methods a 
goal of the industry.  Prior research has observed variation in response to experimental 
challenge with regards to inflammation indicators, S. uberis concentrations, and the 
need for antibiotics.  To determine possible causes of the observed variation following 
experimental S. uberis intramammary challenge, we performed genome association 
analyses (N = 34 – 36 Holstein dairy cows), a linkage analysis, and S. uberis milk 
inoculation (N = 21 Holstein dairy cows) trials.  Association analyses were done using 
Illumina’s BovineSNP50 BeadChip and 10 novel phenotypes developed using S. uberis 
challenge data.  A total of 52 SNPs were significantly associated (p < 9.34x 10-5) with 
our novel phenotypes, with 17 SNPs in regions with prior evidence for mastitis or 
mastitis associated traits.  Linkage analyses were performed using Haploview on BTA 2 
to identify loci in linkage disequilibrium with the IL-8 receptor, CXCR1, which has 
demonstrated importance for neutrophil function critical for mastitis clearance.  We 
determined that CXCR1 is part of two separate haplotype blocks, one that is 13 kb and 
the other is 440 kb.  Between association and linkage analyses, 44 potential candidate 
genes were identified, where the majority have functions related to inflammation/ 
immunity or gene expression regulation.  S. uberis milk inoculation trials were 
conducted in aseptic milk collected within 7 days post-calving from clinically healthy 
cows with differing CXCR1 haplotype combinations.  Milk samples were inoculated with 
three strains of S. uberis (UT366, UT387, and UT888) in vitro and growth was 
monitored for 10 hours.  Both S. uberis strain and CXCR1 haplotype combination 
significantly influenced the rate of S. uberis growth in milk (p < 0.0001) suggesting an 
inhibitory or permissive factor towards S. uberis growth may exist with concentration 
varying dependent on CXCR haplotype concentration.  Further investigation of the 
identified candidate genes and proteomics analysis of milk factors could identify more 
efficient or better genetic selection methods or novel preventative/treatment compounds 
to combat S. uberis mastitis. 
  
v 
 
Table of Contents 
Chapter I: Introduction ..................................................................................................... 1 
References ................................................................................................................... 5 
Chapter II: Literature Review ........................................................................................... 9 
Mastitis ....................................................................................................................... 10 
Genetic Selection ....................................................................................................... 11 
Heritability .................................................................................................................. 13 
Epistasis..................................................................................................................... 16 
Genome Wide Association Studies (GWAS).............................................................. 17 
Loci Associated with Mastitis Phenotypes .............................................................. 18 
Candidate Genes Identified by Loci Associated with Mastitis Phenotypes ............. 22 
References ................................................................................................................. 26 
Chapter III: Genome wide association study identifies loci associated with somatic cell 
count phenotypes following experimental challenge with Streptococcus uberis ............ 33 
Abstract ...................................................................................................................... 34 
Introduction ................................................................................................................ 34 
Materials and Methods ............................................................................................... 36 
Animal Selection ..................................................................................................... 36 
Challenge ............................................................................................................... 37 
Sampling and Phenotype Description ..................................................................... 37 
SNP Chip Analysis .................................................................................................. 38 
Results ....................................................................................................................... 38 
Discussion.................................................................................................................. 41 
Acknowledgements .................................................................................................... 50 
References ................................................................................................................. 51 
Chapter IV: Genome wide association study identifies loci associated with novel 
phenotypes following experimental challenge with Streptococcus uberis ..................... 55 
Abstract ...................................................................................................................... 56 
Introduction ................................................................................................................ 57 
Materials and Methods ............................................................................................... 58 
vi 
 
Animal Selection ..................................................................................................... 58 
Challenge ............................................................................................................... 58 
Sampling and Phenotype Description ..................................................................... 59 
Association Analysis ............................................................................................... 60 
Results ....................................................................................................................... 61 
Discussion.................................................................................................................. 70 
Acknowledgements .................................................................................................... 79 
References ................................................................................................................. 80 
Chapter V: Investigation of Bos taurus CXCR1 gene identifies loci with potential mastitis 
implications using GWAS and linkage analyses ............................................................ 85 
Abstract ...................................................................................................................... 86 
Introduction ................................................................................................................ 86 
Materials and Methods ............................................................................................... 88 
Animal Selection ..................................................................................................... 88 
Haplotyping ............................................................................................................. 89 
Challenge ............................................................................................................... 89 
Sampling and Phenotype Description ..................................................................... 90 
Association and Linkage Analysis ........................................................................... 90 
Results ....................................................................................................................... 91 
Discussion.................................................................................................................. 96 
Candidate Loci in LD with CXCR1: ......................................................................... 96 
Candidate Loci Associated with Antibiotic Therapy Groupings: ............................ 103 
References ............................................................................................................... 105 
Chapter VI: Determining growth potential of Streptococcus uberis in aseptic milk 
samples obtained from cows with differing CXCR1 genetic backgrounds ................... 108 
Abstract .................................................................................................................... 109 
Introduction .............................................................................................................. 110 
Materials and Methods ............................................................................................. 111 
Haplotyping ........................................................................................................... 111 
Milk Sampling and Collection ................................................................................ 112 
vii 
 
Evaluation of Leukocytes in Milk ........................................................................... 112 
S. uberis Cultures ................................................................................................. 113 
Inoculating Milk with S. uberis............................................................................... 113 
Statistical Analysis ................................................................................................ 114 
Results ..................................................................................................................... 114 
Discussion................................................................................................................ 118 
Acknowledgements .................................................................................................. 124 
References ............................................................................................................... 125 
Chapter VII: Conclusion .............................................................................................. 129 
References ............................................................................................................... 133 
Appendix ..................................................................................................................... 135 
Vita .............................................................................................................................. 140 
 
 
 
  
viii 
 
List of Tables 
Table 1: Identified loci associated with developed novel SCC phenotypes. ................. 39 
Table 2: Identified loci associated with developed novel phenotypes. .......................... 62 
Table 3: SNPs identified to be in linkage disequilibrium with CXCR1 SNPs using 
Haploview based on BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) 
positions. ............................................................................................................ 92 
Table 4: Genes and RNAs contained within the haplotype blocks surrounding 
CXCR1 SNPs based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) 
genome build. ..................................................................................................... 95 
Table 5: Frequency of haplotype combinations observed in our sample population 
and their corresponding antibiotic therapy groupings. ........................................ 97 
Table 6: Identified loci associated with the CXCR1 antibiotic therapy phenotype. ........ 98 
Table 7: Frequency of haplotype combinations observed in cows whose milk was 
inoculated with the 3 strains of S. uberis. ......................................................... 115 
Table A- 1: Comprehensive list of SNPs identified using novel phenotypes with 
distance to neighboring SNPs and genotype frequencies indicated.  Final 
column indicates status of the SNP following SNP pruning based on minor 
allele frequencies ............................................................................................... 136 
 
 
  
ix 
 
List of Figures 
Figure 1: Number of cows per SCC cure phenotype category.  Ranges of days 
represent the time range individual cow’s SCC returned to below 200,000 
cells/mL, which is industry standard for healthy.................................................. 42 
Figure 2: Manhattan plot of GWAS for SCC cure phenotype using BovineSNP50 v2 
BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34).  The x-axis shows 
chromosome and SNP order within a chromosome.  The y-axis show the –log(p-
value) for each SNP.  P-value thresholds are indicated by dashed lines: top black 
line p = 1.95x10-5; bottom gray line p = 9.34x10-5. .............................................. 43 
Figure 3: Minimum, median, and maximum SCC AUC values for both 7 and 28 d 
phenotypes displayed in millions of (cells/mL)*d. ............................................... 44 
Figure 4: Manhattan plot of GWAS for SCC 7 day AUC phenotype using BovineSNP50 
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36).  The x-axis shows 
chromosome and SNP order within a chromosome.  The y-axis show the –log(p-
value) for each SNP.  P-value thresholds are indicated by dashed lines: top black 
line p = 1.95x10-5; bottom gray line p = 9.34x10-5. .............................................. 45 
Figure 5: Manhattan plot of GWAS for SCC 28 day AUC phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35).  The 
x-axis shows chromosome and SNP order within a chromosome.  The y-axis 
show the –log(p-value) for each SNP.  P-value thresholds are indicated by 
dashed lines: top black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. ........ 46 
Figure 6: Minimum, median, and maximum for S. uberis 1st clearance, severity score, 
and chronic score phenotypes.  S. uberis 1st clearance is represented by the 
number of days until S. uberis CFU reached zero based on milk culturing.  
Severity and chronic scores are represented by the sum of milk and mammary 
scores over the initial 7 d post-challenge or the entire 28 d challenge period, 
respectively.  Minimums for both severity and chronic score were zero. ............ 64 
Figure 7: Manhattan plot of GWAS for S. uberis 1st clearance phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34).  The 
x-axis shows chromosome and SNP order within a chromosome.  The y-axis 
show the –log10(P-value) for each SNP.  P-value thresholds are indicated by 
dashed lines: top black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. ........ 65 
Figure 8: Number of cows per S. uberis shedding cycle category, where the x-axis 
indicates the number of times S. uberis CFU reached zero within the 28 day 
sampling period. ................................................................................................. 66 
Figure 9: Manhattan plot of GWAS for S. uberis shedding cycles phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34).  The 
x-axis shows chromosome and SNP order within a chromosome.  The y-axis 
x 
 
show the –log10(P-value) for each SNP.  P-value thresholds are indicated by 
dashed lines: top black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. ........ 67 
Figure 10: Minimum, median, and maximum S. uberis CFU AUC values for both 7 and 
28 d phenotypes displayed in millions of CFU*d................................................. 68 
Figure 11: Manhattan plot of GWAS for 7 d S. uberis CFU AUC phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36).  The 
x-axis shows chromosome and SNP order within a chromosome.  The y-axis 
show the –log10(P-value) for each SNP.  P-value thresholds are indicated by 
dashed lines: top black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. ........ 69 
Figure 12: Manhattan plot of GWAS for 28 d S. uberis CFU AUC phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35).  The 
x-axis shows chromosome and SNP order within a chromosome.  The y-axis 
show the –log10(P-value) for each SNP.  P-value thresholds are indicated by 
dashed lines: top black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. ........ 71 
Figure 13: Manhattan plot of GWAS for severity score phenotype using BovineSNP50 
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36).  The x-axis shows 
chromosome and SNP order within a chromosome.  The y-axis show the –
log10(P-value) for each SNP.  P-value thresholds are indicated by dashed lines: 
top black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. .............................. 72 
Figure 14: Manhattan plot of GWAS for chronic score phenotype using BovineSNP50 
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34).  The x-axis shows 
chromosome and SNP order within a chromosome.  The y-axis show the –
log10(P-value) for each SNP.  P-value thresholds are indicated by dashed lines: 
top black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. .............................. 73 
Figure 15: Linkage analysis identifying SNPs on BTA 2 in linkage disequilibrium with 
CXCR1 SNPs using BovineSNP50 v2 BeadChip (Illumina, San Diego, CA).  
Blocks are outlined in thick black lines.  Colors indicate likelihood of linkage 
disequilibrium (LD) as calculated by logarithm of odds (LOD; log10(likelihood of 
LD/likelihood of equilibrium where higher values indicate more likely LD) and D’ 
(disequilibrium coefficient normalized for the observed allele frequencies; values 
closer to 1 or 100% indicate higher LD; numbers in squares).  Red squares = 
LOD ≥ 2, D’ = 1.  Shades of pink = LOD ≥ 2, D’ < 1.  Blue = LOD < 2, D’ = 1.  
White = LOD < 2, D’ < 1; strong evidence of recombination. .............................. 93 
Figure 16: Spatial diagram SNPs identified to be in linkage disequilibrium with CXCR1 
SNPs using Haploview based on BovineSNP50 v2 BeadChip (Illumina, San 
Diego, CA) positions. .......................................................................................... 94 
Figure 17: Number of cows per antibiotic therapy phenotype grouping........................ 99 
Figure 18: Manhattan plot of GWAS for antibiotic therapy phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35).  The 
xi 
 
x-axis shows chromosome and SNP order within a chromosome.  The y-axis 
show the –log10(P-value) for each SNP.  P-value thresholds are indicated by 
dashed lines: top black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. ...... 100 
Figure 19: Growth of three strains of S. uberis, represented as back transformed least 
squares means from log10, in aseptic whole milk obtained from Holstein cows 
within 7 days post-calving.  Letters above the bars indicated means that differ (p 
< 0.0001). ......................................................................................................... 116 
Figure 20: The effect of S. uberis strain on growth over time in aseptic whole milk 
obtained from Holstein cows within 7 days post-calving.  All slopes differed from 
each other significantly over time (p < 0.0001). ................................................ 117 
Figure 21: The effect of haplotype combination on S. uberis growth over time in aseptic 
whole milk obtained from Holstein cows within 7 days post-calving.  All slopes 
differed from each other significantly over time (p < 0.0001). ........................... 119 
Figure 22: Total leukocyte counts observed for each haplotype combination based on 
QScout analysis performed on aseptic whole milk obtained from Holstein cows 
within 7 days post-calving.  Haplotype combination did not influence total 
leukocyte counts p = 6424. ............................................................................... 120 
Figure 23: Percentages of leukocyte sub-populations observed for each haplotype 
combination based on QScout analysis performed on aseptic whole milk 
obtained from Holstein cows within 7 days post-calving.  Haplotype combination 
did not influence the percentages of neutrophils (p = 0.1509), lymphocytes (p = 
0.7863), or macrophages (p = 0.4903) observed. ............................................ 121 
 
 
 
 
  
xii 
 
Abbreviations and Symbols 
AUC Area under the curve 
BTA Bos taurus autosome 
CFU Colony forming units 
CM Clinical mastitis 
DIM Days in milk 
GWAS Genome wide association study (ies) 
IL Interleukin 
LD Linkage disequilibrium 
MY Milk yield 
PL Productive life 
PTA Predicted transmitting ability 
QTL Quantitative trait loci 
SCC Somatic cell count 
SCS Somatic cell score 
SNP Single nucleotide polymorphism 
STA Standard transmitting ability 
 
 
 
1 
 
 
 
 
 
 
 
 
 
 
Chapter I: Introduction 
  
2 
 
 Mastitis, the inflammation of the mammary gland, is one of the most devastating 
diseases in the dairy industry.  Data shows mastitis can affect 20-50% of any herd 
causing an increase in cow morbidity and mortality (Wilson et al. 1997).  Additionally, 
mastitis costs the dairy industry upwards of $2 billion annually (NMC 2005) in the form 
of lost profits, treatment costs, decreased milk yield, and additional labor costs (Akers 
and Nickerson 2011; Fetrow 2000).  Furthermore, mastitis greatly impacts milk quality, 
which is observed by a decreased ability to make cheese, decreased shelf life of dairy 
products, and decreased palatability of dairy products by consumers (Barbano et al. 
1991; Klei et al. 1998; Ma et al. 2000).   
 Mastitis frequently results from pathogenic bacteria invading the mammary gland.  
Once bacteria invade the mammary gland, epithelial cells and resident macrophages 
release cytokines which recruit polymorphonuclear neutrophils (PMN) and other 
leukocytes to the site of infection (Paape et al. 2003).  The recruitment of cytokines 
results in a large influx of leukocytes into the milk, where leukocytes are commonly 
referred to as somatic cells.  Somatic cell counts (SCC), represented as cells/mL, are 
routinely monitored by the majority of dairy producers and are used as an indicator for 
the level of intramammary infection or mastitis.  There are some resident leukocyte 
populations in the mammary gland and/or milk (i.e.: macrophages) meaning even when 
pathogenic bacteria are not present in the gland, SCC is greater than zero.  Industry 
standard considers a SCC below 200,000 cells/mL a healthy gland and SCC above 
200,000 cells/mL to indicate either subclinical or clinical mastitis (Dohoo et al. 2011; 
Schepers et al. 1997; Schukken et al. 2003).  Subclinical mastitis is indicated by only an 
increase in SCC.  Clinical mastitis presents with the hallmarks of inflammation including 
redness, swelling, heat, and pain to the touch, accompanied by a reduction in milk 
production (NMC 1999).  Clinical mastitis also alters milk resulting in flakes, clots, 
and/or strings composed of bacteria, immune cells, and immune related proteins to be 
present.  In severe clinical cases, milk can become yellow, watery, or even bloody.   
 Mastitis pathogens can be contagious or environmental in nature.  Common 
control practices utilized on most US dairy farms, have been successful in controlling 
most contagious pathogens, however, environmental pathogens are still an issue 
especially in regions with high temperatures/humidity.  One common environmental 
pathogen is Streptococcus uberis.  S. uberis is responsible for a high proportion of both 
clinical and subclinical mastitis in addition to being commonly isolated during the dry 
(non-lactating period) (Bradley et al. 2007; Petrovski et al. 2011; Riekerink et al. 2008; 
Verbeke et al. 2014).  S. uberis has some unique pathology characteristics that can 
make clearing the infection from the mammary gland more problematic.  Once S. uberis 
enters the mammary gland, it binds lactoferrin, which is a common milk protein (Fang 
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and Oliver 1999).  Lactoferrin can then act as a bridging molecule and allow binding of 
S. uberis to the mammary epithelial cells (Fang et al. 2000).  After binding, S. uberis 
then invades the host cells via caveolae dependent endocytosis (Almeida and Oliver 
2006; Matthews et al. 1994).  Once internalized, S. uberis can exploit host cell 
transduction and persist in the cytoplasm for hours (Almeida et al. 2000; Tamilselvam et 
al. 2006) effectively evading the host immune system.  Additionally, S. uberis is 
especially problematic because, while it typically originates as an environmental 
pathogen, it can spread throughout the herd in a contagious manner once introduced 
(Zadoks 2007).  Due to the prevalence and impact of S. uberis mastitis, increased 
preventative and control methods are a long standing goal of the industry.   
 One way the industry has attempted to control mastitis incidence is through 
genetic selection.  Traditional genetic selection strategies have focused on selecting 
sires whose daughters have decreased SCC or more desirable udder traits that help 
prevent bacteria entering into the mammary gland (i.e.: tight teat end sphincters) (Rupp 
and Boichard 2003; Seykora and McDaniel 1986).  However, these have had limited 
success.  More recent selection strategies utilizing these same phenotypes have 
focused on increasing sample sizes and marker density in order to improve 
identification of loci of interest (Meredith et al. 2013; Meredith et al. 2012; Schnabel et 
al. 2005).  Additionally, genome wide association studies (GWAS) have branched into 
using clinical mastitis (CM) incidence as a phenotype for selection (Lund et al. 2008; 
Sahana et al. 2014; Tiezzi et al. 2015). Unfortunately, success has still been limited 
primarily by low heritabilities and further complicated by the 100+ different pathogens 
that can cause mastitis, each with its own unique pathology.  Thus, the use of pathogen 
specific phenotypes could be advantageous for the identification of loci that could serve 
to select against particular causative pathogens, but few such studies have been 
conducted (Sørensen et al. 2008). 
A recent experimental intramammary S. uberis challenge demonstrated that cow 
responses with respect to inflammation indicators, S. uberis CFU, and necessity of 
antibiotics differed (Siebert 2013).  Such varying responses could be used as novel 
phenotypes specific to S. uberis mastitis.  We hypothesize that using pathogen specific 
phenotypes will identify regions of the bovine genome and candidate genes associated 
with S. uberis mastitis.  Furthermore, the CXCR1 genetic background of the cow 
significantly influenced these observed responses (Siebert 2013).  CXCR1 is the 
membrane bound receptor for the immune mediator IL-8.  Prior studies have 
demonstrated that CXCR1 is critical for proper neutrophil functions which are critical for 
mastitis clearance (Rambeaud et al. 2006; Rambeaud and Pighetti 2007; Rambeaud 
and Pighetti 2005).  However, other genes could be in linkage disequilibrium (LD) with 
4 
 
CXCR1 and be attributing the varying responses observed.   To address our 
hypothesis, we propose the following three objectives: 
Objective 1: Identify loci and candidate genes associated with S. uberis mastitis using 
novel phenotypes developed from S. uberis challenge data. 
We hypothesize loci linked to the immune response and S. uberis pathology (i.e.: 
inflammatory cytokines, lactoferrin) will be associated with the novel S. uberis 
phenotypes. 
Objective 2: Determine the haplotype block surrounding CXCR1. 
We hypothesize other genes within the CXCR1 haplotype block may be contributing 
to the variation in response to S. uberis challenge observed because they are in LD 
with CXCR1. 
Objective 3: Determine if CXCR1 genetic background influences the ability of S. uberis 
to grow in aseptic whole milk in vitro. 
We hypothesize CXCR1 genetic background will influence the concentration of 
factors (i.e.: cellular components, antimicrobial factors, plasminogen, etc.) in milk 
that could be inhibitory or permissive to S. uberis growth.  
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Mastitis 
 Mastitis, or mammary gland inflammation, is an ongoing issue for the dairy 
industry which results in billions in lost revenues annually (NMC 2005).  Losses include 
discarded milk from infected cows, decreased milk production from infected cows, 
antibiotic treatments, increased labor for treatment of mastitis cows, and replacement of 
culled cows (Akers and Nickerson 2011; Fetrow 2000; Jones et al. 1994).  Additionally, 
mastitis decreases milk quality, where increased mastitis instance decreases the 
palatability of dairy products, decreases the shelf life of products, and decreases the 
ability to make cheese (Barbano et al. 1991; Klei et al. 1998; Ma et al. 2000).  Mastitis is 
the defined as the inflammation of the mammary gland, which is often caused by 
bacteria invading the gland through the teat end.  Once inside the gland, bacteria 
encounter host epithelial cells and macrophages which release cytokines that recruit 
neutrophils and other leukocytes to the site of infection (Paape et al. 2002a; Paape et 
al. 2003; Paape et al. 2002b).  This recruitment of leukocytes results in a large influx of 
immune cells into the milk, where they are commonly referred to as somatic cells.  
Somatic cell counts (SCC) or somatic cell scores (SCS; the log10 of SCC) are routinely 
monitored by dairy producers and processors, and are used as an indicator of mastitis.  
There are some resident somatic cells in the mammary gland and/or milk (i.e.: 
macrophages) meaning even when pathogenic bacteria are not present in the gland, 
SCC is greater than zero.  Industry standard considers a SCC below 200,000 cells/mL a 
healthy gland and SCC above 200,000 cells/mL to indicate mastitis (Dohoo et al. 2011; 
Schepers et al. 1997; Schukken et al. 2003).  Mastitis can be clinical or subclinical, 
where both are hallmarked by an increase in SCC above 200,000 cells/mL, but clinical 
mastitis is also indicated by inflammation and altered milk production, as well as 
reduced milk production (NMC 1999).  
 Several factors can influence the probability of a cow getting mastitis including 
age, parity, stage of lactation, genetics, breed, herd management, climate, and 
causative pathogen.  Mastitis incidence increases with parity, or the more offspring a 
cows has the more likely it is she will contract mastitis (Ruegg 2003).  Stage of lactation 
also influences mastitis risk, with dry (non-lactating) cows that are not being regularly 
handled/milked and cows in early lactation are more susceptible to developing mastitis 
than cows in late lactation (Oliver and Mitchell 1983).  Climate can also influence 
mastitis incidence, specifically warm and moist climates favor the growth of most 
pathogens, which increases their overall numbers in the cow’s environment and 
increases the probability that the pathogen comes into contact with the cow and causes 
mastitis (Hogan and Smith 1987).  The influence of these various factors on mastitis 
incidence lead to a high degree of variation observed in mastitis incidence across herds 
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and breeds of dairy cattle, where most herds demonstrate a mastitis incidence of  20-
50% (Wilson et al. 1997). 
 Mastitis causative pathogens can be environmental or contagious in nature.  
Contagious pathogens are transferred from cow to cow.  Spread of contagious 
pathogens is often facilitated by the milking process where bacteria present on one cow 
can be passed on to the next cow via milker’s hands or the milking claw (Hogan and 
Smith 1987).  Environmental pathogens are those present in the general environment of 
the cow (i.e.: soils) and gain entrance to gland via proximity (Hogan and Smith 1987; 
Hogan et al. 1989; Smith and Hogan 1993).  Common mastitis control and prevention 
strategies (i.e.: pre-dips, post-dips, etc.) used on most US dairies have been successful 
in controlling most contagious pathogens, but environmental pathogens remain an 
issue, particularly in areas with warm and moist climates.  Streptococcus uberis is a 
common mastitis pathogen that is responsible for a high proportion of both clinical and 
subclinical mastitis and is commonly isolated from the dry (non-lactating) period 
(Bradley et al. 2007; Jayarao et al. 1999; Oliver 1988; Petrovski et al. 2011; Phuektes et 
al. 2001; Riekerink et al. 2008; Verbeke et al. 2014).  Furthermore, while S. uberis 
originates as an environmental pathogen, it can spread through a herd in a contagious 
manner (Zadoks 2007).  Thus, control and prevention of mastitis, particularly, S. uberis 
mastitis, is a long standing goal of the dairy industry.   
Genetic Selection 
 One method employed to help control and prevent mastitis is genetic selection.  
The idea of using genetics in animal breeding to improve the overall health of any given 
population by reducing diseases and improving animal performance (i.e.: increasing 
milk yield) has been around for decades (Soller and Beckmann 1983).  Genetic 
selection is the process that makes certain desirable traits more prevalent than other 
less-desirable traits within a given population by carefully breeding individuals with the 
desired traits to make the next generation.  Genetic selection is facilitated by the use of 
PTAs (predicted transmitting abilities) or STAs (standard transmitting abilities), are 
estimates of the genetic superiority or inferiority that a cow or bull will transmit to their 
offspring for given traits (The Holstein Foundation 2015).   
 PTAs are available for a variety of traits including: milk yield, fat percentage, type 
traits (i.e.: traits specific to the breed), udder characteristics, somatic cell score (SCS), 
and others, and are often used to rank bulls by their genetic merit.  PTAs are calculated 
using best linear unbiased predictions (BLUP), which take into account not only the trait 
measurements, but also information on pedigree, environment, and relationships 
between traits to determine the best prediction of the trait that will be passed on to 
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offspring (Campbell and Marshall 1975).  PTAs are represented as differences from the 
genetic base, or average for that trait specific to breed, and are expressed in units 
contingent on the properties of the trait being measured (Wattiaux 1995).  Thus, 
displaying PTAs for different traits for one individual bull on the same graph would help 
to determine if a given bull is an extreme for one trait over others, but is difficult because 
of varying units.  Standard transmitting abilities (STAs) are determined from PTAs of 
linear type traits so that traits are represented on a standardized scale and able to be 
depicted on the same graph (The Holstein Foundation 2015).  STAs are typically 
depicted as within 3 standardized units of zero, positive or negative, where values 
closer to zero indicate the bull is more likely to pass on the breed average phenotype for 
that trait to its offspring (Holstein Association USA 2013).   
 Also important when looking at PTAs, is reliability, often expressed as %R.  
Reliability refers to the estimated accuracy of the calculated PTA and is a factor of the 
amount of information used to calculate the PTA (Wattiaux 1995).  Reliability is 
influenced by several factors including: reliability of PTA values for parents/other 
relatives of the bull, number of records available for that bull’s offspring, and the number 
of herds (varying environments) those offspring are located in (Wattiaux 1995).  As the 
amount of information known about a given sire increases, the reliability of their 
calculated PTAs increases.  When a calf is born, their PTAs are based solely on the 
PTAs of their parents and relatives since the calf does not have offspring yet, which 
results in relatively low reliability.  The reliability of calf PTAs can be improved using 
genomic testing.  Genomic testing involves genotyping the calf at many single 
nucleotide polymorphisms (SNPs).  The resulting genotypes are then compared to a 
subset of individuals (i.e.: training population) that have reliable PTAs based on their 
offspring and have also been genotyped, in order to determine what components of 
PTAs can be attributed to genetics (Wiggans et al. 2011).  Based on the comparison, a 
selection index is developed that combines the parent/relative PTA information and 
genetics to improve the reliability of the calf PTA (The Holstein Foundation 2015; 
VanRaden et al. 2009).  As the calf ages and has offspring whose phenotypes can be 
measured, this information is also included in the PTA calculation, further improving the 
reliability since more information is used.  Bulls that have 100 daughters in 100 different 
herds typically have about 88% reliability without genetic information included (Wattiaux 
1995).  However, even when information about a bull’s parent/relative PTAs, hundreds 
or thousands of daughters, and genetics are included in PTA calculation, the highest 
reliability reachable is 99% since the set of genes the daughters receive from the bull is 
always random (The Holstein Foundation 2015).   
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 PTAs (i.e.: genetic selection) have been used to decrease mastitis incidence.  
Such selection began with selecting against udder traits that would make bacteria 
entrance into the gland easier.  Selection against deep udders, long teats, loose udder 
attachment, and unbalanced udders were correlated with less mastitis incidence likely 
due to reduce proximity of the udder to organic matter on the ground that is heavily 
laden with mastitis causing bacteria (Lund et al. 1994; Rupp and Boichard 1999; 
Sørensen et al. 2000).  Selection efforts against mastitis progressed to selection against 
cows with high somatic cell scores (SCS, log10 of SCC).  Since somatic cell counts are 
used as an indicator of mastitis, where industry standard considers concentrations 
above 200,000 cells/mL to indicate mastitis (Dohoo et al. 2011; Schepers et al. 1997; 
Schukken et al. 2003), cows with higher average SCS over a lactation would correlate 
to cows with frequent mastitis bouts or chronically mastitic cows.  More recently, there 
has been some selection based on clinical mastitis, but this has been limited to 
Scandinavian countries where treatment of clinical mastitis is performed only 
veterinarians, which facilitates the record keep process (Heringstad et al. 2003; 
Philipsson et al. 1995).  Success using these mastitis selection traits has been limited, 
likely due to the complexity of the disease and the variation in causative pathogens with 
each having unique pathology.  Furthermore, complex traits, like SCS, are easily 
influenced by other factors including heritability and epistasis. 
Heritability 
 Heritability is defined as the proportion of phenotypic variance attributed to 
differences in genotypes (Lush 1949).  When attempting to identify causes of 
phenotypic differences, the differences are best represented by their variance (i.e.: the 
differences squared), and can be broken into two subset definitions (Lush 1949).  The 
broad sense of heritability is a function of genotype variance divided by phenotype 
variance and is used in contrast to the environmental effects.  However, this broad 
definition (represented as H2) relies on the genotype being transmitted as one unit, 
which is unrealistic.  Instead, genes that combine to produce a phenotype can 
segregate and recombine to generate new combinations.  Such recombinations could 
cause unique gene interactions resulting in genotype averages that are substantially 
different than the average genotype within the general population.  Thus, the narrow 
sense of heritability (represented as h2) includes only the additive effects or variance of 
the genes (the variance attributed to parent-offspring resemblance) divided by the 
phenotype variance.  The result of narrow heritability is the expected fraction of 
phenotypic variation between parents that can be expected to be passed on to the next 
generation (Lush 1949).   
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The representation of heritability as h2 became popular because of Sewall 
Wright’s use of h to represent heredity in describing his path coefficient model.  The 
path coefficient model describes the correlation squared (i.e.: h2) as the proportion of 
phenotype attributed to ‘the path from genotype to phenotype’ (Wright 1920).  In 
addition, Ronald Fisher described the resemblance among relatives using regression 
and correlation coefficients while estimating the variance in phenotype that is attributed 
to genotypes as a percentage (Fisher 1919).  However, the term heritability is credited 
to Jay L. Lush, who used it to describe proportion of variance due to hereditary factors 
(Lush 1940).  Over the years, statistical methodology in partitioning variation and 
estimating heritability has been thoroughly developed and has largely converged across 
disciplines and species (Lynch and Walsh 1998).  The percentages of variance, first 
described by Fisher, have come to correspond to the current definitions of broad- and 
narrow-sense heritability (Visscher et al. 2008). 
Presently, the equation used to calculate heritability is a ratio of variances.  The 
numerator is the variation from additive genetic values of a given population or breeding 
values, defined as the sum of the parents’ genes average effect that results in a 
phenotypic mean value for all the parents’ progeny (Falconer 1975).  The denominator 
is the total observed variation that has been adjusted to exclude variation attributed to 
certain fixed effects (i.e.: sex, age) (Visscher et al. 2008).  The result of the heritability 
equation is a proportion, represented as a value between 0 and 1, called the heritability 
index (HI).  The higher the heritability index, the higher the probability of the measured 
phenotype being passed on to the next generation through parent genotypes within the 
population it was measured.   
Heritability estimates are based on observed differences between actual and 
expected resemblance between relatives.  When selection pressure is applied, the ratio 
of the amount of change in the mean phenotype between generations to the difference 
in mean phenotype between parents is used to estimate heritability (Visscher et al. 
2008).  Determined over several generations, the heritability is the regression or ratio of 
the cumulative selection response to the cumulative selection differentials (Falconer 
1975).  Traditionally, heritability was measured using simple balanced designs such as 
those involving regressions between offspring and parent phenotypes, correlation of 
siblings’ phenotypes, and correlations between twin pairs of monozygotic and dizygotic 
origins (Falconer 1975).  More recent linear mixed models have allowed for heritability 
calculation from more complex designs including those where phenotype information is 
available for a variety of relationships, unbalanced designs, and those that include 
environmental variances.  The ‘animal model’ is one linear mixed model, which was 
originally designed for use in animal breeding, where an additive genetic relationship is 
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fitted for each individual in the pedigree and weighted appropriately according to their 
sampling variance (Lynch and Walsh 1998; Quaas and Pollak 1980).  Estimations of 
genetic variance components from complex pedigrees are accomplished using residual 
maximum likelihood methodology or Markov chain Monte Carlo methods, with the latter 
deriving more conservative Bayesian estimates (Patterson and Thompson 1971; 
Sorensen and Gianola 2007).  To obtain accurate estimates of heritability, hundreds of 
observations are necessary to reduce the sampling error which is contingent on low 
sampling variance and controlled by large observation numbers (Falconer 1975).   
Considering heritabilities and the variances used to calculate them are 
parameters of a given population it is possible only to estimate heritability opposed to 
determine a defined value of heritability across populations.  This is due to the fact that 
hereditability is not merely a factor of genetics and can be influenced by several factors.  
The main factor that influences heritability is the environment.  In fact, Jacquard (1983) 
states that heritability is actually a result of two factors: the genes transmitted to 
offspring at the time of conception, and the environmental contribution, in all its forms, 
during the entirety of development.  Additionally, heritability can be confounded by 
factors such as sex, age, and cohort.  Thus when determining heritability, these factors 
are adjusted for when calculating the variance in phenotype, which is the denominator 
of the heritability equation (Visscher et al. 2008).  If identifiers for a cofounding factor 
are not present, thus not allowing for correction of the cofounding factor, phenotypic 
variance calculated will be higher and result in a lower heritability calculation (Visscher 
et al. 2008).  Another factor that can influence heritability is time.  If over time a 
selection pressure is applied to a particular phenotype, then the variance of that 
phenotype decreases.  Decreased phenotype variance results in a higher calculated 
heritability such as observed by the increase in first lactation milk yield between the 
1970’s and the present day (Berry et al. 2003).  The fact that heritability can be 
influenced by a variety of factors is supported by the fact that heritabilities calculated for 
the same trait in different populations often vary due to the different combined effects of 
the environmental factors each population is subjected to (Visscher et al. 2008).  
However, heritabilities calculated for the same trait can be very similar to each other 
regardless of the population they are measured in. 
With respect to artificial insemination programs such as those used within the 
dairy industry, heritability is used to speculate the effectiveness of using phenotypic 
information to determine breeding value when selecting mating pairs to improve herd 
genetics.  High heritabilities for traits that are easy to measure (i.e.: milk yield) become 
the basis for producers to develop easy and effective breeding schemes that improve 
the overall herd over time.  However, traits with low heritability (i.e.: somatic cell count) 
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are more difficult to develop breeding schemes around since they require analysis of 
many related individuals to predict somewhat accurately and can be strongly influenced 
by environmental factors like causative pathogen.   
Epistasis 
 Epistasis refers to the interaction of genes that are not alleles and it is thought to 
influence many complex traits/diseases such as SCS/mastitis.  Selection of 
traits/diseases with epistatic influences is more difficult because you need to select for a 
collection of genes working together to cause a desired phenotype instead of one gene 
causing the phenotype.  The term ‘epistatic’ was first used in the early 1900’s to 
describe one loci preventing the manifestation of another loci effect, which was seen as 
an extension of allele dominance (Bateson and Mendel 1909).  Since its first 
description, there have been many refinements to the concept of epistasis, which has 
resulted in variations in the definition.  The original definition is most similar to the 
definition used today by biologists where epistasis refers to the effect of one locus on 
another, often resulting in the ‘masking’ of one locus in the presence of the other 
(Siemiatycki and Thomas 1981).  The original definition implies directional epistatic 
effects where loci A affects loci B, but not vice versa, whereas, the more modern 
definition used by biologists does not imply directionality, making this definition of 
epistasis more generalized than the original (Bateson and Mendel 1909; Neuman et al. 
1992).  In models where epistasis is detected, it is often assumed this has biological 
significance about the mechanisms of disease, which may not be the case depending 
on how the model itself was composed.  There is not always agreement between 
statistical and biological models of epistasis and significant statistical interactions do not 
imply biological or mechanistic interactions (Witte 2005). 
 There are many different molecular mechanisms that are theorized to cause 
epistasis.  First are metabolic models, which describe epistasis between mutations that 
affect one target enzyme or a family of enzymes with similar structure and/or function 
(de Visser et al. 2011).  Because enzymes typically function within a metabolic 
network/pathway, the interactions that characterize the network/pathway often dictate 
epistatic interactions (Szathmary 1993).  In fact, models of yeast pathways have 
demonstrated mutations in successive steps of a pathway typically display redundant 
epistatic effects, whereas, mutations in unrelated pathways demonstrated varied effects 
congruent to the relatedness of the mutated pathways (Segre et al. 2005).  Second is 
pleiotrophy, where mutations can be affecting multiple phenotypes (de Visser et al. 
2011).  Pleiotrophy is frequently demonstrated within proteins where one mutation may 
increase the activity rate of an enzyme but a subsequent mutation that stabilizes the 
same enzyme causes enzyme neutralization or loss of function (DePristo et al. 2005; 
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Wang et al. 2002).  Third is the environment, where varying environmental conditions 
can allow for different and/or novel interactions amongst genetic loci (de Visser et al. 
2011).  In fact, the degree of environmental complexity is thought to influence the 
evolution of epistasis, and can be demonstrated by bacteria showing greater divergence 
when subjected to complex environments opposed to simple environments (Cooper and 
Lenski 2010; Korona et al. 1994; Rozen et al. 2008).  Environmental effects on epistasis 
are most easily demonstrated where a mutation results in an inactive/truncated protein 
wherein alternative proteins/pathways compensate for the lost function (Crow and 
Kimura 1979).  Fourth is robustness or the insensitivity of organisms to the effects of a 
mutation due to the diversity/complexity of the genome (Visser et al. 2003; Wagner 
2013).  If the genome consists of overlapping structures and functions, then any one 
mutation will have a lower impact since other sequences likely have the same or 
overlapping functions (Sanjuán and Elena 2006; Sanjuán and Nebot 2008).  Lastly is 
evolvability, defined as the ability to adapt quickly to a varying environment, likely due to 
mutation/recombination (de Visser et al. 2011).  High mutation rates and recombination 
can inadvertently select for genetic robustness facilitating the epistatic influences 
discussed with robustness (Azevedo et al. 2006; Visser et al. 2003; Wilke et al. 2001).  
However, recombination can cause a reduction in epistasis because recombination 
selects for ‘generalist’ mutations which benefit an array of genetic backgrounds 
opposed to selecting co-adapted complexes (Azevedo et al. 2006; Malmberg 1977).  As 
previously discussed, variation in mastitis phenotype is heavily influenced by the 
environment indicating which could also be influencing the epistatic relationships within 
the genome.  Thus, allowing for the inclusion of multiple traits in disease modeling will 
hopefully allow the identification of genetic variants that may otherwise remain 
undetected for complex disease traits such as mastitis. 
Genome Wide Association Studies (GWAS) 
Genetic selection has had limited success in reducing mastitis by selecting for 
more desirable udder characteristics, reduced SCS, and reduced clinical mastitis, 
genome likely due to low heritability and potential epistatic effects throughout the 
genome.  As a result, other methods, including genome wide association studies 
(GWAS), have emerged to help improve overall mastitis phenotypes in dairy cows 
through genetics.  GWAS attempt to identify associations with specific phenotypes and 
loci throughout the genome.  Such associations could identify causal mutations related 
to the phenotype of interest and/or loci in linkage disequilibrium (LD) with causal 
mutations.  Additionally, GWAS can identify candidate genes, genes that the associated 
SNPs are in or near, whose functions can be investigated further to identify their 
functional relationship to the associated phenotype.   
18 
 
Loci Associated with Mastitis Phenotypes 
Many studies have utilized the GWAS approach to identify loci associated with 
mastitis phenotypes.  Pighetti and Elliott (2011) reviewed much of the research 
completed before 2011, identifying 10 quantitative trait loci (QTLs) for SCC/SCS located 
in similar regions of the genome in more than one study.  Since then, several more 
studies have been completed which have helped to confirm previously identified QTLs 
and identified novel loci associated with mastitis phenotypes.  A QTL website 
(http://www.animalgenome.org/cgi-bin/QTLdb/BT/index) helps to collect the most recent 
information and is updated regularly (Hu et al. 2010).  Since 2011, GWAS have 
discovered loci associated with mastitis phenotypes on every autosome of the bovine 
genome in a variety of breeds and populations.  At least half of the loci discussed were 
previously identified themselves or overlap with previously identified regions in the same 
breed/population and/or new ones.  Newer studies take advantage of advances in 
statistical methodology and new software releases to help improve prior results or 
narrow wide ranges with known associations. 
One more recent GWAS utilized two separate populations of Holstein-Friesians, 
one of sires and one of cows, to identify associations between daughter yield deviations 
(DYD) for SCS, among other economic dairy traits, and the over 50,000 SNPs included 
in the medium density BeadChip from Illumina (Meredith et al. 2012).   Both single SNP 
regression and Bayesian methods were utilized in analysis, where SNPs were included 
as continuous variables.  Additionally, pedigree information for at least the prior four 
generations was included for each animal and accounted for by calculating average 
additive relationships between animals to reduce the likelihood of identifying false 
positives due to close animal pedigrees (Gilmour et al. 2009).  SNP regression analyses 
included individual animal effects as random and multiple testing was accounted for by 
using false discovery rate reduction (Storey and Tibshirani 2003).  The BayesB method 
for Bayesian testing was utilized but modified to account for the reliability of DYD 
phenotype information (Meuwissen et al. 2001).  They identified 9 SNPs associated with 
SCS (p<0.05) using a single SNP regression analysis approach including loci on BTAs 
6, 10, 15, and 20.  Three of the identified SNPs are located in previously identified QTL 
regions on BTAs 6 and 10 (Bennewitz et al. 2004; Daetwyler et al. 2008; Rupp and 
Boichard 2003).  The remaining 6 loci were located in novel regions for SCS association 
with the strongest association on BTA 20.  However, when a Bayesian analysis was 
used in place of a single SNP regression analysis to reduce false discoveries, only one 
SNP on BTA 4 was associated with SCS which had been previously identified by (Tal-
Stein et al. 2010).  The marked reduction in SNP associations with the Bayesian 
approach is speculated to be from the decreased reliability of the SCS proofs used to 
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develop the SCS DYD phenotypes.  Decreased reliability of SCS phenotypes likely 
originates from less certainty in the true breeding value of the animal because 
environment plays such a heavy role in mastitis incidence for cows. 
A second study by Meredith et al. (2013), again utilized Holstein-Friesians to test 
associations with SCS and clinical mastitis DYD, that were based on a larger number of 
progeny, to test associations with SNPs arrayed on Illumina’s high density BeadChip 
with over 777,000 SNPs.  P-values were corrected for multiple testing using the 
Benjamini-Hochberg procedure (Benjamini and Hochberg 1995) and QTL boundaries 
were determined based on pairwise linkage disequilibrium (LD), or the non-random 
association of loci due to close proximity, using Plink (Purcell et al. 2007).  If the 
boundaries of two QTL overlapped, they are combined into one using the 
R/Bioconductor package “GenomicRanges” (Aboyoun et al. 2010; Gentleman et al. 
2004).  Post analysis, a total of 138 significant SNPs were identified across BTA 1, 3, 4, 
5, 6, 9, 10, 13, 17, 20, 21, 22, 23, 24, 25, and 26.  Eleven of the identified SNPs fell 
within known regions of SCS association, leaving 17 novel significant SNPs.  In 
comparing the results between their two studies, Meredith et al. (2013) noted the SNPs 
identified using the high density SNP array (777,000 SNPs) were more strongly 
associated and had more defined QTL boundaries than those they identified previously 
with the medium density array (54,000 SNPs) (Meredith et al. 2012).  In attempts to gain 
more information from the prior study, Meredith et al. (2013) performed imputation on 
the medium density genotypes with BEAGLE software (Browning and Browning 2009) 
using the high density array genotypes as a reference, but results proved unsuccessful 
with no consistency of imputation score across data sets and no significant associations 
being detected with the combined two data sets from both studies.  Speculation was 
made that, either the reference array was of insufficient sample size (n=724) or the 
variation in the surrounding LD structure of significant SNPs caused the inconsistency 
of imputation (de Bakker et al. 2008; Spencer et al. 2009).   
Another 2013 study by Sahana et al. (2013), performed a genome wide 
association analysis for mastitis traits on Nordic Holsteins using the medium density 
array (54,000 SNPs) from Illumina in attempts to confirm and refine the mapped position 
of QTLs identified previously using 356 microsatellite markers by Lund et al. (2008).  
Before running associations, data mining was completed to remove SNPs with call 
scores below 0.65 and minor allele frequencies below 0.05.  Additionally, genotypes 
missing on the array were imputed using Fast-Phase software (Scheet and Stephens 
2006).  To determine associations, a mixed model was used where individual SNPs 
were added step-wise to the model as fixed effects and the polygenic genetic effect was 
a random effect (Yu et al. 2006).  A Bonferroni correction was performed to reduce 
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family-wise error rate, but was found to be too conservative in correcting p-values (Han 
et al. 2009), so instead corrections to reduce false discovery rate as described by 
Benjamini & Hochberg (1995) were applied to help reduce the instance of false 
positives but not be overly conservative.  A total of 143 significant SNP associations 
with clinical mastitis phenotypes were identified with the majority on BTAs 6, 14, 16, and 
20.  Overall, 6 of the identified SNPs (BTA 5, 9, and 24) were within the regions 
previously identified as associated with mastitis QTLs, despite the definitions of mastitis 
used differing slightly across studies (Lund et al. 2008; Lund et al. 2007; Nilsen et al. 
2009; Sahana et al. 2008; Sodeland et al. 2011).   
As a follow up to their prior work, Sahana et al. (2014) performed a targeted 
association study attempting to fine-map QTL regions previously identified in Nordic 
Holsteins for clinical mastitis and SCC (Lund et al. 2008; Lund et al. 2007; Sahana et al. 
2013) using sequence level variants and confirm if the same QTL regions existed in 
Danish Jerseys or if the two breed populations segregated.  Estimated breeding values 
from artificial insemination sires for clinical mastitis and SCC traits were associated with 
SNPs on a medium density SNP array (54,000 SNPs) from Illumina.  Extensive data 
mining was performed again pre-association analysis to remove low quality base calls, 
keep minor allele frequencies below 5%, and prevent deviation from Hardy-Weinberg 
equilibrium, to increase power and reduce false discovery rate.  Like other studies, 
imputation was also used, but here it was targeted to 9 mastitis and SCC traits in Nordic 
Holsteins located on BTAs 5, 6, 13, 16, 19, and 20 using high density array (777,000 
SNPs) information.  Only SNPs with greater than 0.9 imputation certainty were kept to 
perform associations.  Following association analysis with Bonferroni multiple testing 
corrections, a total of 6 wide-peaked regions of association located on the 6 BTA that 
were targeted.  In conjunction with regular association tests, association tests with the 
most important SNP as a cofactor in the model were also run.  These cofactor analyses 
resulted in a collapse of the wide peaks of association on all chromosomes, likely 
indicating the single genetic variant within the targeted region, except for on BTA 5.  
The collapsed peak for each chromosome association likely indicates the causative 
single genetic variant for each region, but extensive LD does not allow for eliminating 
the possibility of multiple causal variants for the regions.  Additionally, loci on BTA 16 
and 20 previously identified in Nordic Holsteins were confirmed present in Danish 
Jerseys. 
Tiezzi et al. (2015) also attempted to identify loci associated with mastitis using 
GWAS.  They utilized producer reported instance of clinical mastitis on N=103,585 
Holsteins associated with their sire’s genotypes using a BovineSNP50 BeadChip from 
Illumina.  However, they employed a single-step genomic BLUP method that 
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incorporated both pedigree and genomics of each animal into a matrix that weighted 
each marker’s contribution by the variance of that marker to better account for 
relatedness of the animals and the genetic variance demonstrated by the population 
measured.  Additionally, the binary nature of the clinical mastitis phenotype was 
accommodated using a threshold-liability model.  This analysis identified 10 genomic 
regions that explained significant portions of the variation observed in clinical mastitis 
incidence which were located on BTAs 2, 8, 11, 14, 16, 19, 20, and 29, with the most 
significance being attributed to the regions on BTA 2, 14, and 20.  While other studies 
have identified loci associated with clinical mastitis on these chromosomes (Klungland 
et al. 2001; Sodeland et al. 2011; Youngerman et al. 2004), only the region identified on 
BTA 20 (32.17-61.61) was also identified using a clinical mastitis phenotype by another 
study (Sodeland et al. 2011).   
Lastly, Biffani et al. (2016) took a novel approach by using a case-control design 
to identified loci associated with mastitis.  Their approach looked at Italian Holstein cows 
that were repeatedly screened for mastitis over time (N=550 with mastitis cases, N=571 
without – controls) and compared them to the results of a prior GWAS on SCC breeding 
values of Italian Holstein sires.  The comparison focused on 9 previously identified 
SNPs that are located on BTA 6 and 14 (Minozzi et al. 2011) and was completed using 
a single-SNP regression model in the ‘qtscore’ function in the GenABEL package 
(Aulchenko et al. 2007) in R.  The results agreed with the prior studies finding 2 of the 
SNPs on BTA 6 and 4 of the SNPs on BTA 14 significantly associated with mastitis 
incidence which validated using historical case-control data for GWAS. 
These recent studies focused on confirming and narrowing the loci previously 
identified in mastitis trait association studies.  Overall, results seemed to favor loci 
located on BTA 6, 14, 16, and 20, but loci were identified on every chromosome of the 
genome.  Bayesian based approaches seems to provide great benefit in reducing false 
discoveries, although studies correcting for family wise error rate through pedigrees met 
with less success than those correcting for false discovery rates, since the latter is less 
abruptly conservative and does not reduce power as heavily as the former.  Studies 
utilizing imputation showed varying success rates, likely the result of varying sample 
sizes and inconsistent LD structure across the genome.  Lastly, higher density SNP 
arrays provided more defined QTL boundaries than those obtained with medium density 
arrays because closer SNPs allow better definition of the local LD structure.  The 
general trend for GWAS approach seems to focus on increasing analysis performance 
through statistics, increased sample size, and increased SNP array density, with little 
focus on the phenotype.  Thus, exploring the phenotypes used and the conditions they 
are generated under could provide important information in the context of GWAS. 
22 
 
Candidate Genes Identified by Loci Associated with Mastitis Phenotypes 
 While numerous genome loci have been associated with mastitis phenotypes 
using GWAS, the potential candidate genes surrounding these loci are even more 
numerous.  Functions of potential candidate genes can be implicated in many aspects 
of mastitis progression and are summarized below.  Of note, the previous review by 
Pighetti and Elliott (2011) covered a range of candidate genes including those for 
pathogen recognition, immune cell migration, bacterial elimination, and resolution of 
infection. 
The innate immune system is composed of non-specific mechanisms that are 
initiated within hours or immediately upon antigen recognition, including things like anti-
microbial peptides.  Several of the loci associated with mastitis phenotypes have 
provided candidate genes that fall within the functions of innate immunity.  Within a QTL 
located on BTA 6, is the GC gene that codes for Gc-globulin.  Gc-globulin leads to 
cathelicidin antimicrobial peptide synthesis by delivering vitamin D needed for synthesis, 
to target monocytes and also helps to enhance macrophage phagocytosis (Hewison 
2011; Yamamoto and Homma 1991).  Regions on BTA 13 associated with SCS include 
genes for β-defensins such as: DEFB117, DEFB119, DEFB122, DEFB122A, DEFB129 
and 2 precursor genes (Cormican et al. 2008).  Another QTL region on BTA 17 is in 
close proximity to SDF2L1 (stromal cell-derived factor 2-like protein 1) gene which plays 
a role in processing many β-defensins (Zheng et al. 2012).  β-defensins are a family of 
anti-microbial peptides that are responsible for initiating the immune response and 
preventing microbial colonization of epithelial surfaces which are known to be 
expressed in mammary tissue (Ganz 2003; Goldammer et al. 2004; Swanson et al. 
2004).  The gene for C9 is located near a QTL region identified on BTA 20 and codes 
for the precursor for the pore-forming unit of the complement membrane attack 
complex.  The complement complex aids in the clearance of microorganisms by 
introducing pores into microbe membranes and mutations in the C9 gene have been 
linked to increases susceptibility to some infections (Horiuchi et al. 1998; Kira et al. 
1998; Ricklin et al. 2010; Zoppi et al. 1990).  Also nearby to the identified BTA 20 region 
is the LIFR gene which produces leukemia inhibitory factor receptor, subunit α.  Once 
the receptor binds leukemia inhibitory factor its effects include modulation of the 
inflammatory response and stimulation of hepatocytes to produce acute-phase proteins 
(Baumann and Wong 1989; Linker et al. 2008).  Each of these functions aid in the 
clearance of invading bacteria and could be implicated in mastitis incidence.   
 Once bacteria are recognized by the immune system, the recruitment of immune 
cells to the site of infection to aid in infection resolution begins.  Identified regions on 
BTA 1, 13, 17, and 20 are close to genes with immune cell recruitment implications.  An 
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identified QTL on BTA 1 is located within the gene for CD166 antigen or ALCAM.  
CD166 antigen is heavily implicated in leukocyte adhesion, migration and the activation 
of T-cells in human cancers and shows ties to mastitis resistance in challenged somatic 
cells from sheep (Bonnefont et al. 2011; Cayrol et al. 2008; Hassan et al. 2004; 
Zimmerman et al. 2006).  The gene for EDN3 (endothelin 3) is located near a QTL 
region on BTA 13.  EDN3, expressed by several cell types including macrophages, has 
vasoconstrictive effects and potentially activates neutrophils needed to phagocytose 
microorganisms (Elferink and De Koster 1998; Giaid et al. 1991; Selsted and Ouellette 
2005).  Also near the QTL on BTA 13 is Phactr 3 (Phosphatase and actin regulator 3) 
which interacts with cell cytoskeleton to facilitate cell migration and spreading essential 
for mobilizing immune cells (Luster et al. 2005; Sagara et al. 2009).  The IL31Rα gene, 
which acts in the IL-31 receptor complex, is located near a BTA 20 QTL.  Upon binding 
cytokine, the IL-31 receptor complex activates JAK-STAT and MAPK pathways which in 
turn initiate a several other immune processes (Cornelissen et al. 2012; Zhang et al. 
2008).  Additionally, the gene for MAPK1, which is a member of the MAPK family and is 
essential for leukocyte recruitment following bacteria invasion, is located near a QTL on 
BTA 17 (Herlaar and Brown 1999; Kaminska 2005).  Deficiencies in the recruitment of 
immune cells to the site of infection could allow for increased incidence of mastitis or 
chronic infections develop. 
In addition to response genes above, other genes related to T-cells, B-cells, and 
antibodies are potential candidate genes.  A region identified on BTA 6, has its most 
significantly associated SNP within the DCK (deoxycytidine kinase) gene.  The DCK 
gene catalyzes the rate limiting step deoxyribonucleoside salvage and results in low 
production of T- and B-cells when knocked out in mice linking its function to 
lymphopoiesis (Toy et al. 2010).  Also in this region on BTA 6, is the gene for IGJ 
(immunoglobulin J polypeptide), which aids assembly of IgM pentamers and IgA dimers.  
Both IgM and IgA play critical roles in defending hosts from microorganisms, with IgM 
being the first antibody produced after microbial recognition and IgA adhering to 
microbes on mucosal surfaces to help prevent adherence to epithelial cells (Lamm 
1997; Racine and Winslow 2009).  Also on BTA 6, associated with another region, is the 
candidate gene DAPP1 or Bam32, which has suspected roles in B-cell receptor 
signaling (Pierce 2002).  B-cell receptors, upon binding antigen, help designate B-cell 
fates like proliferation, differentiation, receptor internalization, and T-cell adhesion and 
subsequent activation (Al-Alwan et al. 2010; Han et al. 2003; Niiro et al. 2004).  
Additionally, the gene for NPFFR2, a member of the NPFF RFamide neuropeptides, is 
located in this region.  These neuropeptides decrease macrophage nitric oxide 
production producing anti-inflammatory activity in mouse models and can influence T-
cell proliferation (Jhamandas and Goncharuk 2014; Lecron et al. 1992; Minault et al. 
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1995; Sun et al. 2013).  Lastly, on BTA 19, an identified QTL region is close to the 
mTORC1 (mTOR complex 1) gene which influences T-cell functions (Zeng et al. 2013).  
Functions above involved in specific antigen responses have the potential to alter 
response to mastitis pathogens.   
 A few candidate genes were identified based on changes in expression level 
following challenge with mastitis pathogens or their components.  Both the IGLL-1 
(lambda-like polypeptide 1 precursor) and the SNAP29 (synaptosomal-associated 
protein 29) genes are located near QTL identified on BTA 17 and have demonstrated 
up-regulated expression following bacterial challenge in different models (Swanson et 
al. 2009; Wesolowski et al. 2012).   Additionally, a micro-RNA, mir301b, has 
demonstrated down regulation following lipopolysaccharide (LPS) challenge.  It is 
located near the same QTL region on BTA 17 (Zheng et al. 2012).  While it is unclear 
the actual function these genes may play in mastitis, their changes in expression level 
following challenge suggest they are influenced by pathogenic bacteria presence.  
Perhaps such genes could be used in PCR based diagnostic techniques if their 
expression changes are consistent across pathogens. 
Lastly, some loci on BTA 5, 6, 13, 20, associated with mastitis phenotypes are 
also associated with milk phenotypes, particularly with decreased milk yield (Grisart et 
al. 2002; Meredith et al. 2012; Sahana et al. 2014; Sahana et al. 2013).  The concurrent 
association with mastitis and milk yield traits suggests the effects of the detected genes 
are pleiotropic and support the widely accepted correlation between SCS and 
decreased milk production (Carlén et al. 2004).  Within these identified regions for milk 
and mastitis traits there are genes that could be implicated in pathways for milk 
synthesis.  The region located on BTA 5 is within the intron of the MGST1 (microsomal 
glutathione S-transferase 1) gene.  MGST1 is localized to sites of lipid synthesis within 
the cell, thought to protect against oxidative stress, and can catalyze lipid 
hydroperoxides making it an excellent candidate for a milk fat QTL (Johansson et al. 
2010; Mosialou et al. 1995).  Close to the region identified on BTA 6 are several Casein 
related proteins.  Caseins are the primary protein component of bovine milk, and a QTL 
for milk protein exists in this region while not actually mapping to within one of the 
casein related genes, thus indicating the potential for multiple causative polymorphisms 
(Sahana et al. 2014).   
The range of candidate genes discussed above, while far from all-inclusive, 
demonstrates QTL associated with mastitis phenotypes are numerous and include a 
variety of functions.  Trends in identified genes are: antimicrobial peptides, immune cell 
recruitment and antigen specific immunity.  General functions follow trends observed 
from the prior review of candidate genes with some being identified in both (Pighetti and 
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Elliott 2011).  Despite the wide range of genes identified utilizing older and newer 
GWAS and QTL analyses, there has been little translation to on farm selection 
practices.   
In summary, many regions of the bovine genome have been identified as 
associated with mastitis phenotypes using a variety of original and revised GWAS 
analyses.  Many studies have identified similar and/or overlapping regions of 
association.  Newer technologies strive to improve the results of GWAS analyses by 
reducing the probability of false discoveries and narrowing the regions of association to 
causative variants.  These identified regions have provided any number of candidate 
genes with potential to influence a cow’s response to mastitis.  Generalized functions of 
candidate genes include bacterial recognition, recruitment of immune cells, and antigen 
specific immune responses.  However, little conversion of these associated loci is 
observed to commonly used selection parameters on farm.  Frequently, the easiest and 
least expensive way to acquire access to sample sizes adequate for GWAS analyses in 
the dairy industry is to rely on public data bases or government records for phenotype 
information.  This is largely because acquiring the resources and financial support to 
house, milk, and collect data on a large population of dairy cows is not feasible for one 
researcher or even a team of researchers.  As a result, phenotypes utilized in dairy 
GWAS are frequently derived from daughter yield deviations (DYD) or estimated 
breeding values (EBV).  Both EBVs and DYDs are estimates or predictions of a sire’s 
progeny based on averages of all the bull’s existing, mature offspring, and do not 
represent that individual cow’s performance directly.  Thus, there is little ability to 
account for the effect of environment or the proportion of genetics received from the 
dam, both of which may cause fluctuation in cows’ mastitis phenotype.  Furthermore, 
Pszczola and Calus (2015) determined that databases used to determine DYD or EBV 
need to be updated with a minimum of 600 individuals per generation to remain reliable 
in their ability to predict, which can become costly depending on the phenotype in 
question.  These discrepancies, could account for a portion of the reason why a great 
deal of research is being completed in identifying regions, but little evidence of 
translation to on farm use of selection for or against discovered loci is observed.  
Perhaps developing novel phenotypes from data collected on smaller sample sizes in 
response to direct challenge with common mastitis pathogens could narrow the field of 
identified associations.  Additionally, identified loci would be associated to the pathology 
of the challenge organism, leading to better candidate genes increasing the likelihood of 
developing novel treatments, preventatives or vaccinations specific to pathogens. 
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Abstract 
Mastitis is a detrimental disease in the dairy industry that costs upwards of $2 
billion annually and decreases milk quality.  Often, mastitis results from bacteria 
entering the gland through the teat end.  A common mastitis causing pathogen is S. 
uberis, which is responsible for a high percentage of subclinical and clinical mastitis 
cases.  Following an intramammary experimental challenge with S. uberis on Holstein 
cows (n=40), milk samples were collected and somatic cell counts (SCC) were 
determined by the Dairy Herd Improvement Association Laboratory.  Traditional GWAS 
have utilized test day SCC, SCC over an entire lactation, or sire EPD/DYD SCC to 
identify loci of interest for mastitis.  Our approach utilizes SCC collected following direct 
S. uberis experimental challenge to generate three novel phenotypes: area under the 
curve (AUC) of SCC for 0-7 d and 0-28 d post-challenge; and individual cows were 
placed in one of three categories (<21 d, 21-28 d, or >28 d) based on when their SCC 
returned to below 200,000 cells/ml post-challenge.  To identify loci of interest a 50K 
SNP chip analysis was performed using the BovineSNP50 v2 DNA BeadChip from 
Illumina.  Associations were tested using Plink and identified 16 significant (p < 9.34x 
10-5) SNPs across the 3 phenotypes.  Five of the identified SNPs are located within 
previously identified quantitative trait loci (QTLs) for traits with links to our generated 
phenotypes.  Additionally, six identified SNPs are located within known genes whose 
functions can be linked to SCC.  The identified loci should be further investigated to 
potentially identify causation behind the observed phenotypes.  Such investigations 
could lead to novel treatment and prevention compounds/protocols for S. uberis mastitis 
or genetic selection methods for cows with greater potential to resist S. uberis infection. 
Introduction 
Mastitis, the inflammation of the mammary gland, decreases milk quality and 
farm revenues generated.  Data shows mastitis can affect 20-50% of a herd causing an 
increase in cow morbidity and mortality (Bradley et al. 2007; Østerås et al. 2006; 
Piepers et al. 2007; Wilson et al. 1997).  Due to the prevalence and impact of mastitis, 
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increased preventative and control methods are a long standing goal of the dairy 
industry.  Mastitis frequently results from pathogenic bacteria invading the mammary 
gland.  Common mastitis causing pathogens include Escherichia coli, Streptococcus 
uberis, and Staphylococcus aureus, where each pathogen has its own unique pathology 
(Schukken et al. 2011).  S. uberis is responsible for a high percentage of both clinical 
and subclinical mastitis and is commonly isolated during the dry (non-lactating) period 
(Bradley et al. 2007; Petrovski et al. 2011; Riekerink et al. 2008; Verbeke et al. 2014).  
Due to S. uberis’s prevalence and its classification as both an environmental and 
contagious pathogen, it is often used as a model organism in challenge studies (Zadoks 
2007).  Once bacteria invade the mammary gland, epithelial cells and resident 
macrophages release cytokines which recruit polymorphonuclear neutrophils (PMN) 
and other leukocytes to the site of infection (Paape et al. 2003).  This cytokine 
recruitment results in a large influx of leukocytes into the milk, where leukocytes are 
commonly referred to as somatic cells.  Somatic cell counts (SCC), represented as 
cells/mL, are routinely monitored by the majority of dairy producers and are used as an 
indicator for the level of intramammary infection or mastitis.  There are some resident 
leukocyte populations in the mammary gland and/or milk (i.e.: macrophages) meaning, 
even when pathogenic bacteria are not present in the gland, SCC is greater than zero.  
Industry standard considers a SCC below 200,000 cells/mL a healthy gland and SCC 
above 200,000 cells/mL to indicate either subclinical or clinical mastitis (Dohoo et al. 
2011; Schepers et al. 1997; Schukken et al. 2003).  Subclinical mastitis is indicated by 
an increase in SCC, whereas clinical mastitis is represented by an increase in SCC and 
the presence of clinical signs (i.e.: inflammation, altered milk production).  Additionally, 
SCC are often converted to somatic cell scores (SCS), which are the log transformation 
of SCC.  
Traditional selection for cows with higher milk production has inadvertently 
selected for cows that are also more susceptible to diseases including mastitis (Rupp 
and Boichard 2003).  Existing mastitis/SCC heritability calculations, ranging from 0.05 to 
0.27, are based on test day measurements or measurements over an entire lactation, 
which do not account for variation in SCC based on causative pathogen (Haile-Mariam 
et al. 2003; Kennedy et al. 1982; Weller et al. 1992).  Additionally, the low SCC 
heritability means the selection response is proportionally small and gene interaction(s) 
and/or environmental factor(s) likely influence SCC heritability.  The advent of high 
throughput genotyping arrays has allowed researchers to perform genome wide 
association studies (GWAS) to identify specific loci or single nucleotide polymorphisms 
(SNPs) within the genome that are associated with SCC or related phenotypes instead 
of relying solely on traditional bull proofs, which are based on observed phenotype 
selection.  The results obtained from GWAS are primarily influenced by two factors: the 
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coverage of the array (i.e.: number of SNPs genotyped) and the number of individuals 
genotyped, amongst other smaller factors (Spencer et al. 2009).  The GWAS approach 
relies heavily on the SNPs included in the array being in linkage disequilibrium (LD), the 
non-random association of alleles at different loci, with the causal variant.  The greater 
the LD between the SNP and the causal variant, the greater the power to detect the 
association (Spencer et al. 2009).  Genome arrays are available in a variety of coverage 
density, which refers to the number of SNPs genotyped, from low density (7,000 SNPs) 
to high density (780,000 SNPs).  Genotyping a larger number of SNPs by using a higher 
density array can increase the power of GWAS results, however, due to the high degree 
of LD present in the Holstein breed, a medium density array (54,000 SNPs) should 
provide sufficient detection power (de Roos et al. 2008).   
Recent mastitis GWAS have utilized medium density arrays to detect 
associations successfully (Cole et al. 2009; Meredith et al. 2012; Pryce et al. 2010).  
These studies took advantage of national genetic breeding evaluations (EBV or DYD) 
for SCC/SCS kept by departments of agriculture or breed associations to develop 
phenotypes for association testing.  Both estimated breeding values (EBVs) and 
daughter yield deviations (DYDs) are estimates or predictions of a bull’s progeny based 
on averages of a sampling of the bull’s offspring, and do not represent an individual 
cow’s performance directly nor do they account for variation in SCC based on stage of 
lactation or causative pathogen.  To circumvent this confounding variation and directly 
utilize an individual cow’s performance against a particular pathogen as the phenotype 
of interest, we propose utilizing SCC data collected from direct experimental challenge 
with S. uberis to develop phenotypes and test associations.  We hypothesize utilizing 
our novel SCC phenotypes derived from S. uberis experimental challenge will detect 
significant associations with SNPs and identify potential target genes directly related to 
S. uberis mastitis pathogenesis post-partum.  The objective of this study was to perform 
a GWAS utilizing 40 Holstein dairy cows that were genotyped using the Illumina 
BovineSNP50 v2 BeadChip (54,609 SNPs) to test associations with novel SCC 
phenotypes derived SCC collected following direct experimental S. uberis challenge.   
Materials and Methods 
Animal Selection 
Holstein dairy cows (N = 40) that were entering their second or third lactation 
were enrolled in a vaccine trial to test the effectiveness of a novel vaccine candidate 
against S. uberis, i.e.: Streptococcus uberis adhesion molecule (SUAM) that involved a 
direct S. uberis challenge (USDA-NIFA AFRI 2011-67015-30168).  Cows were in overall 
37 
 
good health, pregnant, at the end of their first or second lactation, had quarter SCC 
<250,000 cells/mL, and were free of Johne’s, brucellosis, tuberculosis, and bovine 
leukemia virus (BLV).  Both S. uberis and SUAM baseline titers were assessed and 
cows with the lowest titers were enrolled.  All cows were housed at the East Tennessee 
Education and Research Center (ETREC) Little River Dairy (Walland, TN).  Upon arrival 
at ETREC, cows were acclimated to the facility for two weeks prior to the initiation of 
research protocols.  Cows were housed separately from the core herd and cared for in 
accordance with ETREC Little River Dairy standard protocols.  All animal based work 
was approved by and done in accordance with Institutional Care and Use Committee 
(IACUC) guidelines.   
Challenge 
Approximately one week prior to calving and at first milking post-calving, 
secretion samples were collected from each quarter to screen for bacterial presence to 
select a challenge quarter free of pathogens.  A frozen stock of Streptococcus uberis 
(UT888) was thawed in a 37°C water bath and an aliquot used to inoculate a blood agar 
plate.  After 23-24 h of growth on the agar, 3 representative colonies were used to 
inoculate Todd Hewitt Broth for an additional 7 h of growth.  The 1 mL aliquot of the 
resulting liquid culture was serially diluted in PBS to approximately 2,000 CFU for 
infusion.  A total of 5 mL of the diluted culture was used for challenge, resulting in a total 
of 10,000 CFU delivered.  Challenge was performed within 3 days post-calving with 5 
mL of the diluted S. uberis culture immediately following milking.  Prior to intramammary 
infusion, teat ends were cleaned thoroughly with sterile alcohol pads and the inoculum 
was infused using sterile disposable syringes with teat cannulas. The challenge 
inoculum was massaged upward into the teat and gland cisterns and plated (100μL) to 
determine the actual CFU/mL of S. uberis delivered which averaged 2122 ± 371 
CFU/mL and ranged from 1185 to 3202 CFU/mL. 
Sampling and Phenotype Description 
Milk samples were collected from the challenge quarter in Capitol Vials with B-14 
milk preservative pills (Neta Scientific, Inc., Hainesport, NJ) at the following time points: 
immediately before challenge (0 d) and then 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 
6.5, 7, 11, 14, 18, 21, 25, and 28 d post-challenge.  Collected samples were used to 
determine somatic cell counts (SCC), represented as cells/mL, by the Tennessee Dairy 
Herd Information Association (DHIA) lab (Knoxville, TN).  From the SCC data, three 
phenotypes were developed.  Industry standard considers a SCC below 200,000 
cells/mL healthy, individual cows were placed in one of three categories (<21 d, 21-28 
d, or >28 d) based on when their SCC returned to below 200,000 cells/mL post-
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challenge, which will be referred to as SCC cure.  Additionally, area under the curve 
(AUC) for SCC cells/mL for 0-7 days and 0-28 days post-challenge were calculated 
from linear representations of SCC over time for each cow using SAS (Cary, NC), and 
will be referred to as 7d AUC and 28d AUC respectively.  AUCs were calculated in 
order to have a single value for each cow to test for genetic associations, since looking 
at effects over time is not possible with a GWAS approach.  Select cows were sacrificed 
throughout the post-challenge sampling as part of the SUAM vaccine trial which 
resulted in incomplete data sets to generate phenotypes for some cows.  As a result, 
the number of cows per phenotype differed as follows: SCC cure had N=34, 7d AUC 
had N=36, and 28d AUC had N=35. 
SNP Chip Analysis 
Blood samples were collected from each cow via jugular puncture and DNA was 
isolated using UltraClean BloodSpin DNA Isolation Kit (Mo Bio, Carlsbad, CA).  
Resulting DNA was used to perform a 50K SNP chip analysis using the BovineSNP50 
DNA Analysis BeadChip (Illumina, San Diego, CA) (Gunderson et al. 2005; Steemers et 
al. 2006).  The SNP chip has 54,609 SNPs that span all 29 autosomes of the bovine 
genome with an average SNP spacing of 49.4kb and a median spacing of 36.9kb.  
Associations were tested between developed phenotypes and SNPs using Plink 
(Purcell et al. 2007).  Effects of sex were excluded from the analysis because all 
individuals were female and SNPs did not represent sex chromosomes.  The p-value 
cutoffs of p < 1.95x10-5 for highly significant SNPs and p = 1.95x10-5 to 9.34x10-5 for 
suggestively significant SNPs were set based on guidelines for reducing false positives 
and increasing reproducibility (Manly 2005).  For identified SNPs to be reported, the 
minor allele had to be represented by more than one cow, unless the SNP aligned with 
prior evidence for mastitis or mastitis related traits.  A complete index of identified 
SNPs, including those removed based on the minor allele criteria, is included as an 
appendix (Table A-1).  To allow depiction of the numerous SNPs, their genome 
locations, and their variable association p-values, generated Plink results were 
visualized using Manhattan plots created with Integrated Genome Viewer (IGV) 
(Robinson et al. 2011).  All reported gene and SNP locations were reported based on 
the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build. 
Results 
A total of 16 SNPs associated with unique SCC phenotypes generated from S. 
uberis experimental challenge data were identified.  The identified SNPs spanned 11 
chromosomes, with 3 SNPs on BTA 9 and 20, 2 SNPs on BTA 3, and the remaining 8 
SNPs being unique to individual chromosomes (Table 1).  The first phenotype, SCC 
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Table 1: Identified loci associated with developed novel SCC phenotypes. 
Trait rs 
Locus 
(chr: bp
1
) 
SNP type Allele freq
2
 
Nearest 
gene(s) 
Prior evidence P-value 
Loci with prior evidence 
7d AUC rs109961240 20: 63,407,185 5’ upstream A: 0.32  G: 0.68 TAS2R1 
SCS QTL 
(Meredith et al., 
2013) 
4.14x10
-6
 
28d AUC rs41655875 5: 26,621,180 intron variant C: 0.07  T: 0.93 ATF7 
MY QTLs 
(Bennewitz et 
al., 2004, Awad 
et al., 2010) 
2.80x10
-5
 
28d AUC rs109513885 3: 34,263,481 intron variant C: 0.41  T: 0.59 CELSR2 
MY QTLs 
(Viitala et al., 
2003, Ashwell 
et al., 2004) 
5.67x10
-5
 
SCC cure rs42488893 8: 19,967,642 5’ upstream C: 0.62  T: 0.38 U6 (snRNA) 
SCC QTL, CM 
QTL (Klungland 
et al., 2001) 
6.89x10
-5
 
SCC cure rs29015249 18: 24,862,274 intergenic C: 0.36  T: 0.64 
BREH1, 
NUP93 
PL QTL, SCS 
QTL, 
MY QTL 
(Olsen et al., 
2002, Muncie 
et al., 2006) 
8.88x10
-5
 
Newly identified loci 
SCC cure rs109484182 9: 93,183,596 intron variant A: 0.51  G: 0.49 TIAM2 -- 8.54x10
-7
 
28d AUC rs43224998 1: 34,903,570 intergenic A: 0.72  G: 0.28 
CHMP2B, 
VGLL3 
-- 5.57x10
-6
 
SCC cure rs110216702 9: 100,163,987 intron variant A: 0.76  G: 0.24 LOC100336821 -- 8.00x10
-6
 
SCC cure rs29019936 17: 562,366 intron variant C: 0.45  T: 0.55 CPE -- 1.82x10
-5
 
7d AUC rs41951389 20: 59,627,852 5’ upstream C: 0.43  T: 0.57 DNAH5 -- 2.82x10
-5
 
28d AUC rs110556992 7: 65,047,126 intron variant C: 0.56  T: 0.44 GLRA1 -- 4.86x10
-5
 
SCC cure rs41594141 9: 73,368,179 intron variant A: 0.60  G: 0.40 SGK1 -- 5.43x10
-5
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Table 1: Continued 
Trait rs 
Locus 
(chr: bp
1
) 
SNP type Allele freq
2
 
Nearest 
gene(s) 
Prior evidence P-value 
7d AUC rs41612729 28: 5,052,476 5’ upstream A: 0.56  G: 0.44 DISC1 -- 6.48x10
-5
 
SCC cure rs41565622 13: 24,688,809 intron variant A: 0.53  G: 0.47 LOC530173 -- 8.32x10
-5
 
28d AUC rs43499732 3: 6,480,313 intergenic G: 0.20  T: 0.80 
RGS5, 
CCDC190 
-- 8.48x10
-5
 
7d AUC rs109243453 20: 58,928,800 intergenic A: 0.40  G: 0.60 
TRIO, TRNAC-
ACA 
-- 8.59x10
-5
 
1
Reported positions are based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build. 
2
Allele frequencies are representative of the current study population.
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cure, placed cows in one of 3 categories based on when during the post-challenge 
sampling each cow’s SCC returned to below 200,000 cells/mL (Figure 1).  The majority 
of cows (44%) were in the >28 days category, indicating their SCC had not returned to 
below 200,000 cells/mL before the sampling period ended at 28 days post-challenge.  
The next largest category was <21 days, which included 32% of cows that reached 
200,000 cells/mL before 21 days post-challenge.  The last category of 21 – 28 days was 
the smallest category and represented only 24% of cows.  Association analyses 
identified 3 highly significant (p < 1.95x10-5) and 4 suggestively significant (p = 1.95x10-5 
to 9.34x10-5) SNPs associated with SCC cure (Figure 2).  One suggestively significant 
SNP is located on each BTA 8 (rs42488893), 13 (rs41565622), and 18 (rs29015249) in 
regions not associated with any known functions.  A significant SNP (rs29019936) is 
located on BTA 17 within the CPE (carboxypeptidase E) gene and the remaining three 
SNPs are part of a cluster of SNPs located on BTA 9, with SNPs in both the TIAM2 (t-
cell lymphoma invasion and metastasis 2) (rs109484182), SGK1 (serum/glucocorticoid 
regulated kinase 1) (rs41594141), and LOC100336821 (rs41565622) genes. 
The second and third phenotypes were a quantitative representation of SCC 
AUC over time, either for the first 7 days post-challenge (7d AUC) or for the entire 28 
day sampling period (28d AUC).  For 7d AUC, areas ranged from 1.7x106 (cells/mL)*d 
to 91.3x106 (cells/mL)*d, and had a median of 30.6x106 (cells/mL)*d (Figure 3).  
Association analyses identified 1 highly significant (p < 1.95x10-5) and 3 suggestively 
significant (p = 1.95x10-5 to 9.34x10-5) SNPs associated with 7d AUC (Figure 4).  One 
SNP (rs41612729) is located on BTA 28 and the remaining three SNPs are part of a 
cluster of SNPs on BTA 20 (rs109961240, rs41951389, and rs109243453).  None of the 
SNPs identified with 7d AUC are located in regions with known functions.  For 28d AUC, 
areas ranged from 2.5x106 (cells/mL)*d to 246.1x106 (cells/mL)*d, with a median of 
69.4x106 (cells/mL)*d (Figure 3).  Association analyses identified 1 highly significant (p 
< 1.95x10-5) and 4 suggestively significant (p = 1.95x10-5 to 9.34x10-5) SNPs associated 
with 28 day AUC (Figure 5).  One SNP was identified on each BTA 1, 5, and 7, where 
the SNP on BTA 5 (rs41655875) is in the ATF7 (activating transcription factor 7) gene 
and the SNP on BTA 7 (rs110556992) is in the GLRA1 (glycine receptor, alpha 1) gene.  
The remaining 2 SNPs were both on BTA 3, with one located in the CELSR2 (cadherin, 
EGF LAG seven-pass G-type receptor 2) gene (rs109513885). 
Discussion 
This study successfully identified associations between SNPs in the bovine 
genome and novel SCC phenotypes developed from SCC following direct S. uberis 
experimental challenge.  To our knowledge, this study is the first to utilize data 
generated from an experimental challenge to develop GWAS mastitis phenotypes. 
42 
 
 
Figure 1: Number of cows per SCC cure phenotype category.  Ranges of days 
represent the time range individual cow’s SCC returned to below 200,000 cells/mL, 
which is industry standard for healthy. 
  
N=11 
N=8 
N=15 
0
2
4
6
8
10
12
14
16
<21 d 21 - 28 d >28 d
N
u
m
b
e
r 
o
f 
C
o
w
s
 
Days Post-challenge SCC Returned Below 200,000 
cells/mL 
43 
 
 
Figure 2: Manhattan plot of GWAS for SCC cure phenotype using BovineSNP50 v2 
BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34).  The x-axis shows 
chromosome and SNP order within a chromosome.  The y-axis show the –log(p-value) 
for each SNP.  P-value thresholds are indicated by dashed lines: top black line p = 
1.95x10-5; bottom gray line p = 9.34x10-5. 
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Figure 3: Minimum, median, and maximum SCC AUC values for both 7 and 28 d 
phenotypes displayed in millions of (cells/mL)*d. 
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Figure 4: Manhattan plot of GWAS for SCC 7 day AUC phenotype using BovineSNP50 
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36).  The x-axis shows 
chromosome and SNP order within a chromosome.  The y-axis show the –log(p-value) 
for each SNP.  P-value thresholds are indicated by dashed lines: top black line p = 
1.95x10-5; bottom gray line p = 9.34x10-5. 
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Figure 5: Manhattan plot of GWAS for SCC 28 day AUC phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35).  The x-axis 
shows chromosome and SNP order within a chromosome.  The y-axis show the –log(p-
value) for each SNP.  P-value thresholds are indicated by dashed lines: top black line p 
= 1.95x10-5; bottom gray line p = 9.34x10-5. 
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Additionally, this study is unique because of its power, with N=34-36 Holstein cows 
compared to hundreds of individuals in other GWAS studies focused on mastitis 
(Meredith et al. 2013; Sahana et al. 2014; Tal-Stein et al. 2010).  However, 5 of the 
identified SNPs in this study (rs109961240, rs41655875, rs109513885, rs42488893, 
and rs29015249) are located in genomic regions with prior evidence associated with 
mastitis or related phenotypes (Table 1).  Of these, the SCC cure phenotype was 
associated with SNP rs42488893 which was also within a clinical mastitis (CM) QTL 
(Klungland et al. 2001).  This CM QTL was a binary trait where cows either had or did 
not have CM from 15 d pre-calving to 120 d post-calving.  Our SCC cure phenotype 
focused on the first 28 d post-calving, during which we observed 62.5% of cows develop 
clinical mastitis, indicated by inflammation, altered milk production, and an elevated 
(>200,000 c/mL) SCC (data not shown).  The highly inflammatory response observed 
with clinical mastitis suggests a strongly stimulated immune response, which could led 
to a more efficient clearance of invading bacteria and result in a shorter period of time 
with SCC >200,000 c/mL, correlating to a lower SCC cure phenotype.  Three SNPs 
significantly associated with the phenotypes 7d AUC (rs109961240) and SCC cure 
(rs42488893, rs29015249) were located within QTLs associated with SCC and SCS 
(Klungland et al. 2001; Meredith et al. 2013; Muncie et al. 2006).  These QTLs used 
SCC lactation means or SCC averaged across a sire’s daughters as phenotypes 
meaning loci identified are likely associated with cows with higher propensity for 
infections or cows with longer recovery times post-infection.  The 7d AUC phenotype 
accumulated SCC for the first 7 days post-challenge, where cows with higher 7d AUC 
would have higher propensity for infection and those with lower 7d AUC would have 
lower propensity, which links our 7d AUC phenotype directly to the previously identified 
QTLs.  The SCC cure phenotype put cows in categories based on when their SCC 
returned to below 200,000 c/mL, indicating a healthy gland, which would correlate to 
cows with length of time it takes for cows to recover post-infection linking SCC cure 
directly to the previously identified SCC/SCS QTLs.  Of interest, SNPs associated with 
28d AUC (rs41655875, rs109513885) and SCC cure (rs29015249) phenotypes were 
located in regions previously identified as having QTLs for productive life (PL) and/or 
milk yield (MY) (Ashwell et al. 2004; Awad et al. 2010; Bennewitz et al. 2004; Muncie et 
al. 2006; Olsen et al. 2002; Viitala et al. 2003).  Productive life refers to the length of 
time a cow remains in the herd producing milk, which can be affected my many factors 
including health, fertility, and milk yield (Roxström and Strandberg 2002).  A longer SCC 
cure (i.e.: >28d) and/or stronger inflammatory responses for 28d (AUC) indicates cows 
are not as effective at resolving infection.  This would increase their risk of being culled 
from the herd because of mastitis directly or other negative impacts associated with 
mastitis such as reduced fertility and milk yield.  For decades, an association between 
mastitis incidence and reduced milk production has been recognized (Meredith et al. 
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2012; Shaw and Beam 1935; Wilson et al. 1997) since fighting infections sequesters 
energy that would otherwise be partitioned to milk production.  Since SCC is used as an 
indicator of mastitis, is the foundation for both our SCC cure and 28d AUC phenotypes, 
and is associated with decreased milk production, the identification of SNPs in regions 
with MY QTLs is logical.  The identification of SNPs within known QTL regions with prior 
evidence helps establish the validity of using these novel SCC based phenotypes in 
response to direct, experimental S. uberis challenge for GWAS.  Furthermore, while the 
associations identified in this study are associated with our novel S. uberis SCC 
phenotypes, since some of the identified SNPs are located in regions with prior 
evidence linked to varying mastitis and/or MY phenotypes, it is possible these regions 
could be associated with other causative pathogens besides S. uberis. 
 While the identified SNPs themselves may not be causal but rather in linkage 
disequilibrium is the causal variant, they do provide several interesting candidate genes 
based on the genes they are located within.  Of the previously identified loci, the two 
identified using 28d AUC are also located within genes with known functions.  First, 
rs41655875 is located within the ATF7 (activating transcription factor 7) gene. ATF7 
binds the cAMP response element of many cellular promoters including many immune 
genes and helps control the epigenetic regulation of the same genes resulting in the 
speculation that ATF7 is involved in the controlling the ‘memory’ of the innate immune 
system through these epigenetic changes that persist for long periods of time (Yoshida 
et al. 2015).  Control of the innate immune system through gene regulation would allow 
for faster responses to infection states and allow for rapid clearance of invading bacteria 
and be associated with overall lower 28d AUC.  The other SNP, rs109513885, is 
located within the CELSR2 (cadherin EGF LAG seven-pass G-type receptor 2) gene 
that is primarily involved in central nervous system dendrite morphogenesis (Shima et 
al. 2007).  The functions of CELSR2 are linked to calcium signaling, cell adhesion, and 
cell survival, which are functions shared with many g-protein receptors (Beall et al. 
2005; Shima et al. 2007) frequently involved in migration of immune cells to the site of 
infection (Raman et al. 2010; Rambeaud et al. 2006; Rambeaud and Pighetti 2007; 
Richardson et al. 2003), thus impacts in CELSR2 might impact observed SCC and be 
linked to a higher or lower 28d AUC. 
 In addition to the SNPs identified in regions with prior evidence, this study 
identified 12 novel SNPs.  The SCC cure phenotype identified 5 novel SNPs, of these, 3 
are within genes with known functions.  First, rs109484182, located on BTA 9 at 
93.2Mb, is within the TIAM2 (t-cell invasion and metastasis-2) gene, which encodes a 
guanine nucleotide exchange factor that plays a role in the function of small GTPases.  
Roles of TIAM2 based on human research have included increasing cell invasions in 
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cancer development, cellular migration, adhesion, and apoptosis (Chen et al. 2012; 
Rooney et al. 2010).  While the majority of existing research has focused on TIAM2’s 
role in cancer development and metastasis, it has documented roles in general immune 
functions like migration and apoptosis that could affect a cow’s SCC influx in response 
to invading pathogenic bacteria and thus its SCC cure phenotype.  Another SNP, 
rs41594141, also located on BTA 9, but at 73.4Mb, is within the SGK1 
(serum/glucocorticoid regulated kinase 1) gene, which is a serine/threonine kinase that 
is expressed in virtually all tissues where it regulates ion channels (Lang et al. 2009; 
Lang and Shumilina 2013).  SGK1 also helps regulate the expression of NFκB, which is 
a transcription factor for many genes involved in effector functions of innate immune 
system (Baeuerle and Henkel 1994; Lang et al. 2010).  NFκB regulated effector 
functions include the up regulation of the pro-inflammatory cytokine IL-8 and the 
adhesion molecules ICAM-1 and VCAM-1, which are vital for the recruitment of 
neutrophils to the site of infection (Collins et al. 1995; Matsusaka et al. 1993).  
Alterations in the ability to recruit neutrophils to the mammary gland during mastitis 
would likely permit the infection to persist and cause a prolonged period of mildly 
elevated SCC that is not sufficient enough to clear the infection and correlating to a high 
SCC cure phenotype observed.  The third SNP located within a gene identified with the 
SCC cure phenotype, rs29019936, is located on BTA 17 at 0.6Mb, and is within the 
CPE (carboxypeptidase E) gene that primarily functions within the endocrine and 
nervous systems for the biosynthesis of neuropeptides and peptide hormones (Fricker 
1988).  Neuropeptides and peptide hormones have diverse roles in the regulation of the 
immune system including cytokine secretion, adhesion molecule expression, and 
feedback regulation as reviewed by Sternberg (2006).  Additionally, CPE directly has 
been demonstrated to play a role in growth and migration of cancer cells in humans 
(Lee et al. 2011).  The effects of these roles combined could dictate the ability of 
immune cells to migrate to the mammary gland resulting in overall lower SCC observed 
which would correlate to lower SCC cure phenotypes. 
The 7d AUC phenotype identified 3 novel SNPs.  While none of these SNPs 
were directly located in genes, there were a cluster of SNPs identified on BTA 20 
including SNPs at positions 58.9Mb (rs109243453), 59.6Mb (rs41951389), and 63.4Mb 
(rs109961240, previously identified).  Several other GWAS have identified associations 
with loci on BTA20 and SCC based phenotypes (Cole et al. 2011; Meredith et al. 2013; 
Meredith et al. 2012; Sahana et al. 2014; Sodeland et al. 2011; Tal-Stein et al. 2010).  
Within this BTA 20 cluster region there are 11 known genes, 4 tRNAs, 1 miRNA, and 7 
ncRNAs, providing a number of possible candidate genes and functional RNAs.  One 
gene of interest is death-associated protein (DAP)-1 which is a positive mediator of 
interferon (IFN)-γ induced programmed cell death (Deiss et al. 1995).  Higher rates of 
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programmed cell death could lead to lower SCC and would correlate to lower 7d AUC 
phenotypes observed.  Lastly, the 28d AUC phenotype identified the remaining 3 novel 
SNPs, where one SNP is located within a gene with known function.  The SNP on BTA 
7 at 65Mb is located within the GLRA1 (glycine receptor alpha 1) gene.  GLRA1 is a 
subunit of an ion-gated, chlorine channel glycine receptor.  Glycine and its receptor 
primarily function within the central nervous system to mediate synapse impulses (Van 
den Eynden et al. 2009).  Glycine receptors also influence calcium ion fluxes in 
neutrophils and monocytes leading to reduced pro-inflammatory cytokine production, 
increased anti-inflammatory production, and reduced superoxide production resulting in 
overall less stimulation of the immune response to invading pathogens (Spittler et al. 
1999; Wheeler et al. 2000).  Less stimulation of the immune response would result in 
fewer immune cells recruited to the site of infection and lead to overall lower observed 
SCC and lower 28d AUC phenotypes.  
In summary, our study identified SNPs associated with novel SCC based 
phenotypes derived from SCC collected in response to direct, experimental S. uberis 
challenge.  While our study was limited by a low number of individual cows being 
genotyped, many of the identified SNPs (31%) are within genomic regions previously 
reported in considerably larger studies as associated with mastitis related traits, 
providing validity to the effectiveness of our novel phenotypes for identifying regions of 
interest.  The identified SNPs provide several loci to investigate as potential target 
genes that could be linked directly to S. uberis pathogenesis.  Furthermore, 
investigations of these identified loci or those identified in future analyses using 
challenge data could lead to novel treatment or preventative strategies for S. uberis 
mastitis and potentially identify genetic selection markers for cows with greater 
resistance to S. uberis mastitis. 
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Abstract 
 Mastitis is a detrimental disease in the dairy industry that costs upwards of $2 
billion annually and decreases milk quality.  Often, mastitis results from bacteria 
entering the gland through the teat end.  A common mastitis causing pathogen is S. 
uberis, which is responsible for a high percentage of subclinical and clinical mastitis 
cases.  Following an intramammary experimental challenge with S. uberis on Holstein 
cows (n=40), mammary and milk scores were observed to evaluate the level of 
inflammation present and aseptic milk samples were collected to determine CFU of S. 
uberis present in milk.  Traditional GWAS have utilized somatic cell count (SCC) based 
phenotypes or clinical mastitis (CM) observations to identify loci of interest for mastitis.  
We proposed using novel phenotypes developed from data collected following direct S. 
uberis experimental challenge to generate 6 phenotypes.  Four phenotypes were 
generated using S. uberis CFU: S. uberis 1st clearance which enumerated the days until 
CFU reached zero, S. uberis cycles which enumerated the number of times CFU 
reached zero within the 28d sampling period, area under the curve (AUC) of S. uberis 
CFU for 0-7 d and 0-28 d post-challenge.  The last two phenotypes were developed 
using mammary and milk scores: severity score summed all scores for the highly 
inflammatory 0-7 d post-challenge and chronic score summed all scores for the entire 0-
28 d sampling period post-challenge.  To identify loci of interest a 50K SNP chip 
analysis was performed using the BovineSNP50 v2 DNA BeadChip from Illumina.  
Associations were tested using Plink and identified 29 significant (p < 9.34x 10-5) SNPs 
across the 6 phenotypes.   Nine of the identified SNPs are located within previously 
identified quantitative trait loci (QTLs) for traits with links to our generated phenotypes.  
Additionally, 14 identified SNPs are located within known genes, with most having 
functions related to the immune response or gene/protein regulation.  The identified loci 
should be further investigated to potentially identify causation behind the observed 
phenotypes.  Such investigations could lead to novel treatment and prevention 
compounds/protocols for S. uberis mastitis or genetic selection methods for cows with 
greater potential to resist S. uberis infection. 
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Introduction 
 Mastitis affects 20-50% of cows within any given herd resulting in dramatic 
decreases in milk quality and farm revenues (Akers and Nickerson 2011; Barbano et al. 
1991; Bradley et al. 2007; Klei et al. 1998; Ma et al. 2000; NMC 2005; Østerås et al. 
2006; Piepers et al. 2007; Wilson et al. 1997).  Because of the impact and high 
incidence of mastitis, improved control and prevention is a constant goal of the dairy 
industry.  Mastitis frequently results from pathogenic bacteria invading the mammary 
gland.  Common mastitis causing pathogens include Escherichia coli, Streptococcus 
uberis, and Staphylococcus aureus, where each pathogen has its own unique pathology 
(Schukken et al. 2011).  S. uberis is responsible for a high percentage of both clinical 
and subclinical mastitis and is commonly isolated during the dry (non-lactating) period 
(Bradley et al. 2007; Petrovski et al. 2011; Riekerink et al. 2008; Verbeke et al. 2014).  
S. uberis is especially  problematic because, while it typically originates as an 
environmental pathogen, it can spread throughout the herd in a contagious manner 
once introduced (Zadoks 2007).  Intramammary infections are characterized by 
increases in somatic cell counts (SCC), which enumerate the number of immune cells 
recruited to the infection site to combat invading bacteria.  Some resident immune cells 
(i.e.: macrophages) reside in the mammary gland to provide protection at all time, thus, 
industry standard considers a SCC below 200,000 cells/mL a healthy gland and SCC 
above 200,000 cells/mL to indicate either subclinical or clinical mastitis (Dohoo et al. 
2011; Schepers et al. 1997; Schukken et al. 2003).  Subclinical S. uberis infections are 
indicated by an increase in SCC, whereas clinical S. uberis infections are represented 
by an increase in SCC and the presence of clinical signs (i.e.: inflammation, altered milk 
production) (Rambeaud et al. 2003).  Additionally, S. uberis has some unique pathology 
characteristics that can make clearing the infection from the mammary gland more 
problematic.  Once S. uberis enters the mammary gland, it binds lactoferrin, which is a 
common milk protein (Fang and Oliver 1999).  Lactoferrin can then act as a bridging 
molecule and allow binding of S. uberis to the mammary epithelial cells (Fang et al. 
2000).  After binding, S. uberis then invades the host cells via caveolae dependent 
endocytosis (Almeida and Oliver 2006; Matthews et al. 1994).  Once internalized, S. 
uberis can exploit host cell transduction and persist in the cytoplasm for hours (Almeida 
et al. 2000; Tamilselvam et al. 2006) effectively evading the host immune system.  
Since S. uberis mastitis is a common problem dairy producers combat and S. uberis 
has mechanisms to evade the immune response, identifying specific host genes 
involved in S. uberis pathogenesis could prove beneficial for the control and prevention 
of S. uberis mastitis on dairy farms. 
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Many studies attempting to identify genes important for mastitis have been 
conducted (Cole et al. 2009; Meredith et al. 2013; Meredith et al. 2012; Pryce et al. 
2010).  These genome wide association studies (GWAS) have utilized SCC based 
phenotypes or observations of clinical mastitis to test for associations.  Our prior study, 
(Siebert et al., 2017, unpublished) was the first to utilize SCC collected in response to 
direct experimental intramammary challenge to identify associations with genomic 
regions.  For the present study, we propose utilizing other subsets of data (i.e.: CFU of 
S. uberis in milk, mammary score, milk scores) collected in response to direct 
experimental intramammary S. uberis challenge to develop novel phenotypes and test 
associations with the bovine genome.  We hypothesize utilizing our novel phenotypes 
derived from experimental challenge will increase specificity of associations and identify 
potential target genes directly related to S. uberis mastitis pathogenesis.  The objective 
of this study was to perform a GWAS utilizing 40 Holstein dairy cows that were 
genotyped using the Illumina BovineSNP50 v2 BeadChip (54,609 SNPs) to test 
associations with novel phenotypes derived data collected following direct experimental 
S. uberis challenge. 
Materials and Methods 
Animal Selection 
Holstein dairy cows (N = 40) that were entering their second or third lactation 
were enrolled in a trial to test the effectiveness of a novel vaccine candidate against S. 
uberis, i.e.: Streptococcus uberis adhesion molecule (SUAM) that involved a direct S. 
uberis challenge (USDA-NIFA AFRI 2011-67015-30168).  Cows were in overall good 
health, pregnant, at the end of their first or second lactation, had quarter SCC <250,000 
cells/mL, and were free of Johne’s, brucellosis, tuberculosis, and bovine leukemia virus 
(BLV).  Both S. uberis and SUAM baseline titers were assessed and cows with the 
lowest titers were enrolled.  All cows were housed at the East Tennessee Education 
and Research Center (ETREC) Little River Dairy (Walland, TN).  Upon arrival at 
ETREC, cows were acclimated to the facility for two weeks prior to the initiation of 
research protocols.  Cows were housed separately from the core herd and cared for in 
accordance with ETREC Little River Dairy standard protocols.  All animal based work 
was approved by and done in accordance with Institutional Care and Use Committee 
(IACUC) guidelines.   
Challenge 
Approximately one week prior to calving and at first milking post-calving, 
secretion samples were collected from each quarter to screen for bacterial presence to 
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select a challenge quarter free of pathogens.  A frozen stock of Streptococcus uberis 
(UT888) was thawed in a 37°C water bath and an aliquot used to inoculate a blood agar 
plate.  After 23-24 h of growth on the agar, 3 representative colonies were used to 
inoculate Todd Hewitt Broth for an additional 7 h of growth.  The 1 mL aliquot of the 
resulting liquid culture was serially diluted in PBS to approximately 2,000 CFU for 
infusion.  A total of 5 mL of the diluted culture was used for challenge, resulting in a total 
of 10,000 CFU delivered.  Challenge was performed within 3 days post-calving 
immediately following milking.  Prior to intramammary infusion, teat ends were cleaned 
thoroughly with sterile alcohol pads and the inoculum was infused using sterile 
disposable syringes with teat cannulas. The challenge inoculum was massaged upward 
into the teat and gland cisterns and plated (100μL) to determine the actual CFU/mL of 
S. uberis delivered which averaged 2122 ± 371 CFU/mL and ranged from 1185 to 3202 
CFU/mL within the 5mL inoculation volume. 
Sampling and Phenotype Description 
Cows were closely monitored post-challenge for the development of mastitis with 
specific collections and observations taken at the following time points: immediately 
before challenge (0 d) then 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 11, 14, 18, 
21, 25, and 28 d post-challenge.  At each time point, a variety of measures were taken 
and used to develop novel phenotypes to test for associations with genomic regions.   
Milk samples collected aseptically were used to determine the amount of S. 
uberis present, in CFU/mL, via culturing on blood agar plates as outlined in the NMC lab 
handbook (NMC 1999) and carried out by the Tennessee Quality Milk Lab (Knoxville, 
TN).  Determined CFU/mL of S. uberis was used to develop four separate novel 
phenotypes.  All cows became infected from challenge, based on S. uberis isolation 
from challenged quarter, thus, all cows had initially high S. uberis CFU/mL post-
challenge.  The number of days until S. uberis CFU/mL reached zero the first time post-
challenge was used to establish the days until S. uberis 1st clearance phenotype.  
Some cows showed S. uberis CFU/mL increases following the initial clearance, the 
number of times this occurred in the 28 d sampling period was used to identify the 
number of S. uberis shedding cycles, which defined the second novel phenotype.  
The remaining two S. uberis phenotypes were developed from calculating the area 
under the curve (AUC) for S. uberis CFU/mL for 0-7 days (7d AUC) and 0-28 days  
(28d AUC) post-challenge from linear representations of CFU/mL over time for each 
cow using SAS (Cary, NC).  AUCs were calculated in order to have a single value for 
each cow to test for genetic associations, since looking at effects over time is not 
possible with a GWAS approach. 
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Mammary and milk scores on the challenge quarter were evaluated on a 0 to 3 
scale by ETREC Little River Staff to make 2 additional novel phenotypes.  Mammary 
scores were defined as follows: 0 = normal, 1 = slight swelling, 2 = moderate swelling, 3 
= edema.  Milk scores were defined as follows: 0 = normal, 1 = small flakes or clots, 2 = 
large clots, 3 = stringy, off color, watery, or bloody.  To focus on cows with a quick and 
severe inflammatory response to challenge, mammary and milk scores for the first 7 d 
post-challenge were summed to create the severity score phenotype.  Contrastingly, to 
concentrate on cows with a more slow and steady, chronic response to challenge, 
mammary and milk scores were summed for the entire 28 d sampling period to create 
the chronic score phenotype. 
Of note, select cows were sacrificed throughout the post-challenge sampling as 
part of the SUAM vaccine trial which resulted in incomplete data sets to generate 
phenotypes for some cows.  As a result, the number of cows per phenotype differed as 
follows: S. uberis 1st clearance had N=34, S. uberis shedding cycles had N=34, 7d AUC 
had N=36, 28d AUC had N=35, severity score had N=36, and chronic score had N=34. 
Association Analysis 
Blood samples were collected from each cow via jugular puncture and DNA was 
isolated using UltraClean BloodSpin DNA Isolation Kit (Mo Bio, Carlsbad, CA).  
Resulting DNA was used to perform a 50K SNP chip analysis using the BovineSNP50 
DNA Analysis BeadChip (Illumina, San Diego, CA) (Gunderson et al. 2005; Steemers et 
al. 2006).  The SNP chip has 54,609 SNPs that span all 29 autosomes of the bovine 
genome with an average SNP spacing of 49.4kb and a median spacing of 36.9kb.  
Associations were tested between developed phenotypes and SNPs using Plink 
(Purcell et al. 2007).  Effects of sex were excluded from the analysis because all 
individuals were female and SNPs did not represent sex chromosomes.  The p-value 
cutoffs of p < 1.95x10-5 for highly significant SNPs and p = 1.95x10-5 to 9.34x10-5 for 
suggestively significant SNPs were set based on guidelines for reducing false positives 
and increasing reproducibility (Manly 2005).  For identified SNPs to be reported, the 
minor allele had to be represented by more than one cow, unless the SNP aligned with 
prior evidence for mastitis or mastitis related traits.  A complete index of identified 
SNPs, including those removed based on the minor allele criteria, is included as an 
appendix (Table A-1).  To allow depiction of the numerous SNPs, their genome 
locations, and their variable association p-values, generated Plink results were 
visualized using Manhattan plots created with Integrated Genome Viewer (IGV) 
(Robinson et al. 2011). All reported gene and SNP locations were reported based on 
the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build. 
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Results 
A total of 29 SNPs associated with unique novel phenotypes generated from S. 
uberis experimental challenge data were identified (Table 2).  The identified SNPs span 
18 chromosomes, with 2 SNPs each on BTAs 1, 3, 13, 14, 17, 18, 21, 22, and 28.  The 
first S. uberis CFU based phenotype, S. uberis 1st clearance, enumerated the days until 
S. uberis CFU reached zero post-challenge.  Days until S. uberis 1st clearance ranged 
from 4 to 47 days, and had a median of 23.5 days (Figure 6).  Association analyses 
identified 3 suggestively significant (p < 9.34x10-5) SNPs associated with S. uberis 1st 
clearance time (Figure 7).  One significant SNP each was identified on BTA 2 
(rs41645172), 11 (rs41610542), and 28 (rs41653441), with the SNP on BTA 28 being 
located within the PSAP (prosaposin) gene.   
The second S. uberis CFU based phenotype, S. uberis shedding cycles, counted 
the number of times S. uberis CFU reached zero within the 28 day post-challenge 
sampling period.  The number of S. uberis cycles ranged from 1 to 4, with the majority 
of cows (47%) being represented by 2 cycles (Figure 8).  Three suggestively significant 
SNPs (p < 9.34x10-5) were identified as associated with the S. uberis shedding cycles 
phenotype (Figure 9).  One significant SNP each was identified on BTA 4 (rs41576873), 
15 (rs109427689), and 17 (rs41570578).  The SNP identified on BTA 4 is located within 
the SND1 (staphylococcal nuclease and tudor domain containing 1) gene and the SNP 
on BTA 17 is located in the HECTD4 (HECT domain E3 ubiquitin protein ligase 4) gene.   
The last two S. uberis CFU based phenotypes were a quantitative representation 
of CFU AUC over time, either for the first 7 days post-challenge (7d AUC) or the entire 
28 day sampling period (28d AUC).  Areas under the curve for 7 days post-challenge 
ranged from 24.5 CFU*d to 1.27x108 CFU*d, with a median of 3.17x107 CFU*d (Figure 
10).  Association analyses identified 9 highly significant (p < 1.95x10-5) SNPs and 6 
suggestively significant (p = 1.95x10-5 to 9.34x10-5) SNPs associated with 7d AUC 
(Figure 11).  The 7d AUC associated SNPs were located on BTAs 1 (rs110974478), 3 
(rs43709346 and rs109880729), 5 (rs43423752), 9 (rs41665257), 12 (rs110866336), 13 
(rs110804434), 17 (rs41831243), 18 (rs109290019 and rs109070561), 21 
(rs111021268 and rs42651398), 22 (rs109747337 and rs110942101), and 26 
(rs110747207).  Five of these identified SNPs are within genes with known functions: 
rs110866336 is within HS6ST3 (heparan sulfate 6-O-sulfotransferase 3), rs110804434 
is within TMEM189 (transmembrane protein 189), rs41831243 is within FBXW7 (F-box 
and WD repeat domain containing 7), rs111021268 is within FSD2 (fibronectin type III 
and SPRY domain containing 2), and rs110942101 is within CCR4 (C-C motif 
chemokine receptor 4).   
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Table 2: Identified loci associated with developed novel phenotypes. 
Trait rs 
Locus 
(Chr: bp)
1
 
SNP type 
Allele 
Frequencies
2
 
Nearest gene(s) Prior Evidence P-value 
Loci with prior evidence 
7d AUC rs41665257 9: 4,581,947 5’ upstream C: 0.08  T: 0.92 LOC104968410 
CM QTL 
(Lund et al., 2008) 
6.56x10
-6
 
7d AUC rs43709346 3: 74,836,184 intergenic A: 0.98 G: 0.02 PTGER3, CTH 
CM QTL 
(Klungland et al., 
2001) 
7.64x10
-6
 
7d AUC rs43423752 5: 2,925,015 3’ downstream C: 0.98  T: 0.02 TRHDE 
MY QTL 
(Daetwyler et al., 
2008) 
7.64x10
-6
 
7d AUC rs111021268 21: 23,530,389 Intron variant C: 0.95  T: 0.05 FSD2 
SCS QTL 
(Schulman et al., 
2004) 
7.64x10
-6
 
7d AUC rs109880729 3: 27,600,325 Intergenic C: 0.05  T: 0.95 NHLH2, CASQ2 
MY QTLs 
(Viitala et al., 2003, 
Ashwell et al., 2004) 
3.10x10
-5
 
Severity 
Score 
rs110199901 14: 2,524,432 Intron variant A: 0.48  G: 0.52 ZNF696 
MY QTLs, SCS QTL 
(Viitala et al., 2003, 
Ashwell et al., 2004) 
3.65x10
-5
 
S. uberis  1
st
 
clearance 
rs41610542 11:7,625,345 3’ downstream A: 0.78  G: 0.22 TMEM182 
SCC QTL 
(Schnabel et al., 
2005) 
4.27x10
-5
 
Severity 
Score 
rs55617160 14: 4,468,478 Intron variant A: 0.40  G: 0.60 TRAPPC9 
MY QTL, SCS QTL 
(Kaupe et al., 2007) 
7.04x10
-5
 
S. uberis 
shedding 
cycles 
rs109427689 15: 25,622,211 Intron variant A: 0.50  C: 0.50 LOC101908225 
SCS QTL 
(Boichard et al., 2003) 
7.75x10
-5
 
Newly identified loci 
7d AUC rs41831243 17: 5,221,649 Intron variant C: 0.08  T: 0.92 FBXW7 -- 2.68x10
-6
 
7d AUC rs110804434
♦
 13: 78,901,415 Intron variant A: 0.41  G: 0.59 TMEM189* -- 4.96x10
-6
 
7d AUC rs110866336 12: 77,746,796 Intron variant A: 0.78  G: 0.22 HS6ST3 -- 5.21x10
-6
 
7d AUC rs109747337 22: 58,790,629 Intergenic A: 0.93  G: 0.07 CHCHD4, WNT7A -- 9.39x10
-6
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Table 2: Continued 
Trait rs 
Locus (Chr: 
bp)
1
 
SNP type 
Allele 
Frequencies
2
 
Nearest gene(s) Prior Evidence P-value 
7d AUC rs109290019
~
 18: 53,260,898 Intergenic A: 0.57  G: 0.43 
TRAPPC6A, 
EXOC3L2 
-- 1.94x10
-5
 
Chronic 
Score 
rs43273037 1: 134,069,561 Intron variant G: 0.59  T: 0.41 PCCB -- 2.00x10
-5
 
Severity 
Score 
rs109788678 13: 11,784,421 Intron variant C: 0.67  T: 0.33 CAMK1D -- 2.40x10
-5
 
7d AUC rs42651398 21: 39,716,280 3’ downstream C: 0.49  T: 0.51 FOXG1 -- 2.46x10
-5
 
7d AUC rs110942101 22: 7,385,040 Intron variant G: 0.07  T: 0.93 CCR4 -- 3.10x10
-5
 
7d AUC rs109070561 18: 53,281,931 Intron variant A: 0.46  G: 0.54 LOC508455 -- 3.96x10
-5
 
28d AUC rs110804434
♦
 13: 78,901,415 Intron variant A: 0.41  G: 0.59 TMEM189* -- 4.52x10
-5
 
S. uberis 1
st
 
clearance 
rs41645172 2: 109,778,246 5’ upstream A: 0.69  G: 0.31 EPHA4 -- 5.74x10
-5
 
S. uberis 
shedding 
cycles 
rs41576873 4: 92,742,789 Intron variant A: 0.62  G: 0.38 SND1 -- 6.12x10
-5
 
7d AUC rs110974478 1: 150,141,293 Intergenic A: 0.09  G: 0.91 SETD4, CBR3 -- 6.15x10
-5
 
28d AUC rs110693161 24: 48,872,488 Intron variant A: 0.20  G: 0.80 CTIF -- 6.73x10
-5
 
S. uberis 1
st
 
clearance 
rs41653441 28: 28,149,081 Intron variant C: 0.51  T: 0.49 PSAP* -- 7.04x10
-5
 
7d AUC rs110747207 26: 50,933,887 
Non-coding 
transcript 
variant 
A: 0.17  G: 0.83 LOC100850437 -- 7.14x10
-5
 
S. uberis 
shedding 
cycles 
rs41570578 17: 64,142,204 Intron variant G: 0.70  T: 0.30 HECTD4 -- 7.47x10
-5
 
28d AUC rs109290019
~
 18: 53,260,898 Intergenic A: 0.57  G: 0.43 
TRAPPC6A, 
EXOC3L2 
-- 8.91x10
-5
 
Chronic 
Score 
rs110599808 28: 247,173 Intron variant A: 0.43  G: 0.57 RAB4A -- 9.70x10
-5
 
1
Reported positions are based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build. 
2
Allele frequencies are representative of the current study population. 
*Gene is a partial start transcript 
♦~
Indicate SNPs identified using more than one novel phenotype, each symbol is unique to one rs number.
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Figure 6: Minimum, median, and maximum for S. uberis 1st clearance, severity score, 
and chronic score phenotypes.  S. uberis 1st clearance is represented by the number of 
days until S. uberis CFU reached zero based on milk culturing.  Severity and chronic 
scores are represented by the sum of milk and mammary scores over the initial 7 d 
post-challenge or the entire 28 d challenge period, respectively.  Minimums for both 
severity and chronic score were zero. 
  
4 
23.5 
43 
54.5 
47 
50 
71 
0
10
20
30
40
50
60
70
80
90
100
110
120
130
S. uberis
Clearance
Severity Score Chronic Score
N
u
m
b
e
r 
o
f 
D
a
y
s
 o
r 
S
u
m
 o
f 
M
il
k
 a
n
d
 M
a
m
m
a
ry
 
S
c
o
re
s
 
Phenotype 
Maximum
Median
Minimum
. ri  
Clearance 
0 0 
65 
 
 
Figure 7: Manhattan plot of GWAS for S. uberis 1st clearance phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34).  The x-axis 
shows chromosome and SNP order within a chromosome.  The y-axis show the –
log10(P-value) for each SNP.  P-value thresholds are indicated by dashed lines: top 
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. 
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Figure 8: Number of cows per S. uberis shedding cycle category, where the x-axis 
indicates the number of times S. uberis CFU reached zero within the 28 day sampling 
period. 
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Figure 9: Manhattan plot of GWAS for S. uberis shedding cycles phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34).  The x-axis 
shows chromosome and SNP order within a chromosome.  The y-axis show the –
log10(P-value) for each SNP.  P-value thresholds are indicated by dashed lines: top 
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. 
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Figure 10: Minimum, median, and maximum S. uberis CFU AUC values for both 7 and 
28 d phenotypes displayed in millions of CFU*d. 
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Figure 11: Manhattan plot of GWAS for 7 d S. uberis CFU AUC phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36).  The x-axis 
shows chromosome and SNP order within a chromosome.  The y-axis show the –
log10(P-value) for each SNP.  P-value thresholds are indicated by dashed lines: top 
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. 
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Areas under the curve for the 28 day time period ranged from 38.5 CFU*d to 
1.27x108 CFU*d, with a median of 5.55x107 CFU*d (Figure 10).  Association analyses 
identified 3 suggestively significant (p < 9.34x10-5) associated with 28 d S. uberis AUC 
(Figure 12).  Two of the identified SNPs (rs110804434 on BTA 15 and rs109290019 on 
BTA 18) were also identified using the 7d AUC phenotype.  The remaining identified 
SNP (rs110693161) is on BTA 24 and located within the CTIF (cap binding complex 
dependent translation initiation factor) gene. 
The next two phenotypes were generated using sums of mammary and milk 
scores to identify levels of inflammation.  Severity score focused on cows displaying 
acute clinical signs post-challenge by summing their scores for the first 7 days after 
challenge.  Severity scores ranged from 0 to 50, with a median of 43 (Figure 6).  
Analyses identified 3 suggestively significant (p < 9.34x10-5) SNPs associated with 
severity score located on BTAs 13 (rs109788678), 14 (rs110199901 and rs55617160) 
(Figure 13).  All three SNPs are within genes with known functions.  The BTA 13 SNP, 
rs109788678, is within the CAMK1D (calcium/calmodulin dependent protein kinase 1D) 
gene.  The SNPs on BTA 14, rs110199901 and rs55617160 are within the ZNF696 
(zinc finger protein 696) gene and the TRAPPC9 (trafficking protein particle complex 9) 
gene, respectively.  Chronic score focused on chronically symptomatic cows by 
summing scores across the entire 28 day sampling period.  Chronic scores ranged from 
0 to 71 and had a median of 54.5 (Figure 6).  Chronic score identified 2 suggestively 
significant SNPs (p < 9.34x10-5), with one SNP each on BTA 1 (rs43273037) and 28 
(rs110599808) (Figure 14).  Both SNPs are within known genes; rs43273037 is located 
within the PCCB (Propionyl CoA carboxylase, beta polypeptide) gene and rs110599808 
is within the RAB4A (RAB4A, member RAS oncogene family) gene.   
Discussion 
 This study successfully identified associations between SNPs in the bovine 
genome and novel phenotypes generated from data obtained using an S. uberis 
challenge model.  Our prior study (Siebert Dissertation, Chapter 3) utilized the same 
study design to develop SCC based phenotypes and successfully identified 16 SNPs, 
where 4 SNPs were located directly in potential candidate genes, 3 more SNPs were in 
quantitative trait loci (QTLs) previously linked to mastitis or mastitis related phenotypes, 
and 2 more SNPs within candidate genes and previously identified QTLs.  The success 
of our prior study helps lend strength to the results of the present study.  Additionally, 9 
of the SNPs identified in this study (rs41665257, rs43709346, rs43423752, 
rs111021268, rs109880729, rs110199901, rs41610542, rs55617160, and rs109427689) 
are located in genomic regions with prior evidence associated with mastitis or related 
phenotypes.  Considering both our studies successfully identified genomic  
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Figure 12: Manhattan plot of GWAS for 28 d S. uberis CFU AUC phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35).  The x-axis 
shows chromosome and SNP order within a chromosome.  The y-axis show the –
log10(P-value) for each SNP.  P-value thresholds are indicated by dashed lines: top 
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. 
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Figure 13: Manhattan plot of GWAS for severity score phenotype using BovineSNP50 
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36).  The x-axis shows 
chromosome and SNP order within a chromosome.  The y-axis show the –log10(P-
value) for each SNP.  P-value thresholds are indicated by dashed lines: top black line p 
= 1.95x10-5; bottom gray line p = 9.34x10-5. 
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Figure 14: Manhattan plot of GWAS for chronic score phenotype using BovineSNP50 
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34).  The x-axis shows 
chromosome and SNP order within a chromosome.  The y-axis show the –log10(P-
value) for each SNP.  P-value thresholds are indicated by dashed lines: top black line p 
= 1.95x10-5; bottom gray line p = 9.34x10-5. 
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regions with prior evidence linked to mastitis or traits associated with mastitis, the use of 
novel phenotypes derived from S. uberis challenge data to identify genomic regions of 
interest for S. uberis mastitis may be a viable new method for identifying candidate 
genes. 
Of the identified SNPs in the present study, two SNPs associated with the 7d 
AUC phenotype (rs41665257 and rs43709346) were located within QTLs for clinical 
mastitis (CM) (Klungland et al. 2001; Lund et al. 2008).  Clinical mastitis is hallmarked 
by mammary gland inflammation and altered milk production.  The inflammation 
associated with CM typically indicates a strong immune response correlating to higher 
recruitment of SCC.  Higher SCC could lead to faster clearance of S. uberis from the 
gland and lead to lower observed 7d AUC phenotypes.  Another 5 SNPs significantly 
associated with the phenotypes S. uberis first clearance (rs41610542), S. uberis 
shedding cycles phenotype (rs109427687), 7d AUC (rs111021268), and severity score 
(rs110199901 and rs55617160) were located within QTLs associated with SCC and 
SCS (Ashwell et al. 2004; Boichard et al. 2003; Kaupe et al. 2007; Schnabel et al. 2005; 
Schulman et al. 2004).  More elevated SCC/SCS would indicate more immune cells to 
fight the infection and would likely correlate to faster bacteria clearance post-challenge 
linking SCC/SCS directly to our S. uberis 1st clearance and 7d AUC phenotypes.  The 
more elevated SCC/SCS and subsequent faster bacteria clearance would also lead to 
more inflammation observed and higher mammary and milk scores which ties SCS to 
our severity score phenotype.  Conversely, lower SCC/SCS would indicate fewer 
immune cells to fight the infection and potentially allow for the infection to persist, or 
even demonstrate cycling of bacteria clearance when the immune cell populations are 
depleted and more haven’t yet reached the gland, which links SCS to our S. uberis 
cycles phenotype.  Of interest, SNPs associated with 7d AUC (rs43423752 and 
rs109880729) and severity score (rs110199901 and rs55617160) phenotypes were 
located in regions previously identified as associated with milk yield (MY) QTLs (Ashwell 
et al. 2004; Daetwyler et al. 2008; Kaupe et al. 2007; Viitala et al. 2003).  The 
association of mastitis incidence and milk yield has been known for decades (Meredith 
et al. 2012; Shaw and Beam 1935; Wilson et al. 1997) since fighting infections 
sequesters energy that would otherwise be partitioned to milk production.  Since, higher 
S. uberis CFU would lead to higher SCC (used as an indicator of mastitis) and higher 
SCC causes higher mammary and milk scores, both 7d AUC and severity score could 
impact MY.   
 While the identified SNPs themselves may not be causal but rather in linkage 
disequilibrium is the causal variant, they do provide several interesting candidate genes 
based on the genes they are located within.  Of the SNPs identified with prior evidence, 
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3 are also within known genes.  First, rs111021268, identified with the 7d AUC 
phenotype, is located within the FSD2 (fibronectin type III and SPRY domain containing 
2) gene.  While there is not a specific known function for FSD2, the domains it contains 
(FN3 and SPRY) are components of many other proteins.  The FN3 domain is an 
extracellular free-acting domain that provides a scaffold for the binding of a variety of 
ligands (Bloom and Calabro 2009; Campbell and Spitzfaden 1994).  The SPRY domain 
is intracellular and is also involved in protein interactions, including those that regulate 
the innate and adaptive immune systems through transcriptional regulation and 
production of reactive compounds (D'Cruz et al. 2013).  Inabilities to properly interact 
with ligand and/or mount an effective immune response would permit S. uberis growth 
in the mammary gland and lead to higher 7d AUC phenotypes observed. 
The other two SNPs with prior evidence and within genes were identified using 
the severity score phenotype.  Within the ZNF696 (zinc finger protein 696) gene is the 
rs110199901SNP.  While no specific function is attributed to ZFN696, zinc finger 
proteins are frequently involved in DNA/RNA binding and subsequent regulation of 
transcription/translation (Laity et al. 2001).  Lastly, rs55617160 is within the TRAPPC9 
(trafficking protein particle complex 9).  TRAPPC9 has been linked to increased 
cytokine-mediated NFĸB activation through phosphorylation of the IKK complex (Hu et 
al. 2005).  NFĸB is a transcriptional activator of many genes including many that are 
critical for inflammation and immunity (Bonizzi and Karin 2004).  The inability to properly 
regulate transcriptional and/or translational changes following an infection would likely 
result in lower observed inflammation and reduced immune responses despite bacteria 
presence, leading to the lower severity score phenotypes observed.   
 The S. uberis 1st clearance phenotype identified 2 novel SNPs, one SNP 
(rs41645172) on BTA 2 at 109.8Mb, and another SNP (rs41653441) on BTA 28 at 
28.1Mb that is within the PSAP (prosaposin) gene.  Prosaposin is the precursor that 
generates saposin A, B, C, and D through limited proteolytic processing (O'Brien and 
Kishimoto 1991).  Saposins are involved in lipid degradation within the lysosome and 
also play a role in loading lipid antigens onto CD1 molecules (Barral and Brenner 2007).  
Antigen presentation by CD1 activates several sub-sets of T-cells, including CD8+ T-
cells which have demonstrated importance in for killing S. uberis in the mammary gland 
(Barral and Brenner 2007; Denis et al. 2011).  Additionally, the un-cleaved prosaposin 
precursor may play a role in regulating cell proliferation and apoptosis (Sun et al. 2010).  
Thus, PSAP could play a role eliciting a more efficient response to and clearance of 
invading pathogens and lead to lower observed S. uberis 1st clearance phenotype. 
 The S. uberis cycles phenotype identified two other novel SNPs in genes, one 
SNP (rs41576873) on BTA 4 at 92.7Mb and another SNP (rs41570578) on BTA 17 at 
76 
 
64.1Mb.  The BTA 4 SNP is within the SND1 (staphylococcal nuclease and tudor 
domain containing 1) gene.  SND1 is a transcriptional coactivator that interacts with 
many other transcriptional activators including STAT5 and STAT6 (Yang et al. 2002; 
Yang et al. 2007).  STAT5 plays a role in preventing apoptosis of lymphocytes (Mui et 
al. 1995).  STAT6 is involved in IL-4 signal transduction to differentiate naïve t-helper 
cells into Th2 cells that are essential for activating the humoral (B-cell) response 
(Takeda et al. 1997).  Reduced lymphocyte survival and humoral response could result 
in fewer immune cells to fight infection.  Fewer immune cells to fight infection could lead 
to a cycling of bacteria clearance when immune cell populations are depleted or 
unprimed with antigen leading to higher numbers of S. uberis cycles observed.  The 
BTA 17 SNP is within the HECTD4 (HECT domain E3 ubiquitin protein ligase 4) gene.  
The HECT domain subfamily of a ubiquitin ligase protein helps determine the type of 
ubiquitin chain formed during ubiquination (Sheng et al. 2012).  Ubiquination helps 
determine the biological fates of protein by targeting them for degradation, altering their 
cellular location, or affecting their interactions/ activity (Glickman and Ciechanover 
2002; Schnell and Hicke 2003).  Ubiquination has been demonstrated to control the 
immune response through NFĸB regulation, thus alterations in HECT domains could 
result in altered NFĸB regulation and subsequent altered immune response (Magnani et 
al. 2000).  Alterations in immune response could alter S. uberis’s ability to proliferate 
within the gland and possibly allow for bacterial clearance cycling as other aspects of 
the immune system attempt to compensate for those ubiquination may affect. 
 The 7d AUC phenotype identified the most SNPs when compared to other 
phenotypes, with 10 SNPs being novel.  Four of these novel SNPs are located in genes 
with known functions.  One SNP, rs41831243, on BTA 17 at 5.2Mb, is in the FBXW7 (F-
box and WD repeat domain containing 7) gene.  FBXW7 is a subunit of the SCF 
ubiquitin protein ligase complex that targets mediators of the cell cycle and cell division 
using phosphorylation-dependent ubiquination.  Specifically, FBXW7 is critical for 
immature CD4+CD8+ T-cells to exit the cell cycle and for the proliferation of mature T-
cells (Onoyama et al. 2007).  Since CD8+ T-cells have demonstrated particular 
importance in for killing S. uberis in the mammary gland (Barral and Brenner 2007; 
Denis et al. 2011), inadequate T-cell maturation and proliferation could permit S. uberis 
to persist in the gland post-challenge and lead to higher the 7d AUC phenotypes 
observed.  Another SNP on BTA 13 at 78.9Mb, rs110804434, also identified with the 
28d AUC phenotype, is within the TMEM189 (transmembrane protein 189) gene.  
TMEM189 is closely downstream to UBE2V1 (ubiquitin-conjugating enzyme E2 variant 
1) and the two genes are often expressed as a conjoined gene (Prakash et al. 2010).  
While there is no known function tied to the conjoined genes, it is hypothesized they 
play a role in gene regulation (Prakash et al. 2010).  Additionally, overexpression of this 
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particular conjoined gene has been linked to slower degradation of other (EGF) receptor 
complexes via endocytosis (Duex et al. 2010).  Therefore, TMEM189 could help 
regulate gene expression and receptor-ligand complex degradation during the infection 
process and lead to higher or lower observed 7d and 28d AUC observed phenotyped 
depending on the effect.  The third SNP identified with 7d AUC, rs110866336, at 
77.7Mb on BTA 12, is in the HS6ST3 (heparan sulfate 6-O-sulfotransferase 3) gene.  
HS6ST3 modifies heparan sulfate, found in heparan sulfate proteoglycans on the cell 
surface and in the extracellular matrix, to generate a variety of structures needed for 
protein interactions (Habuchi et al. 1995; Yanagishita and Hascall 1992).  Such protein 
interactions have demonstrated importance for both inflammation and bacteria 
adherence/infection (Rostand and Esko 1997; Tanaka et al. 1993).  Therefore, a 
reduction of modified heparan sulfates would likely lead to less inflammation and 
reduced bacterial adherence/infection and probably correlate with lower 7d AUC 
phenotypes.  The final SNP (rs110942101) within a gene for 7d AUC is on BTA 22 at 
7.4Mb and is within the CCR4 (C-C motif chemokine receptor) gene.  CCR4 is the g-
protein coupled receptor for chemokine CCL22, which is released by macrophages 
upon the initiation of immune responses (Imai et al. 1998).  CCR4 is expressed on both 
CD4+ and CD8+ T-cells and its expression is upregulated after activation (i.e.: ligand 
binding) (D’Ambrosio et al. 1998).  Receptor-ligand complexes helps increase 
extravasation, cell migration, and effector T-cell positioning at the recruitment site 
(Chang et al. 1997; D’Ambrosio et al. 1998).  During mastitis, significant increases in T-
cell recruitment to the gland has been observed and CD8+ T-cells have demonstrated 
specific and substantial killing ability towards S. uberis (Denis et al. 2011; Mehrzad et al. 
2008).  Thus, alterations in CCR4 could correlate to faster clearance of invading 
bacteria in the mammary gland and lower observed CFU leading to lower 7d AUC 
phenotypes observed. 
 The 28d AUC phenotype identified 3 novel SNPs.  Both rs109290019 and 
rs110804434 were also identified by 7d AUC phenotype and were discussed previously.  
The third SNP, rs100693161, located on BTA 24 at 48.9Mb, is located within the CTIF 
(cap binding complex dependent translation initiation factor) gene.  CTIF is a 
component of the CBP80/20-dependent translation initiation complex that co-
transcriptionally binds the cap end of nascent mRNAs (Kim et al. 2009).  The CBP80/20 
complex recognizes premature termination codons (PTCs) during translation which 
helps minimize expression of truncated proteins by targeting them for decay (Chang et 
al. 2007).  A mutation in CTIF could permit a breakdown in this editing process allowing 
a higher expression of truncated proteins that are either non-functional or toxic to host 
cells, which depending on the effected proteins, could permit more growth of S. uberis 
and lead to higher observed 28d AUC phenotypes. 
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 The severity score phenotype identified only one novel SNP located on BTA 13 
at 11.8Mb and within the CAMK1D (calcium/calmodulin dependent protein kinase 1D) 
gene.  CAMK1D is a component of the calcium-regulated calmodulin-dependent protein 
kinase cascade which has been implicated in the migration of neutrophils following 
chemoattractant stimulation (Verploegen et al. 2002).  Inefficiencies in stimulating 
neutrophil migration would lead to lower levels of inflammation observed at the site of 
infection and result in the observation of lower severity score phenotypes. 
Both of the novel SNPs identified by the chronic score phenotype are located 
within genes.  Within the PCCB (propionyl CoA carboxylase, beta polypeptide) gene, on 
BTA 1 at 134.1Mb, is rs43273037.  PCCB is a subunit of propionyl CoA carboxylase 
which is involved in the metabolism of propionic acid that has no definitive connections 
to the chronic score phenotype (Tietz and Ochoa 1959).  However, propionic acid is one 
of the main energy sources used by dairy cattle and energy status has demonstrated 
importance for susceptibility to mastitis (Knegsel et al. 2005; Rezamand et al. 2007).  
Thus, reduced ability to metabolize propionic acid could decrease available energy and 
influence susceptibility to mastitis and potentially allow for infections to persist and 
cause increased chronic scores observed.  Lastly, rs110599808 is on BTA 28 at 0.2Mb 
and is in the RAB4A (RAB4A, member RAS oncogene family) gene.  RAB4A is a 
member of the RAS superfamily of small GTPases that are involved in regulating 
membrane trafficking.  Specifically, RAB4A regulates the secretion of α-granules from 
platelets (Shirakawa et al. 2000).  Platelet α-granules contain P-selectin which is a vital 
cell adhesion molecule needed for monocyte and neutrophil extravasation which is 
required for cell recruitment to the site of infection (Furie et al. 2001).  Improper 
extravasation would result in fewer immune cells at the infection site and result in lower 
levels of inflammation and lower chronic scores observed. 
 In conclusion, this study was successful in identifying SNPs associated with 
novel phenotypes generated from data collected following direct S. uberis experimental 
challenge.  Considering 31% of the SNPs identified using our novel phenotypes are in 
regions with prior evidence linked to mastitis, the probability that our remaining identified 
loci are valid associations is high.  The majority of the identified SNPs are also located 
within known genes where 17% have functions linked to immune functions and 28% 
have roles in the regulation of gene or protein expression.  Associations with immune 
function and gene regulation are logical since recognition of S. uberis within the 
mammary gland would cause the upregulation of many genes, especially those linked to 
immune processes.  Thus, the investigation of these candidate genes could potentially 
uncover novel treatment or preventative strategies for S. uberis mastitis or serve as 
selections markers for cows less susceptible to S. uberis mastitis.  Furthermore, the 
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possibility that these genes could be associated with other causative pathogens exists 
since the identified genes seem to have links to more generic immune processes rather 
than to S. uberis’s unique pathology. 
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Abstract 
Mastitis is a detrimental disease in the dairy industry that costs upwards of $2 
billion annually and decreases milk quality.  Often, mastitis results from bacteria 
entering the gland through the teat end.  A common mastitis causing pathogen is S. 
uberis, which is responsible for a high percentage of subclinical and clinical mastitis 
cases.  Following an intramammary experimental challenge with S. uberis on Holstein 
cows (N=40), differing phenotypes with respect to S. uberis counts, inflammation 
indicators, and antibiotic therapies were observed depending on the CXCR1 haplotype 
combination of the cow.  However, phenotypic differences are suspected to have other 
genetic influences.  To test this both linkage and association tests were performed to 
identify other candidate genes.  Linkage analysis was performed in Haploview and 
identified that the CXCR1 gene is within 2 haplotype blocks, blocks 413 and 414.  Block 
413 contains only the 3’ end of CXCR1 (rs43323012 and 43323013).  Block 414, which 
contains the 5’ end of the CXCR1 haplotype combinations (rs211042414 and 
rs208795699) also contains another 21 genes that the CXCR1 SNPs could be serving 
as markers for.  To identify loci of interest a 50K SNP chip analysis was performed 
using the BovineSNP50 v2 DNA BeadChip from Illumina.  Associations were tested 
using Plink and identified 7 significant (p < 9.34x 10-5) SNPs outside of the CXCR1 
haplotype blocks.  One of the identified SNPs is within a gene with known function and 
three more are within a previously identified QTL for productive life.  The identified loci 
should be further investigated to potentially identify causation behind the observed 
phenotypes.  Such investigations could lead to novel treatment and prevention 
compounds/protocols for S. uberis mastitis or genetic selection methods for cows with 
greater potential to resist S. uberis infection. 
Introduction 
Mastitis is a devastating disease to the dairy industry that affects 20-50% of 
cows, causing increases in cow morbidity/mortality, decreased milk quality, and 
decreased farm revenues (Akers and Nickerson 2011; Barbano et al. 1991; Bradley et 
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al. 2007; Klei et al. 1998; Ma et al. 2000; Piepers et al. 2007).  Invasion of bacteria into 
the mammary gland through the teat end is typically what causes mastitis.  One of the 
most common mastitis causing pathogens is Streptococcus uberis.  S. uberis causes 
roughly 14-26% of all the subclinical and clinical incidences of mastitis and is the most 
commonly isolated pathogen during the dry (non-lactating) period (Bradley et al. 2007; 
Petrovski et al. 2011; Verbeke et al. 2014).  S. uberis is especially  problematic 
because, while it typically originates as an environmental pathogen, it can spread 
throughout the herd in a contagious manner once introduced (Zadoks 2007).  
Additionally, S. uberis has some unique pathology characteristics that can make 
clearing the infection from the mammary gland more problematic.  Once S. uberis 
enters the mammary gland, it binds lactoferrin, which is a common milk protein (Fang 
and Oliver 1999).  Lactoferrin can then act as a bridging molecule and allow binding of 
S. uberis to the mammary epithelial cells (Fang et al. 2000).  After binding, S. uberis 
then invades the host cells via caveolae dependent endocytosis (Almeida and Oliver 
2006; Matthews et al. 1994).  Once internalized, S. uberis can exploit host cell 
transduction and persist in the cytoplasm for hours (Almeida et al. 2000; Tamilselvam et 
al. 2006) effectively evading the host immune system.  Since S. uberis mastitis is a 
common problem dairy producers combat and S. uberis has mechanisms to evade the 
immune response, identifying specific genes involved in S. uberis pathogenesis could 
prove beneficial for the control and prevention of S. uberis mastitis on dairy farms. 
Once in the gland, bacteria encounter several cell types including alveolar and 
ductal epithelial cells that are responsible for synthesizing and secreting milk, 
fibroblasts, and resident immune cells (i.e.: macrophages, dendritic cells, neutrophils).  
The encountered host cell types release immune mediators in response to recognition 
of bacterial presence.  Immune mediators can include, but are not limited to: growth 
related oncogene (GRO)-γ, epithelial-derived neutrophil-activating peptide (ENA)-78, 
and interleukin (IL)-8 (Baggiolini and Clark-Lewis 1992; Rainard et al. 2008; Walz et al. 
1991).  The released immune mediators initiate the visual signs associated with 
mastitis, such as udder inflammation and altered milk production (i.e.: reduced volume, 
clots, etc.).  Specifically, IL-8, upon binding its receptors CXCR1 and CXCR2, can 
induce migration of immune cells to the site of infection, cause increased cell survival, 
and modify chemokine/cytokine production (Grob et al. 1990; Kettritz et al. 1998; 
Shamaladevi et al. 2009; Takata et al. 2004).  These functions influence the rate of 
response to infection and are critical to resolution of infections like mastitis.  
Furthermore, associations between single nucleotide polymorphisms (SNPs) in the IL-8 
receptor, CXCR1 gene and mastitis have been identified (Galvão et al. 2011; Grosse et 
al. 1999; Leyva-Baca et al. 2008; Verbeke et al. 2012; Youngerman et al. 2004).  Some 
of the identified SNPs have also been associated with diminished migration, binding of 
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secondary mediators, and receptor internalization following IL-8 binding (Fan et al. 
2002; Fan et al. 2000; Raman et al. 2010; Rambeaud et al. 2006; Rambeaud and 
Pighetti 2007; Rambeaud and Pighetti 2005; Yang et al. 1999).  Within the coding 
sequence of the CXCR1 gene, there are 5 SNPs (+365 (rs211042414), +621 
(rs135751317), +735 (rs208795699), +980 (rs43323012), and +995 (rs43323013)) that 
allowed for the identification of three dominant amino acid haplotypes (VWHKH, 
VWHRR, AWQRR) (Pighetti et al. 2012).   
A recent S. uberis challenge study demonstrated that Holstein cows (N=40) 
displayed differing phenotypes with respect to S. uberis counts, inflammation indicators, 
and antibiotic therapies depending on the CXCR1 haplotype combination of the cow 
(Siebert 2013).  However, we suspect that the observed differences in phenotype 
following challenge could have other genetic influences.  Other genetic influences could 
include loci in linkage disequilibrium with the previously identified CXCR1 SNPs or loci 
throughout the genome that work together with CXCR1 pleiotropically.  To test for 
genetic influences, we will identify the haplotype block surrounding the bovine CXCR1 
gene and perform an association analysis using a phenotype which includes genetic 
CXCR1 haplotype combination with antibiotic therapy grouping following intramammary 
S. uberis experimental challenge.  This approach will identify genes that are in linkage 
disequilibrium with CXCR1 and genes that could be working pleiotropically with CXCR1 
throughout the genome that could be influencing the different phenotypes observed 
following S. uberis challenge in our prior study (Siebert 2013).  Both approaches will 
identify other candidate genes that can be investigated for potential novel preventative 
or treatment compounds or improved genetic selection methods for cows less 
susceptible to S. uberis mastitis. 
Materials and Methods 
Animal Selection 
Holstein dairy cows (N = 40) that were entering their second or third lactation 
were enrolled in a trial to test the effectiveness of a novel vaccine candidate against S. 
uberis, i.e.: Streptococcus uberis adhesion molecule (SUAM) that involved a direct S. 
uberis challenge (USDA-NIFA AFRI 2011-67015-30168).  Cows were in overall good 
health, pregnant, at the end of their first or second lactation, had quarter SCC <250,000 
cells/mL, and were free of Johne’s, brucellosis, tuberculosis, and bovine leukemia virus 
(BLV).  Both S. uberis and SUAM baseline titers were assessed and cows with the 
lowest titers were enrolled.  All cows were housed at the East Tennessee Education 
and Research Center (ETREC) Little River Dairy (Walland, TN).  Upon arrival at 
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ETREC, cows were acclimated to the facility for two weeks prior to the initiation of 
research protocols.  Cows were housed separately from the core herd and cared for in 
accordance with ETREC Little River Dairy standard protocols.  All animal based work 
was approved by and done in accordance with Institutional Care and Use Committee 
(IACUC) guidelines.   
Haplotyping 
Blood samples (n=1 for each cow), collected during the dry period via jugular 
puncture, were used to isolate DNA with UltraClean BloodSpin DNA Isolation Kit (Mo 
Bio, Carlsbad, CA).  The SNP containing portion of the CXCR1 gene was amplified as 
follows: 1-2 ng of bovine genomic DNA was used as template in a 25 µl reaction 
containing specific primers (Forward: 5’-CTTCATC-TTCCGGTGAGGCCTATCAAC-3’; 
Reverse: 5’-AAGGGAAGGGGACTTTCCTGGCTG-3’) and Eppendorf HotMaster Mix 
(Eppendorf North America; Westbury, NY) according to manufacturer's guidelines.  DNA 
concentration was confirmed via spectrophotometry using NanoDrop 1000 (Thermo 
Fisher Scientific; Wilmington, DE).  Conditions for amplification were:  an initial hot-start 
denaturation at 94oC for 2 min, followed by 50 cycles of 94oC denaturation for 15 s, 
62oC annealing for 20 s, and 72oC extension for 60 s.  After the last cycle, a 10 min final 
extension step at 72oC was added before reactions were chilled to 4oC.  Amplified 
products were purified to remove primer and excess nucleotides.  The resulting purified 
CXCR1 DNA was sequenced using bovine CXCR1 specific primers (Forward: 5’-
CTTCATC-TTCCGGTGAGGCCTATCAAC-3’; Reverse: 5’-
AAGGGAAGGGGACTTTCCTGGCTG-3’) and the CXCR1 haplotype, comprised of 
positions +365 (rs211042414), +621 (rs135751317), +735 (rs208795699), +980 
(rs43323012), and +995 (rs43323013), was determined based on nucleotide expression 
at tagSNP positions +621 (rs135751317), +735 (rs208795699), +816 (rs210501501), 
and +980 (rs43323012) in the CXCR1 gene previously identified using phasing on a 
larger population (Pighetti et al. 2012; Stephens and Scheet 2005; Stephens et al. 
2001).    Within the haplotype combination groups: VWHRR x VWHRR cows did not 
share any parentage back three generations; VWHKH x VWHRR, AWQRR x VWHRR, 
and AWQRR x VWHKH groups each had two cows sharing a grandsire, which was the 
same grandsire for each haplotype combination; and AWQRR x AWQRR cows were the 
most related group, with two pairs of cows sharing sires, one pair of cows sharing a 
maternal grandsire, and one set of three cows sharing a paternal grandsire. 
Challenge 
Approximately one week prior to calving and at first milking post-calving, 
secretion samples were collected from each quarter to screen for bacterial presence to 
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select a challenge quarter free of pathogens.  A frozen stock of Streptococcus uberis 
(UT888) was thawed in a 37°C water bath and an aliquot used to inoculate a blood agar 
plate.  After 23-24 h of growth on the agar, 3 representative colonies were used to 
inoculate Todd Hewitt Broth for an additional 7 h of growth.  The 1 mL aliquot of the 
resulting liquid culture was serially diluted in PBS to approximately 2,000 CFU for 
infusion.  A total of 5 mL of the diluted culture was used for challenge, resulting in a total 
of 10,000 CFU delivered.  Challenge was performed within 3 days post-calving 
immediately following milking.  Prior to intramammary infusion, teat ends were cleaned 
thoroughly with sterile alcohol pads and the inoculum was infused using sterile 
disposable syringes with teat cannulas. The challenge inoculum was massaged upward 
into the teat and gland cisterns and plated (100μL) to determine the actual CFU/mL of 
S. uberis delivered which averaged 2122 ± 371 CFU/mL and ranged from 1185 to 3202 
CFU/mL. 
Sampling and Phenotype Description 
Cows were closely monitored post-challenge for the development of mastitis for 
28 d post-challenge.  Mammary and milk scores were evaluated on a 0 to 3 scale by 
ETREC Little River Staff twice daily.  Mammary scores were defined as follows: 0 = 
normal, 1 = slight swelling, 2 = moderate swelling, 3 = edema.  Milk scores were defined 
as follows: 0 = normal, 1 = small flakes or clots, 2 = large clots, 3 = stringy, off color, 
watery, or bloody.  Cows with 3 consecutive sets of severe scores (a 2 in both 
mammary and milk or a 3 in either) were treated with antibiotics.  Alternatively, if cows 
were still shedding S. uberis 14 d post-challenge, antibiotics were administered to clear 
the infection, since the end goal was to return healthy cows back to the general milking 
herd.  Following the 28 d sampling period, the percentage of cows within each CXCR1 
haplotype combination that required antibiotics to clear the infection was determined.  
This resulted in 3 percentage groups used to test for associations: 100% antibiotic 
therapy (VWHRR x VWHRR and AWQRR x VWHRR), 75% antibiotic therapy (AWQRR 
x VWHKH and AWQRR x AWQRR), and 33% antibiotic therapy (VWHKH x VWHRR).  
The haplotypes of two cows, 222 and 237, could not be determined and were not 
included in response variable analyses, resulting in N=38 cows. 
Association and Linkage Analysis 
Blood samples were collected from each cow via jugular puncture and DNA was 
isolated using UltraClean BloodSpin DNA Isolation Kit (Mo Bio, Carlsbad, CA).  
Resulting DNA was used to perform a 50K SNP chip analysis using the BovineSNP50 
DNA Analysis BeadChip (Illumina, San Diego, CA) (Gunderson et al. 2005; Steemers et 
al. 2006).  The SNP chip has 54,609 SNPs that span all 29 autosomes of the bovine 
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genome with an average SNP spacing of 49.4kb and a median spacing of 36.9kb.  
Associations were tested between developed the phenotype and SNPs using Plink 
(Purcell et al. 2007).  Effects of sex were excluded from the analysis because all 
individuals were female and SNPs did not represent sex chromosomes.  The p-value 
cutoffs of p < 1.95x10-5 for highly significant SNPs and p = 1.95x10-5 to 9.34x10-5 for 
suggestively significant SNPs were set based on guidelines for reducing false positives 
and increasing reproducibility (Manly 2005).  For identified SNPs to be reported, the 
minor allele had to be represented by more than one cow, unless the SNP aligned with 
prior evidence for mastitis or mastitis related traits.  A complete index of identified 
SNPs, including those removed based on the minor allele criteria, is included as an 
appendix (Table A-1).  To allow depiction of the numerous SNPs, their genome 
locations, and their variable association p-values, generated Plink results were 
visualized using Manhattan plots created with Integrated Genome Viewer (IGV) 
(Robinson et al. 2011).   
For linkage analysis a subset of the 50K SNP chip data was created to include 
only SNPs on BTA 2, the chromosome where the CXCR1 gene is located.  Genotypes 
for each of the 5 CXCR1 SNPs were added to the SNP chip dataset based on the 
haplotyping results for each cow.  Additionally the locations of the CXCR1 SNPs were 
added to the SNP map file.  Linkage analyses were performed using Haploview (Barrett 
et al. 2005).  SNPs were excluded from the linkage analysis when the minor allele was 
not observed in the genotyped cows, which resulted in the removal of the CXCR1 +621 
(rs135751317).  Additionally, SNPs where less than 50% of cows were genotyped due 
to poor reads were removed from analysis.  After SNP editing, a total of 692 SNPs were 
removed, resulting in 2,142 SNPs on BTA being included in the linkage analysis.  
Haplotype blocks surrounding the CXCR1 SNPs were determined using the solid spine 
algorithm such that the first and last marker in each block is in strong linkage 
disequilibrium with all the intermediate markers.  All reported gene and SNP locations 
for both analyses were reported based on the Bos taurus UMD_3.1.1 
(GCF_000003055.6) genome build. 
Results 
The linkage analysis identified a total of 529 haplotype blocks on BTA 2, which is 
137.24 Mb in length, using solid spine linkage analysis.  The CXCR1 SNPs were 
included within 2 blocks, block 413 and block 414 (Table 3, Figure 15, Figure 16).  Block 
413 ranges from rs43323008 to rs43323012 which is 106,924,044 – 106,937,600 bp 
(13kb) on BTA 2 .  The only gene coded within block 413 is the 3’ end of CXCR1 which 
includes SNPs rs43323012 and 43323013 (Table 4).  Block 414 ranges from 
rs208795699 to rs110289171 which is 106,937,845 – 107,378,666 bp (440kb) on BTA 2  
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Table 3: SNPs identified to be in linkage disequilibrium with CXCR1 SNPs using 
Haploview based on BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) positions. 
SNP Name rs BTA 2 Location 
Block 413 (13 kb) 
ARS-BFGL-NGS-3684 rs43323008 106,924,044 
CXCR1c995 rs43323013 106,937,585 
CXCR1c980 rs43323012 106,937,600 
Block 414 (440 kb) 
CXCR1c735 rs208795699 106,937,845 
CXCR1c621 rs135751317 106,937,962 
CXCR1c365 rs211042414 106,938,215 
BTA-48880-no-rs rs41585646 106,952,479 
BTA-48881-no-rs rs41585647 106,984,473 
Hapmap60413-ss46526389 rs41255527 107,005,982 
Hapmap31750-BTA-134395 rs109464198 107,168,923 
ARS-BFGL-NGS-116634 rs109230217 107,318,080 
ARS-BFGL-NGS-5566 rs110289171 107,378,666 
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Figure 15: Linkage analysis identifying SNPs on BTA 2 in linkage disequilibrium with 
CXCR1 SNPs using BovineSNP50 v2 BeadChip (Illumina, San Diego, CA).  Blocks are 
outlined in thick black lines.  Colors indicate likelihood of linkage disequilibrium (LD) as 
calculated by logarithm of odds (LOD; log10(likelihood of LD/likelihood of equilibrium 
where higher values indicate more likely LD) and D’ (disequilibrium coefficient 
normalized for the observed allele frequencies; values closer to 1 or 100% indicate 
higher LD; numbers in squares).  Red squares = LOD ≥ 2, D’ = 1.  Shades of pink = 
LOD ≥ 2, D’ < 1.  Blue = LOD < 2, D’ = 1.  White = LOD < 2, D’ < 1; strong evidence of 
recombination. 
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Figure 16: Spatial diagram SNPs identified to be in linkage disequilibrium with CXCR1 
SNPs using Haploview based on BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) 
positions. 
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Table 4: Genes and RNAs contained within the haplotype blocks surrounding CXCR1 
SNPs based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build. 
Bp Range 
Gene 
Abbreviation 
Gene Name NCBI ID 
Block 413 (106,924,044-106,937,600 bp) 
 106,936,878-106,937,600  CXCR1 C-X-C motif receptor 1 281863 
Block 414 (106,937,845-107,387,666 bp) 
 106,937,845-106,938,583  CXCR1 C-X-C motif receptor 1 281863 
 106,943,692-106,949,081  LOC107131616 non-coding RNA 107131616 
 106,978,526-107,006,143  ARPC2 actin related protein complex, subunit 2 540838 
 107,011,567-107,015,000  GPBAR1 g-protein coupled bile acid receptor 1 317756 
 107,015,357-107,020,300  AAMP angio-associated migratory cell protein 767919 
 107,020,657-107,093,550  PNKD paroxysmal non-kinesigenic dyskinesia 616561 
 107,023,823-107,041,372  TMBIM1 
transmembrane BAX inhibitor motif 
containing 1 
404134 
 107,082,988-107,087,346  LOC104971306 non-coding RNA 104971306 
 107,099,749-107,106,176  CATIP 
ciliogenesis associated TTC17 
interacting protein 
514380 
 107,103,742-107,105,782  LOC104971307 non-coding RNA 104971307 
 107,114,929-107,125,854  SLC11A1 
solute carrier family 11 (proton-coupled 
divalent metal ion transporter) 
282470 
 107,130,426-107,139,000  CTDSP1 
CTD (carboxy-terminal domain) small 
phosphatase 1 
516199 
 107,133,394-107,133,478  MIR26B microRNA 26b MI0004745 
 107,145,511-107,169,204  VIL1 villin 1 281573 
 107,170,031-107,255,579  USP37 ubiquitin specific peptidase 37 407168 
 107,256,013-107,289,222  RQCD1 
RCD1 required for cell differentiation 1 
homolog (S. pombe) 
536537 
 107,294,531-107,321,327  PLCD4 phospholipase C, delta 4 540771 
 107,322,027-107,341,857  ZNF142 zinc finger protein 142 511573 
 107,341,872-107,345,831  BCS1L BCS1-like  (S. cerevisiae) 539713 
 107,346,275-107,355,558  RNF25 ring finger protein 25 511571 
 107,355,281-107,387,666  STK36 serine/threonine kinase 36 508408 
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and includes the 5’ end of the CXCR1 gene (rs211042414 and rs208795699).  There 
are a total of 17 protein coding genes, 3 non-coding RNAs, and 1 micro RNA coded 
within block 414 (Table 4). 
For the antibiotic therapy phenotype developed from both CXCR1 haplotype 
combination and the necessity of antibiotics following challenge (Table 5, Figure 17), 
the 70-75% antibiotic therapy phenotype was most common, representing N=18 cows 
with both AWQRR x VWHKH and AWQRR x AWQRR haplotype combinations.  The 
second most common phenotype was the 100% antibiotic therapy, with N=10 cows from 
both VWHRR x VWHRR and AWQRR x VWHRR haplotype combinations.  The 33.3% 
antibiotic therapy phenotype was the least common, representing only VWHKH x 
VWHRR cows with N=6 cows.  Association analyses identified a total of 7 SNPs 
associated with the antibiotic therapy phenotype (Table 6 and Figure 18).  Three of the 
identified SNPs were highly significant (p < 1.95x10-5) and 4 were suggestively 
significant (p = 1.95x10-5 to 9.34x10-5).  The identified SNPs spanned 4 chromosomes, 
with 1 SNP on each BTA 7 (rs41612889) and BTA 8 (rs109792349), 3 SNPs on BTA 16 
(rs41660125, rs41576666, rs41596554) and 2 SNPs on BTA 2 (rs43317360, 
rs41644229).  One SNP on BTA 2, rs43317360, is located within the CRYBA2 
(crystallin beta A2) gene. 
Discussion 
 The goal of this study was to identify genes in linkage disequilibrium with SNPs in 
CXCR1 and could be serving as markers for and to identify genes that could be working 
pleiotropically with CXCR1 located throughout the genome.  These loci of interest could 
help explain the different phenotypes observed with respect to inflammation indicators, 
S. uberis CFU, and the need for antibiotics to clear the infection from our prior study by 
providing candidate genes for further investigation (Siebert 2013).  Both approaches to 
identify genes were successful and a total of 21 candidate genes were identified and 
are discussed below. 
Candidate Loci in LD with CXCR1: 
 The linkage analysis identified 2 separate blocks encompassing the previously 
identified CXCR1 SNPs on BTA 2.  Block 413 did not include any candidate genes that 
were in linkage disequilibrium (LD) with the CXCR1 SNPs.  However, block 414 
included 22 candidate genes that are in LD with two CXCR1 SNPs.  Since these genes 
are in LD with the CXCR1 3’ SNPs rs211042414 and rs208795699 previously 
associated with phenotypic differences following S. uberis challenge, the CXCR1 SNPs 
could be markers for the functions of these candidate genes.  Several of these  
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Table 5: Frequency of haplotype combinations observed in our sample population and 
their corresponding antibiotic therapy groupings. 
Haplotype Combination Frequency 
Antibiotic Therapy 
Phenotype 
VWHRR x VWHRR 5 100% 
VWHKH x VWHRR 7 33.3% 
AWQRR x VWHRR 6 100% 
AWQRR x VWHKH 9 70-75% 
AWQRR x AWQRR 11 70-75% 
Total 38  
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Table 6: Identified loci associated with the CXCR1 antibiotic therapy phenotype. 
rs 
Locus 
(chr: bp)
1
 
SNP type 
Allele 
frequencies
2
 
Nearest gene(s) Prior evidence P-value 
Loci with prior evidence 
rs41660125 16: 10389306 intergenic 
A: 0.45 
G: 0.55 
LOC100848559, CDC73 
PL QTL 
(Zhang et al., 1998) 
1.30x10
-5
 
rs41576666 16: 9941492 intergenic 
C: 0.61 
T: 0.39 
LOC100848559, CDC73 
PL QTL 
(Zhang et al., 1998) 
3.70x10
-5
 
rs41596554 16: 10740538 intergenic 
G: 0.50 
T: 0.50 
LOC100848559, CDC73 
PL QTL 
(Zhang et al., 1998) 
9.36x10
-5
 
Newly identified loci 
rs43317360 2: 107657675 intron variant 
A: 0.70 
C: 0.30 
CRYBA2 -- 2.20x10
-6
 
rs41644229 2: 107681700 5' upstream 
C: 0.65 
T: 0.35 
LOC101906201 -- 1.54x10
-5
 
rs41612889 7: 107527276 5' upstream 
C: 0.45 
T: 0.55 
EFNA5 -- 2.75x10
-5
 
rs109792349 8: 8618532 intergenic 
A: 0.61 
T: 0.39 
LOC783359, PRSS55 -- 3.74x10
-5
 
1
Reported positions are based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build. 
2
Allele frequencies are representative of the current study population. 
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Figure 17: Number of cows per antibiotic therapy phenotype grouping. 
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Figure 18: Manhattan plot of GWAS for antibiotic therapy phenotype using 
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35).  The x-axis 
shows chromosome and SNP order within a chromosome.  The y-axis show the –
log10(P-value) for each SNP.  P-value thresholds are indicated by dashed lines: top 
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5. 
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candidate genes have functions that could be linked to S. uberis pathogenesis or 
immune processes.   
The ARPC2 (actin related protein 2/3 complex, subunit 2) gene is a subunit of the 
ARP complex.  The ARP complex is implicated in the control of actin polymerization 
within cells, which is critical for a variety of cellular processes including cell motility and 
cell-to-cell adhesion (DeMali et al. 2002; Goley and Welch 2006; Pollard and Borisy 
2003; Weiner et al. 1999).  Alterations in a cow’s cell’s ability to migrate and adhere to 
other cells could alter its ability to respond to an infection state since the recruitment of 
neutrophils to the site of infection is heavily dependent on both actions and could 
explain the differences in phenotype observed following our S. uberis challenge.  
Another gene in LD with CXCR1 3’ SNPs rs211042414 and rs208795699 is 
GPBAR1 (g-protein coupled bile acid receptor 1) which is the cell surface receptor for 
bile acids.  Links between GPBAR1 and macrophage function have been established by 
applying agonists where such agonists have resulted in reduced monocyte adhesion to 
endothelial cells and decreased production of pro-inflammatory cytokines shifting 
monocyte conversion to primarily M2 macrophage-like anti-inflammatory cells 
(Högenauer et al. 2014; Kida et al. 2013).  Alterations in monocyte and macrophage 
function in an infection state could alter a cow’s ability to clear an infection and influence 
the intensity of the inflammatory response initiated in response to bacteria presence as 
observed following our S. uberis challenge.   
AAMP (angio-associated migratory cell protein) is another gene in LD with 
CXCR1 3’ SNPs rs211042414 and rs208795699 that is part of the immunoglobulin 
superfamily (Beckner et al. 1995).  AAMP plays a role in the formation of endothelial 
tube formation and is associated with angiogenesis, but can also activate NFĸB 
(Beckner et al. 2002; Beckner and Liotta 1996; Bielig et al. 2009).  NFĸB is a 
transcriptional activator of numerous genes including many that are critical for 
inflammation and immunity (Bonizzi and Karin 2004).  Decreased transcriptional 
activation of genes critical for inflammation and immunity could result in a diminished 
response to bacteria presence and allow for S. uberis continued growth as observed in 
the varying responses to our challenge.   
TMBIM1 (transmembrane BAX inhibitor motif containing 1) is also in LD with 
CXCR1 3’ SNPs rs211042414 and rs208795699 and is associated with extrinsic 
apoptosis regulation and negative regulation of MMP9 (Xu and Reed 1998; Zhao et al. 
2006).  MMP9 is required for macrophage migration necessary for invading pathogen 
elimination (Gong et al. 2008).  Reductions in extrinsic apoptosis and macrophage 
migration could result in a diminished immune response to invading pathogens leading 
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to lower inflammation observed and allowing continued pathogen growth as observed in 
the responses to our S. uberis challenge (Siebert 2013).   
Another gene in LD with CXCR1 3’ SNPs rs211042414 and rs208795699 is 
SLC11A1 (solute carrier family 11 – proton-coupled divalent metal ion transporter).  
SLC11A1 is a member of the proton-coupled divalent metal ion transporters that 
transports iron, zinc, and manganese cations that is localized to late lysosomes and 
endosomes (Goswami et al. 2001; Gruenheid et al. 1997; Searle et al. 1998).  
Additionally, SLC11A1 has been implicated in disease resistance through cation control 
in macrophages which protects macrophages from their own ROS generation and 
sequesters cations that pathogens could use to produce protective enzymes as 
reviewed by Blackwell et al. (2001).  Thus, SLC11A1 could play a role in a cow’s ability 
to properly clear S. uberis following challenge through proper macrophage function.   
The VIL1 (villin 1) gene is also in LD with CXCR1 3’ SNPs rs211042414 and 
rs208795699 and is a calcium regulated actin binding protein within the cytoskeleton 
(Bretscher and Weber 1980).  Expression of VIL1 has been observed in the leading 
edge of lamellipodia implying a regulating role in actin remodeling needed for cell 
migration and it has been demonstrated to regulate apoptosis by maintaining 
mitochondrial integrity (Nusrat et al. 1992; Wang et al. 2008).  Thus, alterations in VIL1 
function could influence the immune response to invading pathogens, specifically the 
ability of immune cells to migrate to the site of infection and survive long enough to 
eliminate the pathogen which could explain the differences we observed post S. uberis 
challenge.   
PLCD4 (phospholipase C delta 4), another gene in LD with CXCR1 3’ SNPs 
rs211042414 and rs208795699, is a member of the delta class of phospholipase C 
enzymes which hydrolyzes PIP2 (phosphatidylinositol 4,5-bisphosphate) to make DAG 
(diacylglycerol) and IP3 (inositol 1,4,5-triphosphate) (Ochocka and Pawelczyk 2003).  
The production of these secondary messengers is the first step of the arachidonic acid 
pathway that is responsible for the production of leukotrienes, thromboxanes, 
prostaglandins, and lipoxins which have an array of roles in inflammation, where 
alterations in their production could result in different responses to invading pathogens.   
The last gene in LD with CXCR1 3’ SNPs rs211042414 and rs208795699 is 
RNF25 (ring finger protein 25) which interacts with the p65 subunit of NFĸB to support 
transcription (Asamitsu et al. 2003).  As discussed with AAMP above, decreased 
transcriptional activation of inflammation and immunity genes could result in diminished 
response to invading bacteria allowing growth to continue as observed in response to 
our S. uberis challenge.  Thus, the identification of the haplotype block surrounding the 
103 
 
bovine CXCR1 gene has provided several potential candidate genes that the CXCR1 3’ 
SNPs rs211042414 and rs208795699 could be serving as markers for and could be 
influencing the phenotypic differences observed following our S. uberis challenge.   
Furthermore, there are an additional 13 genes in this block that are either 
uncharacterized or do not have a documented link to inflammation, immunity, or 
transcriptional regulation that should be further investigated to determine if they could 
play a role in S. uberis pathogenesis.   
Candidate Loci Associated with Antibiotic Therapy Groupings: 
 To determine if there were other genes throughout the bovine genome that could 
be working pleiotropically with our CXCR1 SNPs or the loci in LD with the CXCR1 SNPs 
to cause the phenotypic differences observed following our S. uberis challenge, we 
performed an association analysis.  The phenotype used grouped cows based on both 
CXCR1 haplotype combination and that haplotype combination’s need for antibiotics to 
clear S. uberis from the gland.  This association analysis identified a total of 7 SNPs.  
None of these identified SNPs are within the CXCR1 haplotype blocks discussed above, 
but one SNP (rs43317360) was identified on BTA 2 just 0.28 Mb outside of the CXCR1 
haplotype block 414.  While the identified SNPs themselves may not be causal but 
rather in linkage disequilibrium is the causal variant, they do provide several interesting 
candidate genes based on the genes they are located within.  This SNP (rs43317360) is 
an intron variant in the CRYBA2 (crystallin beta A2) gene.  Crystallins are the major 
structural component of the eye ocular lens but are also implicated in retinal ganglion 
cell axonal regeneration following injury (Piri et al. 2013).  Additionally, another 
crystallin, CRYBB2, has been implicated in promoting neurite activity, demonstrating 
roles in tissues besides eyes (Liedtke et al. 2007).  The possibility exists that CRYBA2 
could play a role in tissue regeneration following injury in other tissues such as the 
mammary gland and contribute to resolving the infection state following S. uberis 
challenge.  This could allow cows to clear the infection more readily leading to the 
demonstration of reduced mammary and milk scores.  Since highly inflammatory 
mammary and milk scores were used as the basis for antibiotic therapy administration, 
and CRYBA2 could help explain the variation observed in antibiotic therapy groupings 
based on CXCR1 haplotype combination following our S. uberis challenge.   
Also of interest, the 3 associated SNPs on BTA 16 (rs41660125, rs41576666, 
rs41596554) are within a productive life QTL (Zhang et al. 1998).  Productive life refers 
to the length of time a cow remains in the herd producing milk, which can be affected 
my many factors including health, fertility, and milk yield (Roxström and Strandberg 
2002).  Cows with phenotypes indicating they can mount an effective immune response 
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to invading pathogens and clear the infection without the aid of antibiotic therapy (i.e.: 
33% antibiotic therapy phenotype; VWHKH x VWHRR cows) would be more likely to be 
retained in the herd, barring other issues, because they would be less labor intensive 
and cost producers less money in treatment then cows with the other phenotypes. 
 In conclusion, this study successfully identified an array of candidate genes that 
could help explain the phenotypic differences observed following S. uberis challenge 
either because they are in LD with the CXCR1 SNPs or because they are associated 
with the antibiotic therapy groupings developed with the cow’s CXCR1 genetic 
backgrounds.  Many of these candidate genes have roles in immunity, inflammation, or 
the regulation of gene expression.  Further investigation of these candidate genes 
should determine their expression levels in the mammary gland and could help identify 
potential preventative or novel treatment compounds for S. uberis mastitis.  Additionally, 
these results could discover better defined or more accurate genetic markers for 
selecting cows with less susceptibility to S. uberis mastitis. 
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Abstract 
 Mastitis, inflammation of the mammary gland, is a devastating disease for the 
dairy industry causing billions in lost revenues annually and decreasing milk quality.  
Due to prevalence and impacts of mastitis, improved prevention and treatment protocols 
are a consistent goal of the industry.  S. uberis is a common mastitis pathogen whose 
growth in milk is influenced by stage of lactation.  The IL-8 receptor, CXCR1, has 
demonstrated importance for mastitis and SNPs within CXCR1 have been associated 
with mastitis and neutrophil migration.  A prior S. uberis intramammary challenge study 
demonstrated Holsteins with different CXCR1 haplotype combinations display varying 
phenotypes with respect to inflammation indicators and S. uberis counts suggesting 
CXCR1 haplotype combination could influence the ability or rate of S. uberis to grow in 
milk and the recruitment of leukocytes to the mammary gland.  To test this, we collected 
aseptic milk samples from cows with differing CXCR1 genetic backgrounds within 7 
days post-calving and inoculated them in vitro with 3 strains of S. uberis.  Additionally, 
leukocyte profiles were evaluated in the aseptic milk samples using the QScout® 
platform to determine if CXCR1 haplotype combination influenced total leukocyte 
recruitment or type of leukocytes recruited to the mammary gland.  Results indicate that 
both CXCR1 haplotype combination and S. uberis strain influence the rate of S. uberis 
in milk (p < 0.0001).  VWHRR x VWHRR milk had the highest rate of S. uberis growth 
(slope = 0.58) and AWQRR x AWQRR milk had the lowest rate of S. uberis growth 
(slope = 0.098).  The highest rate of S. uberis growth was observed from strain UT366 
(slope = 0.58) and the lowest rate of growth was observed from strain UT387 (slope = 
0.17).  CXCR1 haplotype combination did not influence total leukocyte counts or 
percentages of leukocyte subpopulations observed in milk (p > 0.05).  These results 
indicate that both CXCR1 haplotype combination and S. uberis strain virulence 
influence S. uberis growth rate in milk which could indicate that concentration of an 
inhibitory or permissive factor towards S. uberis growth in milk differs depending on cow 
CXCR1 haplotype combination.  Future proteomics studies would be beneficial in 
identifying any potential factors of interest and lead to the development of novel 
preventative or treatment compounds towards S. uberis mastitis.   
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Introduction 
 Mastitis, the inflammation of the mammary gland, is typically caused by bacteria 
invading the mammary gland.  Impacts of mastitis include dramatic decreases in milk 
quality and farm revenues (Fetrow 2000; Klei et al. 1998; Ma et al. 2000).  
Streptococcus uberis is a common mastitis pathogen which is commonly isolated from 
the mammary gland during the non-lactating period and accounts for a high percentage 
of clinical and subclinical mastitis (Bradley et al. 2007; Petrovski et al. 2011; Verbeke et 
al. 2014).  S. uberis originates in the environment of the cow (i.e.: soils), but can be 
passed from cow-to-cow in a contagious manner (Zadoks 2007), making it a large 
proportion of the mastitis problem dairy producers combat.   
 In order for mastitis to occur, invading pathogenic bacteria must be able to 
survive and proliferate within the mammary gland by overcoming the host defenses.  
The host defenses in the mammary gland are numerous and milk contains a variety of 
anti-microbial factors that inhibit pathogen growth (Oliver and Calvinho 1995).  Prior 
work on growth of S. uberis in mammary secretions has focused stage of lactation.  
Periods of intense physiological change demonstrate greater susceptibility to S. uberis 
(Jayarao et al. 1999).  Secretions obtained during any stage of mammary gland 
involution (the period when the mammary gland undergoes shrinkage and tissue 
remodeling after lactation cessation) or the dry (non-lactating) period support S. uberis 
growth better than secretions obtained during lactation (Oliver 1991; Todhunter et al. 
1985).  The differences in growth of S. uberis observed during periods of intense 
physiological change were attributed to concentrations of antimicrobial factors (i.e.: 
lactoperoxidase) and or essential nutrients (i.e.: plasminogen degradation by-products) 
needed for S. uberis growth, where secretions obtained during lactation had more 
antimicrobial factors or less essential nutrients and supported less S. uberis growth 
(Kliem and Hillerton 2002; Leigh 1993; Todhunter et al. 1985).  However, when 
considering only phases when the mammary gland is actively lactating, early lactation 
better permits S. uberis growth than mid or late lactation (Rambeaud et al. 2004).  Early 
lactation being a highly susceptible period for S. uberis mastitis was supported by the 
observation of a 100% infection rate in N=40 Holstein cows in an intramammary 
experimental challenge administered within three days post-calving (Siebert 2013).  
Early lactation supporting S. uberis growth more than mid or late lactation contradicts 
that essential nutrients could be driving differences in S. uberis growth.  Plasminogen 
concentrations increase as lactation progresses meaning more available nutrients to 
promote S. uberis growth, which would dictate more S. uberis growth in later lactation 
not less (Benslimane et al. 1990).  This suggests there is another mechanism that is 
capable of influencing S. uberis growth in milk during lactation. 
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Studies have demonstrated that the IL-8 receptor, CXCR1, plays a critical role in 
the defense of the mammary gland by influencing neutrophil migration, survival, calcium 
signaling, and reactive oxygen species (ROS) generation (Rambeaud et al. 2006; 
Rambeaud and Pighetti 2007; Rambeaud and Pighetti 2005).  Additionally, 
polymorphisms in the CXCR1 gene sequence have been linked to mastitis incidence 
(Galvão et al. 2011; Grosse et al. 1999; Leyva-Baca et al. 2008; Verbeke et al. 2012; 
Youngerman et al. 2004).  A recent S. uberis intramammary challenge study 
demonstrated that Holstein cows (N=40) with different CXCR1 haplotype combinations 
(Pighetti et al. 2012) displayed varying phenotypes with respect to S. uberis counts, 
inflammation indicators, and antibiotic therapies (Siebert 2013).  The differing 
phenotypes observed following intramammary challenge could indicate that a cow’s 
CXCR1 haplotype combination influences the ability or rate of S. uberis to grow in milk 
and/or the recruitment of leukocytes to the mammary gland.  To test this, we collected 
aseptic whole milk from non-infected cows with different CXCR1 haplotype 
combinations and inoculated them with three strains of S. uberis obtained from mastitic 
cows to monitor growth rates for 12 hours in a laboratory setting.  Additionally, leukocyte 
profiles were evaluated in the aseptic milk samples using the QScout® platform to 
determine if CXCR1 haplotype combination influenced total leukocyte recruitment or 
type of leukocytes recruited to the mammary gland.   
Materials and Methods 
Haplotyping 
Blood samples (N=1 for each cow), collected during the dry period via coccygeal 
vein puncture, were obtained from all cows expected to calve at Little River ETREC 
dairy.  Blood was used to isolate DNA with UltraClean BloodSpin DNA Isolation Kit (Mo 
Bio, Carlsbad, CA).  The SNP containing portion of the CXCR1 gene was amplified as 
follows: 1-2 ng of bovine genomic DNA was used as template in a 25 µl reaction 
containing specific primers (Forward: 5’-CTTCATC-TTCCGGTGAGGCCTATCAAC-3’; 
Reverse: 5’-AAGGGAAGGGGACTTTCCTGGCTG-3’) and Eppendorf HotMaster Mix 
(Eppendorf North America; Westbury, NY) according to manufacturer's guidelines.  DNA 
concentration was confirmed via spectrophotometry using NanoDrop 1000 (Thermo 
Fisher Scientific; Wilmington, DE).  Conditions for amplification were:  an initial hot-start 
denaturation at 94oC for 2 min, followed by 50 cycles of 94oC denaturation for 15 s, 
62oC annealing for 20 s, and 72oC extension for 60 s.  After the last cycle, a 10 min final 
extension step at 72oC was added before reactions were chilled to 4oC.  Amplified 
products were purified to remove primer and excess nucleotides.  The resulting purified 
CXCR1 DNA was sequenced using bovine CXCR1 specific primers (Forward: 5’-
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CTTCATC-TTCCGGTGAGGCCTATCAAC-3’; Reverse: 5’-
AAGGGAAGGGGACTTTCCTGGCTG-3’) and the CXCR1 haplotype, comprised of 
positions +365 (rs211042414), +621 (rs135751317), +735 (rs208795699), +980 
(rs43323012), and +995 (rs43323013), was determined based on nucleotide expression 
at tagSNP positions +621 (rs135751317), +735 (rs208795699), +816 (rs210501501), 
and +980 (rs43323012) in the CXCR1 gene previously identified using phasing on a 
larger population (Pighetti et al. 2012; Stephens and Scheet 2005; Stephens et al. 
2001).  Not all haplotypes combinations were enrolled in the study because of infection 
status prior to milk inoculation. 
Milk Sampling and Collection 
 Between two and three days post-calving, aseptic quarter samples were taken 
from each cow.  Samples were kept on ice and transported back to the lab.  One mL of 
each sample was plated on an individual blood agar plate using flame sterilized hockey 
sticks under a sterile hood.  Plates were allowed to completely dry under the hood, then 
inverted and place in an incubator at 37°C, 5%CO2 for 48 hrs.  Cows with two or more 
plates showing no bacteria growth after incubation were chosen to proceed to the milk 
inoculation.  Composite, aseptic, 100 mL inoculation samples were collected between 4 
and 6 days post-calving.  An aliquot of the aseptic milk sample was used to determine 
the types of leukocytes present in milk using two methods.  First, overall somatic cell 
counts (SCC) were determined using a benchtop DeLaval Cell Counter DCC (DeLaval, 
Kansas City, Missouri).  The DeLaval SCC was used as a final screening measure, 
where cows with SCC above 200,000 cells/mL (industry standard division point 
indicating an intramammary infection), were excluded from milk inoculation protocols 
even though their initial microbiology screening two days prior indicated they did not 
have an infection.  Samples that passed the SCC screening were kept on ice and 
transported back to the lab.  Prior to inoculation, samples were partitioned into 4 20mL 
aliquots (1 for each of the 3 strains and a negative) and warmed to 37°C for 30 mins.  
After pre-warming, 1mL of the negative sample was plated on a blood agar plate to 
determine if any infection occurred between screening and inoculation sample collection 
or if contamination occurred. 
Evaluation of Leukocytes in Milk 
The aliquot of the aseptic milk used for inoculation was used to determine the 
types of leukocytes present in the milk using QScout® MLD platform (Advanced Animal 
Diagnostics, Morrisville, NC).  QScout® MLD utilizes special cartridges, where 10μL of 
the milk sample is loaded onto the cartridge which is inserted into the machine.  The 
resulting data includes a total leukocyte count (TLC) which is equivalent to a SCC, as 
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well as counts and percentages for 3 specific leukocyte populations per microliter 
(neutrophils, lymphocytes, and macrophages). 
S. uberis Cultures 
 Frozen stock cultures of 3 strains of S. uberis (UT366, UT387, and UT888) were 
obtained from the Tennessee Quality Milk Lab.  Stocks were used to inoculate 25 mL of 
Todd Hewitt Broth (THB) and cultures were grown at 37°C, 5%CO2 for 24 hrs.  
Resulting cultures were used to make 50μL aliquots that were frozen at -80°C.  One 
fresh aliquot for each strain was used for each inoculation.   
 Two days prior to milk inoculation, the 50μL aliquots are thawed to room 
temperature then plated on a blood agar plate, one plate per strain, using streak 
technique.  Streak plates were grown at 37°C, 5%CO2 for 24 hrs.  After incubation, for 
each strain, a sterile loop was used to select 3 individual colonies and then inoculate a 
pre-warmed, 15mL aliquot of THB which was incubated overnight at 37°C, 5%CO2.  The 
next morning, 3 hours prior to milk inoculation, overnight cultures were removed from 
the incubator, vortexed, and then 500μL were used to inoculate a pre-warmed 5mL THB 
aliquot.  New aliquots were incubated at 37°C, 5%CO2 for 3 hrs, and then serially diluted 
to approximately 1,000 CFU/mL.  Four hundred μL of the diluted culture for each strain 
was then used to inoculate the 20mL, pre-warmed milk aliquot for each cow.  
Additionally, 100μL of the diluted cultures was plated on Todd Hewitt agar (THA) to 
determine actual CFU inoculated for each strain, which was used as the time zero CFU 
for each strain’s growth curve. 
Inoculating Milk with S. uberis 
 The diluted S. uberis culture for each strain (400μL) was added to the 
corresponding pre-warmed 20mL milk sample.  Milk cultures were then vortexed and 
placed in the incubator at 37°C, 5%CO2 for 12 hrs.  At the start of each hour, samples 
were removed from the incubator, vortexed, and 1mL was plated using a flame 
sterilized hockey stick to determine how strain growth progressed.  After time point, milk 
cultures were also serially diluted to ensure colonies were sparse enough to count.  
Inoculated milk samples were plated on THA and the negative sample was plated on 
blood agar.  Plates were allowed to dry completely in the hood, inverted, and then 
placed in an incubator at 37°C, 5%CO2.  After 48 hrs of incubation, plates were 
removed and colonies of S. uberis were counted and used to determine total CFU 
present in milk at each time point for each strain. 
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Statistical Analysis 
 A mixed model analysis of variance tested the fixed effects of CXCR1 haplotype 
combination, strain, and time and their interactions.  The random effect of cow nested 
within CXCR1 haplotype combination was also included to account for unknown 
variation that an individual’s background and physiology may have introduced into the 
model.  Time was declared as repeated measures since time point samples were 
collected from the same inoculated milk sample.  Missing time points were due to 
colonies on plates being too numerous to count or because plate contamination was 
observed that made counting colonies of S. uberis impossible.  Time points 7, 11, and 
12 were removed due to > 50% missing data points.  The same model was also used to 
determine if slopes of S. uberis growth over time differed between CXCR1 haplotype 
combinations and strains of S. uberis by including significant interaction terms as fixed 
effects directly.  Data was log10 transformed in order to maintain normality.  Additionally, 
QScout® MLD data was utilized to determine if leukocyte populations differed 
dependent on CXCR1 haplotype combination, where the model tested the fixed effect of 
CXCR1 haplotype combination only, but still included the random effect of cow nested 
within CXCR1 haplotype combination to account for unknown variation that an 
individual’s background and physiology may have introduced.  Analyses were 
performed in SAS (v 9.4, Cary, NC) where significance was declared at p < 0.05, and a 
trend was declared at p = 0.05 to p = 0.1. 
Results 
 The dominant haplotype combination of the inoculated cows was AWQRR x 
VWHRR, which represented 42.9% of cows.  The second most frequent haplotype was 
homozygous AWQRR representing 33.3% of cows.  The remaining two haplotype 
combinations (VWHRR x VWHRR, VWHKH x VWHRR) represented much smaller 
percentages of the inoculated cows (Table 7).  Cows with haplotype combination 
VWHKH x AWQRR were not observed. 
 S. uberis growth was significantly influenced by strain (p < 0.0001) (Figure 19). 
Strain 888 grew the most (200.1 ± 178.5) but was statistically similar to strain 366 (70.8 
± 61.4 CFU).  Strain 366 was also similar to strain 387 (11.7 ± 10.2 CFU).  All strains 
were statistically unique from the negative (0.07 ± 0.06 CFU).  Additionally, the 
interaction of strain and time was significant (p < 0.0001) indicating the rate of growth 
over time differed across the strains (Figure 20).  Strain 366 had the greatest slope, 
0.58 CFU/hr. indicating the quickest rate of growth over time.  Strain 888 had the 
second largest slope, 0.31 CFU/hr., followed by strain 387 with a slope of 0.17 CFU/hr.  
The smallest slope was observed by the negative, and it actually showed a decrease in 
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Table 7: Frequency of haplotype combinations observed in cows whose milk was 
inoculated with the 3 strains of S. uberis. 
Haplotype Combination Frequency Percent 
VWHRR x VWHRR 2 9.5 
VWHKH x VWHRR 3 14.3 
AWQRR x VWHRR 9 42.9 
AWQRR x AWQRR 7 33.3 
Total 21 100 
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Figure 19: Growth of three strains of S. uberis, represented as back transformed least 
squares means from log10, in aseptic whole milk obtained from Holstein cows within 7 
days post-calving.  Letters above the bars indicated means that differ (p < 0.0001). 
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Figure 20: The effect of S. uberis strain on growth over time in aseptic whole milk 
obtained from Holstein cows within 7 days post-calving.  All slopes differed from each 
other significantly over time (p < 0.0001). 
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growth over time with a slope of -0.16. 
S. uberis growth was not influenced by haplotype combination (p = 0.668), nor 
was a strain by haplotype combination interaction observed (p = 7879).  However, the 
interaction of haplotype combination and time was significant (p < 0.0001) indicating the 
rate of S. uberis growth over time differed across haplotype combinations (Figure 21).  
VWHRR x VWHRR milk samples grew the fastest with a slope of 0.58 CFU/hr.  
AWQRR x AWQRR milk samples grew the slowest with a slope of only 0.098 CFU/hr.  
VWHKH x VWHRR and AWQRR x VWHRR milk samples had intermediate slopes at 
0.41 and 0.21 CFU/hr. respectively. 
Haplotype combination did not influence total leukocyte counts collected using 
the QScout® MLD platform (p = 0.6424) (Figure 22).  Haplotype combination also did 
not influence the percentages of neutrophils (p = 0.1509), lymphocytes (p = 0.7863), or 
macrophages (p = 0.4903) observed in the aseptic milk collected (Figure 23).  However, 
for all haplotype combinations, neutrophils were the majority of leukocytes present (60-
50%) with lymphocytes and macrophages each representing smaller fractions (15-30% 
each) (Figure 23). 
Discussion 
The present study determined that CXCR1 haplotype combination influences the 
rate that S. uberis growth in whole milk.  These results are consistent with results from 
our prior S. uberis intramammary challenge study that demonstrated cows with differing 
CXCR1 haplotype combinations showed differing S. uberis CFU in the gland post-
challenge (Siebert 2013).  The VWHRR x VWHRR displayed the highest overall S. 
uberis CFU in the challenge study and had the highest rate of S. uberis growth in the 
present study suggesting S. uberis most easily grows in VWHRR x VWHRR milk.  The 
challenge study identified AQWRR x VWHRR as the haplotype combination with the 
least amount of S. uberis growth and in the present study this combination had the 
second smallest rate of S. uberis growth in milk.  Combined this suggests that the 
AWQRR allele better permits S. uberis growth than the VWHRR allele.  This is further 
confirmed by the AWQRR x AWQRR milk displaying the overall lowest S. uberis rate of 
growth in the present study.  The VWHKH x VWHRR milk displayed an intermediate 
rate of S. uberis growth in the present study and had overall S. uberis CFU similar to all 
other haplotype combination in the challenge study suggesting the VWHKH allele 
supports growth of S. uberis better than AWQRR but not as well as VWHRR.   
 The differences in S. uberis growth based on CXCR1 haplotype combination 
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Figure 21: The effect of haplotype combination on S. uberis growth over time in aseptic 
whole milk obtained from Holstein cows within 7 days post-calving.  All slopes differed 
from each other significantly over time (p < 0.0001). 
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Figure 22: Total leukocyte counts observed for each haplotype combination based on 
QScout analysis performed on aseptic whole milk obtained from Holstein cows within 7 
days post-calving.  Haplotype combination did not influence total leukocyte counts p = 
6424. 
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Figure 23: Percentages of leukocyte sub-populations observed for each haplotype 
combination based on QScout analysis performed on aseptic whole milk obtained from 
Holstein cows within 7 days post-calving.  Haplotype combination did not influence the 
percentages of neutrophils (p = 0.1509), lymphocytes (p = 0.7863), or macrophages (p 
= 0.4903) observed. 
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could be due to differences in neutrophil ability.  The middle position of the haplotype 
(amino acid position 245, SNP 735, rs208795699) is associated with the ability of 
neutrophils to migrate and survive as well as internal calcium signaling and reactive 
oxygen species (ROS) generation (Rambeaud et al. 2006; Rambeaud and Pighetti 
2007; Rambeaud and Pighetti 2005).  Where VWHRR x VWHRR cows would be less 
capable of recruiting neutrophils to the site of infection and have better killing ability 
compared to AWQRR x AWQRR cows.  However, the QScout® MLD analysis 
conducted in the present study did not show that the percentages of neutrophils differed 
across haplotype combinations.  Furthermore, S. uberis has demonstrated the ability to 
evade neutrophil killing in vitro, but is effectively killed by macrophages suggesting the 
percentage of macrophages could be more important for S. uberis clearance from the 
mammary gland (Oliver et al. 1998a).  But the present study also demonstrated that the 
percentage of macrophages present in milk did not differ based on haplotype 
combination, suggesting other mechanisms may be at work.  Of interest, since the 
present study was conducted in vitro where introduction of S. uberis occurred once milk 
was removed from the cow, differences in S. uberis clearance by neutrophils and 
macrophages would rely on leukocytes present in the milk at the time of collection since 
the ability to recruit more leukocytes is irrelevant. 
Variation in proteomic profiles of milk could influence a cow’s ability to clear S. 
uberis from the mammary gland.  Proteomics studies of bovine milk and its fractions 
(i.e.: exosomes, whey, milk fat globule membranes) have identified many components 
that can influence the immune response to invading pathogens (Ibeagha-Awemu et al. 
2010; Reinhardt and Lippolis 2006; Reinhardt and Lippolis 2008; Reinhardt et al. 2012; 
Reinhardt et al. 2013; Smolenski et al. 2014).  Milk fat globule membranes and 
exosome milk fractions contain immune components that are essential for the detection 
of infection and for proper immune response to infection (Reinhardt and Lippolis 2006; 
Reinhardt et al. 2012).  Additionally, following Staphylococcus aureus infection, there is 
an increase in the components of neutrophil NETs seen in milk fat globule membranes 
(Reinhardt et al. 2013).  Neutrophil NETs function to trap and bacteria to prevent further 
pathogenesis (Brinkmann et al. 2004).  Thus, alterations in concentration of any of 
these immune components could influence the growth of S. uberis in milk.  If levels of 
these components essential for fighting off invading pathogens differ based on CXCR1 
haplotype combination, they could explain the differences in S. uberis growth rate 
observed in the present study.  Of note, while these results may prove relevant for the 
results we observed, they were reported based on individual milk fractions whereas our 
study was conducted using whole milk.  Thus, the interactions between all the different 
fractions and their components could have an effect on the ability of S. uberis to grow.  
Also of interest, a prior study suggested that plasminogen concentration could influence 
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growth rate of S. uberis because its degradation is essential for S. uberis to get the 
essential nutrients it needs for growth (Kliem and Hillerton 2002).  If plasminogen, or 
other S. uberis nutrient sources, vary with CXCR1 haplotype combination, haplotype 
combinations with higher nutrient source concentrations would better permit S. uberis 
growth. 
The present study also observed differences in the ability and rate of S. uberis 
growth based on S. uberis strain.  These findings were consistent with prior findings by 
Rambeaud et al. (2004) and are likely due to differences in virulence between S. uberis 
strains.  Both UT366 and UT888 demonstrated the two highest overall S. uberis growth 
in the present study and are known to cause clinical mastitis.  Strain UT366 is 
associated with the rapid onset of acute clinical systemic symptoms (Doane et al. 1987) 
which is supported by its steep rate of S. uberis growth in the present study.  The 
UT888 strain is associated with milder clinical mastitis and a lag in S. uberis growth 
while it adapts to the mammary gland environment (Oliver et al. 2003; Rambeaud et al. 
2003) which is supported by its rate of S. uberis growth in the present study being lower 
than UT366 but higher than UT387.  Furthermore, both UT366 and UT888 have 
demonstrated the ability to internalize into host cells via binding lactoferrin, a common 
milk protein, and exploiting caveolae mediated endocytosis (Almeida et al. 2010).  
However, UT888 has enhanced ability to bind lactoferrin and has higher transcytosis 
when compared to UT366 (Almeida et al. 2010), suggesting UT888 has a better ability 
to internalize and hide from the immune system than UT366.  Better ability to internalize 
and hide from the immune system would facilitate lower growth observed in milk as 
observed in the present study and the ability of UT888 infections to sometimes persist 
for more than one lactation (Oliver et al. 1998b).  UT387 displays the lowest rate of S. 
uberis growth in the present study likely because it expresses a capsule making growth 
and proliferation more time intensive than the other two strains studied which do not 
express capsules. 
 In conclusion, this study provides evidence that S. uberis growth in milk during 
early lactation is influenced by both the cow CXCR1 haplotype combination and S. 
uberis strain virulence.  This could indicate that the concentration of an inhibitory or 
permissive factor towards S. uberis growth in milk differs depending on cow CXCR1 
45haplotype combination.  Conducting a proteomics survey of milk from cows with 
differing CXCR1 haplotype combinations could identify any potential compounds of 
interest and lead to the development of novel preventative or treatment compounds 
towards S. uberis mastitis.  
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The objective of this dissertation was to identify genetic associations with unique 
mastitis phenotypes developed using data from an experimental intramammary S. 
uberis challenge.  Data collected following challenge included somatic cell counts 
(SCC), S. uberis CFU, mammary scores, milk scores, and antibiotic therapy use 
(Siebert 2013), which were used to develop 10 novel phenotypes directly related to S. 
uberis mastitis.  Association analyses for these novel phenotypes identified 17 SNPs 
that are within previously identified quantitative trait loci (QTLs) for mastitis or 
phenotypes with links to mastitis (i.e.: productive life, milk yield).  Identifying 
associations with SNPs in regions with prior evidence linked to mastitis helps establish 
the validity of using our novel phenotypes in response to direct, experimental S. uberis 
challenge for GWAS.  Furthermore, genomic studies with pathogen specificity have 
been limited (Sørensen et al. 2008), which has limited the identification of candidate loci 
with functions linked to individual pathogens, a gap our S. uberis specific study may 
help fill.  Additionally, because we identified SNPs in regions with prior evidence for 
mastitis or related phenotypes that were not pathogen specific, these SNPs could also 
be associated with other causative pathogens.  Besides SNPs in regions with prior 
evidence, our novel phenotypes were associated an additional 35 SNPs across the 
bovine genome.   
Identified SNPs have provided an array of candidate genes whose functions 
could be linked to the variation in phenotypes observed following S. uberis 
intramammary experimental challenge.  We identified a total of 23 possible candidate 
genes where the majority of identified candidate genes fall into one of two categories: 
inflammation/immune response or gene expression regulation.  Once bacteria invade 
the mammary gland and are recognized by host cells, inflammation is initiated.  
Inflammatory cytokines/chemokines then initiate the immune response.  The immune 
response is controlled by many aspects, but a key regulator is gene transcription, where 
bacterial recognition and pro-inflammatory cytokines induce the transcription of other 
genes needed for a proper immune response.  Therefore, candidate genes associated 
with these processes are critical to a cow’s ability to combat invading pathogens within 
the mammary gland such as S. uberis.   
Of particular interest are two candidate genes: TIAM2 (t-cell invasion and 
metastasis-2) identified with the SCC cure phenotype and TRAPPC9 (trafficking protein 
particle complex 9) identified with the severity score phenotype.  TIAM2 is a guanine 
nucleotide exchange factor that functions within small GTPases that has been 
implicated in cell invasion, migration, adhesion, and apoptosis in cancers (Chen et al. 
2012; Rooney et al. 2010).  Since TIAM2 was identified with the SCC cure phenotype, 
which grouped cows based on how long post-challenge their SCC returned to a healthy 
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level indicating clearance of infection, TIAM2 could play a role in ensuring cells migrate 
to the site of infection efficiently following inflection allowing for fast resolution of 
infection.  TRAPPC9 plays a role in phosphorylating the IKK complex which controls 
activation of NFĸB (Hu et al. 2005).  NFĸB is a transcriptional activator of many genes 
including many that are critical for inflammation and immunity including pro-
inflammatory cytokine/chemokine production and adhesion molecule expression 
(Bonizzi and Karin 2004).  TRAPPC9 was identified as associated with the severity 
score phenotype which summed milk and mammary score for the first 7 days post-
challenge.  Cows with higher severity scores would have demonstrated more 
inflammation following challenge indicating a strong immune response and strong 
activation of NFĸB.  Further support of this is that a QTL for SCS was identified in this 
same region (Kaupe et al. 2007).  Strong activation of NFĸB would likely result in better 
recruitment of SCC to the infection site because of increased cytokine and adhesion 
molecule expression. 
Furthermore, prior studies have identified CXCR1 as a gene important for 
mastitis (Rambeaud et al. 2006; Rambeaud and Pighetti 2007; Rambeaud and Pighetti 
2005; Siebert 2013; Youngerman et al. 2004a; Youngerman et al. 2004b).  Additionally, 
CXCR1 genetic background has been demonstrated to influence cow response to S. 
uberis intramammary challenge (Siebert 2013).  However, observed variation in 
response to challenge could be attributed to other genes in LD with CXCR1.  We 
identified the haplotype block surrounding the CXCR1 gene to identify other genes in 
LD with the polymorphisms in CXCR1 that are potential candidate genes.  Linkage 
analysis identified that the CXCR1 SNPs are part of 2 separate haplotype blocks which 
also contain 21 candidate genes.   
Of particular interest of the candidate genes identified from linkage analysis is the 
SLC11A1 (solute carrier family 11 – proton-coupled divalent metal ion transporter; 
NRAMP1) located from 107,114,929 – 107,125,854 bp on BTA 2.  SLC11A1 is a 
member of the proton-coupled divalent metal ion transporters that transports iron, zinc, 
and manganese cations that is localized to late lysosomes and endosomes (Goswami 
et al. 2001; Gruenheid et al. 1997; Searle et al. 1998).  Additionally, SLC11A1 has been 
implicated in disease resistance through cation control in macrophages which protects 
macrophages from their own ROS generation and sequesters cations that pathogens 
could use to produce protective enzymes as reviewed by Blackwell et al. (2001).  
Proper macrophage function and killing ability are particularly important for S. uberis 
infections S. uberis evades neutrophils, which are the primary phagocytic cell present 
following infection of the mammary gland (Oliver et al. 1998).  Furthermore, SLC11A1 
has been associated with resistance to intracellular pathogens by prohibiting their 
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replication and S. uberis has the ability to internalize into host cells (Almeida et al. 2000; 
Gruenheid et al. 1997; Tamilselvam et al. 2006).  Thus, SLC11A1 could play a role in a 
cow’s ability to properly clear S. uberis following challenge. 
Lastly, we demonstrated that CXCR1 haplotype combination influences the rate 
of S. uberis growth in milk in vitro.  Where VWHRR x VWHRR milk supported S. uberis 
growth the most and AWQRR x AWQRR milk supported S. uberis growth the least 
regardless of S. uberis strain used for inoculation.  These two haplotype combinations 
differ only at positions 365 and 735 which are the positons demonstrated to be in LD 
with SLC11A1.  This provides further support that SLC11A1 could be a valid candidate 
gene for explaining variation in responses following S. uberis intramammary challenge 
and that variation in divalent metal ions, which are controlled by SLC11A1, may 
influence the growth rate of S. uberis in milk. 
Overall, we have identified many candidate genes, whose functions are primarily 
linked to inflammation/immunity and gene regulation.  We also have identified that S. 
uberis growth rate in milk differs depending on the CXCR1 haplotype combination 
expressed by the cow, suggesting concentration of an inhibitory or permissive factor 
towards S. uberis growth differs with CXCR1 haplotype combination.  Considered 
together, our results imply that variation in one of the identified candidate genes could 
be influencing the rate of S. uberis growth and thus S. uberis mastitis.  Furthermore, 
using pathogen specific phenotypes like those generated here could provide an ideal 
method for identifying host genes involved in mediating the virulence of S. uberis which 
we also demonstrated to be an important factor in the rate of S. uberis growth in milk.  
Further investigation of identified candidate genes could lead to the establishment of 
more effective or better defined genetic selection methods or uncover novel 
preventative or treatment compounds that could be used against S. uberis mastitis. 
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Table A- 1: Comprehensive list of SNPs identified using novel phenotypes with distance 
to neighboring SNPs and genotype frequencies indicated.  Final column indicates status 
of the SNP following SNP pruning based on minor allele frequencies. 
SNP (rs) 
Locus 
(Chr: bp) 
Dist. to 
3'SNP 
(bp) 
Dist. To 
5' SNP 
(bp) 
# 
Genotypes 
Genotypes 
Freqs. 
# Missing 
Missing 
Freq. 
Status 
rs43273037 1: 134,069,561 38,757 20,683 
GG: 7 
GT: 16 
TT: 0 
GG: 0.30 
GT: 0.70 
TT: 0.0 
17 0.43 Keep 
rs110974478 1: 150,141,293 26,075 27,008 
AA: 0 
AG: 4 
GG: 36 
AA: 0.0 
AG: 0.10 
GG: 0.90 
0 0.00 Keep 
rs43224998 1: 34,903,570 39,073 30,946 
AA: 25 
AG: 14 
GG: 1 
AA: 0.63 
AG: 0.35 
GG: 0.03 
0 0.00 Keep 
rs43317360 2: 107,657,675 40,772 24,025 
AA: 22 
AC: 17 
CC: 0 
AA: 0.56 
AC: 0.44 
CC: 0.00 
1 0.03 Keep 
rs41644229 2: 107,681,700 24,025 24,019 
CC: 17 
CT: 17 
TT: 1 
CC: 0.49 
CT: 0.49 
TT: 0.02 
5 0.13 Keep 
rs41645172 2: 109,778,246 37,402 34,097 
AA: 22 
AG: 18 
GG: 0 
AA: 0.55 
AG: 0.45 
GG: 0.0 
0 0.00 Keep 
rs41619984 2: 132,148,018 54,001 22,137 
AA: 39 
AC: 1 
CC: 0 
AA: 0.97 
AC: 0.03 
CC: 0.0 
0 0.00 Remove 
rs110345656 2: 133,861,562 44,754 27,677 
AA: 0 
AG: 1 
GG: 39 
AA: 0.0 
AG: 0.03 
GG: 0.97 
0 0.00 Remove 
rs41637469 2: 132,404,449 118,720 22,533 
AA: 0 
AG: 1 
GG: 37 
AA: 0.0 
AG: 0.03 
GG: 0.97 
2 0.05 Remove 
rs43499732 3: 6,480,313 36,955 30,339 
GG: 3 
GT: 6 
TT: 29 
GG: 0.08 
GT: 0.16 
TT: 0.76 
2 0.05 Keep 
rs109880729 3: 27,600,325 45,685 41,976 
CC: 0 
CT: 2 
TT: 38 
CC: 0.0 
CT: 0.05 
TT: 0.95 
0 0.00 Keep 
rs109513885 3: 34,263,481 35,397 21,762 
CC: 4 
CT: 20 
TT: 15 
CC: 0.10 
CT: 0.51 
TT: 0.39 
1 0.03 Keep 
rs43709346 3: 74,836,184 91,656 61,282 
AA: 39 
AG: 1 
GG: 0 
AA: 0.97 
AG: 0.03 
GG: 0.0 
0 0.00 Keep 
rs43352862 3: 89,649,212 27,834 26,390 
GG: 33 
GT: 1 
TT: 0 
GG: 0.97 
GT: 0.03 
TT: 0.00 
6 0.15 Remove 
rs43161729 3: 91,379,427 26,464 22,825 
GG: 38 
GT: 1 
TT: 0 
GG: 0.97 
GT: 0.03 
TT: 0.00 
1 0.03 Remove 
rs41615858 3: 91,402,252 22,825 31,407 
CC: 39 
CG: 1 
GG: 0 
CC: 0.97 
CG: 0.03 
GG: 0.0 
0 0.00 Remove 
rs41677930 3: 93,543,745 20,056 45,499 
CC: 39 
CT: 1 
TT: 0 
CC: 0.97 
CT: 0.03 
TT: 0.0 
0 0.00 Remove 
rs41630751 3: 93,589,244 45,499 58,424 
AA: 39 
AC: 1 
CC: 0 
AA: 0.97 
AC: 0.03 
CC: 0.0 
0 0.00 Remove 
rs43715308 3: 115,115,735 22,332 25,008 
GG: 0 
GT: 1 
TT: 39 
GG: 0.0 
GT: 0.03 
TT: 0.97 
0 0.00 Remove 
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Table A- 1: Continued 
SNP (rs) 
Locus 
(Chr: bp) 
Dist. to 
3'SNP 
(bp) 
Dist. To 
5' SNP 
(bp) 
# 
Genotypes 
Genotypes 
Freqs. 
# Missing 
Missing 
Freq. 
Status 
rs109567359 3: 116,110,288 48,493 21,672 
CC: 31 
CT: 1 
TT: 0 
CC: 0.97 
CT: 0.03 
TT: 0.0 
8 0.20 Remove 
rs41576873 4: 92,742,789 37,598 22,337 
AA: 16 
AG: 18 
GG: 3 
AA: 0.43 
AG: 0.49 
GG: 0.08 
3 0.08 Keep 
rs43423752 5: 2,925,015 79,943 43,556 
CC: 39 
CT: 1 
TT: 0 
CC: 0.97 
CT: 0.03 
TT: 0.0 
0 0.00 Keep 
rs41655875 5: 26,621,180 59,518 39,863 
CC: 0 
CT: 2 
TT: 24 
CC: 0.00 
CT: 0.08 
TT: 0.92 
14 0.35 Keep 
rs41612889 7: 107,527,276 26,324 74,705 
CC: 4 
CT: 18 
TT: 9 
CC: 0.13 
CT: 0.58 
TT: 0.29 
9 0.23 Keep 
rs110556992 7: 65,047,126 36,604 24,768 
CC: 10 
CT: 20 
TT: 4 
CC: 0.29 
CT: 0.59 
TT: 0.12 
6 0.15 Keep 
rs109792349 8: 8,618,532 78,759 33,274 
AA: 17 
AT: 16 
TT: 5 
AA: 0.45 
AT: 0.42 
TT: 0.13 
2 0.05 Keep 
rs42488893 8: 19,967,642 26,627 51,187 
CC: 12 
CT: 16 
TT: 1 
CC: 0.41 
CT: 0.55 
TT: 0.04 
11 0.28 Keep 
rs41665257 9: 4,581,947 33,954 33,076 
CC: 0 
CT: 3 
TT: 32 
CC: 0.0 
CT: 0.09 
TT: 0.91 
5 0.13 Keep 
rs41594141 9: 73,368,179 27,358 49,534 
AA: 14 
AG: 22 
GG: 2 
AA: 0.37 
AG: 0.58 
GG: 0.05 
2 0.05 Keep 
rs109484182 9: 93,183,596 39,525 30,067 
AA: 9 
AG: 18 
GG: 8 
AA: 0.26 
AG: 0.51 
GG: 0.23 
5 0.13 Keep 
rs110216702 9: 100,163,987 25,797 140,058 
AA: 27 
AG: 12 
GG: 0 
AA: 0.69 
AG: 0.31 
GG: 0.00 
1 0.03 Keep 
rs41903759 10: 68,693,555 25,657 28,870 
GG: 0 
GT: 1 
TT: 37 
GG: 0.0 
GT: 0.03 
TT: 0.97 
2 0.05 Remove 
rs109629398 10: 74,011,076 31,092 21,743 
AA: 39 
AG: 1 
GG: 0 
AA: 0.98 
AG: 0.02 
GG: 0.0 
0 0.00 Remove 
rs41610542 11: 7,625,345 39,598 46,097 
AA: 28 
AG: 10 
GG: 1 
AA: 0.72 
AG: 0.26 
GG: 0.02 
1 0.03 Keep 
rs110866336 12: 77,746,796 51,412 69,844 
AA: 28 
AG: 11 
GG: 0 
AA: 0.72 
AG: 0.28 
GG: 0.0 
1 0.03 Keep 
rs109788678 13: 11,784,421 51,340 47,059 
CC: 22 
CT: 11 
TT: 5 
CC: 0.58 
CT: 0.29 
TT: 0.13 
2 0.05 Keep 
rs41565622 13: 24,688,809 43,157 43,307 
AA: 9 
AG: 25 
GG: 5 
AA: 0.23 
AG: 0.64 
GG: 0.13 
1 0.03 Keep 
rs110804434 13: 78,901,415 43,289 26,890 
AA: 0 
AG: 7 
GG: 3 
AA: 0.0 
AG: 0.70 
GG: 0.30 
30 0.75 Keep 
rs110199901 14: 2,524,432 32,876 29,093 
AA: 10 
AG: 17 
GG: 12 
AA: 0.25 
AG: 0.44 
GG: 0.31 
1 0.03 Keep 
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Table A- 1: Continued 
SNP (rs) 
Locus 
(Chr: bp) 
Dist. to 
3'SNP 
(bp) 
Dist. To 
5' SNP 
(bp) 
# 
Genotypes 
Genotypes 
Freqs. 
# Missing 
Missing 
Freq. 
Status 
rs55617160 14: 4,468,478 30,211 25,426 
AA: 3 
AG: 18 
GG: 14 
AA: 0.09 
AG: 0.51 
GG: 0.40 
5 0.13 Keep 
rs109427689 15: 25,622,211 86,644 47,186 
AA: 4 
AC: 25 
CC: 4 
AA: 0.11 
AC: 0.78 
CC: 0.11 
7 0.18 Keep 
rs41576666 16: 9,941,492 57,705 39,509 
CC: 19 
CT: 12 
TT: 8 
CC: 0.49 
CT: 0.31 
TT: 0.20 
1 0.03 Keep 
rs41660125 16: 10,389,306 30,896 36,406 
AA: 5 
AG: 20 
GG: 11 
AA: 0.14 
AG: 0.56 
GG: 0.30 
4 0.10 Keep 
rs41596554 16: 10,740,538 37,074 30,430 
GG: 7 
GT: 18 
TT: 7 
GG: 0.22 
GT: 0.56 
TT: 0.22 
8 0.20 Keep 
rs41803475 16: 34,994,367 30,219 29,812 
CC: 39 
CT: 1 
TT: 0 
CC: 0.97 
CT: 0.03 
TT: 0.0 
0 0.00 Remove 
rs29019936 17: 562,366 86,303 85,971 
CC: 2 
CT: 26 
TT: 8 
CC: 0.06 
CT: 0.72 
TT: 0.22 
4 0.10 Keep 
rs41831243 17: 5,221,649 30,026 25,007 
CC: 0 
CT: 3 
TT: 32 
CC: 0.0 
CT: 0.09 
TT: 0.91 
5 0.13 Keep 
rs41570578 17: 64,142,204 92,914 22,597 
GG: 20 
GT: 10 
TT: 3 
GG: 0.60 
GT: 0.31 
TT: 0.09 
7 0.18 Keep 
rs29015249 18: 24,862,274 79,879 35,464 
CC: 1 
CT: 20 
TT: 17 
CC: 0.03 
CT: 0.52 
TT: 0.45 
2 0.05 Keep 
rs109290019 18: 53,260,898 36,260 21,033 
AA: 14 
AG: 18 
GG: 6 
AA: 0.37 
AG: 0.47 
GG: 0.16 
2 0.05 Keep 
rs109070561 18: 53,281,931 21,033 26,408 
AA: 6 
AG: 20 
GG: 11 
AA: 0.16 
AG: 0.54 
GG: 0.30 
3 0.08 Keep 
rs109243453 20: 58,928,800 63,912 22,186 
AA: 6 
AG: 16 
GG: 17 
AA: 0.15 
AG: 0.41 
GG: 0.44 
1 0.03 Keep 
rs41951389 20: 59,627,852 28,119 36,539 
CC: 6 
CT: 19 
TT: 14 
CC: 0.15 
CT: 0.49 
TT: 0.36 
1 0.03 Keep 
rs109961240 20: 63,407,185 27,332 27,944 
AA: 3 
AG: 14 
GG: 22 
AA: 0.08 
AG: 0.36 
GG: 0.56 
1 0.03 Keep 
rs111021268 21: 23,530,389 44,067 81,952 
CC: 38 
CT: 2 
TT: 0 
CC: 0.95 
CT: 0.05 
TT: 0.0 
0 0.00 Keep 
rs42651398 21: 39,716,280 56,906 42,242 
CC: 0 
CT: 27 
TT: 1 
CC: 0.0 
CT: 0.96 
TT: 0.04 
12 0.30 Keep 
rs109417302 21: 58,323,035 23,590 86,031 
GG: 19 
GT: 1 
TT: 0 
GG: 0.95 
GT: 0.05 
TT: 0.0 
20 0.50 Remove 
rs110942101 22: 7,385,040 71,997 35,676 
GG: 0 
GT: 3 
TT: 37 
GG: 0.0 
GT: 0.08 
TT: 0.92 
0 0.00 Keep 
rs109747337 22: 58,790,629 42,027 25,750 
AA: 37 
AG: 3 
GG: 0 
AA: 0.93 
AG: 0.07 
GG: 0.0 
0 0.00 Keep 
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Table A- 1: Continued 
SNP (rs) 
Locus 
(Chr: bp) 
Dist. to 
3'SNP 
(bp) 
Dist. To 
5' SNP 
(bp) 
# 
Genotypes 
Genotypes 
Freqs. 
# Missing 
Missing 
Freq. 
Status 
rs109473352 22: 59,325,992 48,161 33,959 
CC: 0 
CT: 1 
TT: 39 
CC: 0.0 
CT: 0.03 
TT: 0.97 
0 0.00 Remove 
rs110693161 24: 48,872,488 87,497 27,307 
AA: 2 
AG: 7 
GG: 30 
AA: 0.05 
AG: 0.18 
GG: 0.77 
1 0.03 Keep 
rs110747207 26: 50,933,887 56,392 19,618 
AA: 0 
AG: 8 
GG: 31 
AA: 0.0 
AG: 0.21 
GG: 0.79 
1 0.03 Keep 
rs110599808 28: 247,173 37,280 61,632 
AA: 4 
AG: 23 
GG: 13 
AA: 0.10 
AG: 0.58 
GG: 0.32 
0 0.00 Keep 
rs41612729 28: 5,052,476 46,198 70,546 
AA: 12 
AG: 23 
GG: 4 
AA: 0.31 
AG: 0.59 
GG: 0.10 
1 0.03 Keep 
rs110196308 28: 7,899,978 21,253 40,207 
AA: 0 
AG: 1 
GG: 39 
AA: 0.0 
AG: 0.03 
GG: 0.97 
0 0.00 Remove 
rs41653441 28: 28,149,081 50,031 36,613 
CC: 8 
CT: 18 
TT: 7 
CC: 0.24 
CT: 0.55 
TT: 0.21 
7 0.18 Keep 
 
  
140 
 
Vita 
Lydia Jean Siebert was born on July 13, 1988, in Baltimore, Maryland.  She 
graduated class salutatorian from Harford Technical High School in Bel Air, Maryland, in 
2006.  After high school she attended the University of Tennessee, Knoxville, where she 
majored in microbiology and earned her Bachelor of Science degree, cum laude in 
Biology in December of 2010.  She pursued her graduate education under the guidance 
of Dr. Gina Pighetti in Animal Science at the University of Tennessee, Knoxville.   Her 
Master of Science degree entitled “Bovine mammary interleukin-8 receptor expression 
and genetic association with Streptococcus uberis based mastitis” was completed in 
December 2013.  She continued to focus on mastitis for her Doctorate degree and 
completed her dissertation titled “Identifying associations with unique mastitis 
phenotypes in response to intramammary Streptococcus uberis challenge” in May of 
2017. 
 
 
